data_1azh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1azh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.4 -74.06 1.17 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.957 0.789 . . . . 0.0 114.597 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.87 117.14 7.13 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -83.9 -55.0 4.47 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 125.09 1.356 . . . . 0.0 111.801 149.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.5 167.42 21.98 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 125.792 1.663 . . . . 0.0 116.511 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 -119.03 1.85 Allowed Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.061 1.185 . . . . 0.0 116.061 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.72 85.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 125.975 1.71 . . . . 0.0 113.111 -166.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.15 36.05 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 126.047 1.784 . . . . 0.0 115.803 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.69 148.97 23.31 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 t -174.51 -55.59 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.382 1.873 . . . . 0.0 111.6 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.06 152.01 4.22 Favored Glycine 0 CA--C 1.55 2.232 0 C-N-CA 124.051 0.834 . . . . 0.0 114.269 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.97 71.31 5.03 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.359 2.706 . . . . 0.0 113.255 -167.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -75.37 43.0 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.562 1.545 . . . . 0.0 112.744 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.9 93.74 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -148.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.35 158.51 20.29 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.886 -1.133 . . . . 0.0 111.761 148.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.42 -179.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.3 m -51.49 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 129.302 3.041 . . . . 0.0 117.081 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -39.15 34.76 Favored Glycine 0 CA--C 1.545 1.942 0 C-N-CA 123.695 0.664 . . . . 0.0 114.331 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.269 0.5 OUTLIER 64.93 -49.46 0.34 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.3 2.64 . . . . 0.0 114.862 -175.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 p -92.75 173.48 7.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.229 1.411 . . . . 0.0 111.901 158.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -129.18 83.44 2.15 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.813 1.245 . . . . 0.0 112.312 -159.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -105.1 -106.43 0.3 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.498 1.119 . . . . 0.0 113.628 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -168.59 147.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 121.596 1.998 . . . . 0.0 114.969 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -60.9 1.45 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.536 1.636 . . . . 0.0 110.526 155.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -127.67 138.56 33.11 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.296 2.638 . . . . 0.0 108.751 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -26.35 -57.44 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 126.224 4.616 . . . . 0.0 118.508 -166.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -64.45 -35.67 81.68 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -92.84 85.64 5.25 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.005 1.322 . . . . 0.0 112.336 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -69.02 49.25 0.07 Allowed 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -136.25 174.53 10.52 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 118.815 -2.428 . . . . 0.0 114.362 -158.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 t 60.44 90.31 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 150.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.491 2.716 . . . . 0.0 111.545 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.93 82.71 0.84 Allowed Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 111.397 -162.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 22.1 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.521 2.728 . . . . 0.0 116.733 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 p -42.99 -72.12 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.898 2.079 . . . . 0.0 115.493 164.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.3 78.08 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 C-N-CA 124.517 1.056 . . . . 0.0 113.812 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 -122.76 4.6 Favored Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.428 1.49 . . . . 0.0 113.836 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.01 121.03 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.872 -1.37 . . . . 0.0 111.971 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.49 27.56 38.9 Favored Glycine 0 CA--C 1.545 1.945 0 C-N-CA 124.898 1.237 . . . . 0.0 114.935 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.38 178.17 10.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.197 1.799 . . . . 0.0 112.065 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 t 179.15 -49.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.604 1.962 . . . . 0.0 111.748 171.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.15 147.01 42.4 Favored Glycine 0 CA--C 1.552 2.374 0 O-C-N 121.21 -0.931 . . . . 0.0 113.836 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.67 142.87 49.5 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 123.509 2.806 . . . . 0.0 113.701 -171.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -140.28 71.06 1.36 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.743 1.735 . . . . 0.0 112.609 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.44 149.25 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -160.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.49 -131.34 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.956 0.902 . . . . 0.0 113.352 166.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.38 -70.92 0.53 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 119.916 -1.74 . . . . 0.0 112.77 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -172.24 -178.41 2.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.824 2.45 . . . . 0.0 111.992 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.6 -34.2 1.82 Allowed Glycine 0 CA--C 1.543 1.835 0 C-N-CA 126.25 1.881 . . . . 0.0 113.998 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.318 13.0 t 51.86 49.54 20.54 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.359 1.864 . . . . 0.0 115.155 -167.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.9 p -114.14 70.11 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.199 2.2 . . . . 0.0 114.194 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.53 70.01 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 O-C-N 120.171 -1.581 . . . . 0.0 111.664 165.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -162.39 0.78 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.664 1.986 . . . . 0.0 112.938 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.8 132.3 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 120.915 -1.116 . . . . 0.0 112.677 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.26 -60.99 1.58 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.129 1.371 . . . . 0.0 110.988 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.23 163.23 27.82 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.105 1.762 . . . . 0.0 109.916 161.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -46.97 -35.76 19.11 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.052 3.168 . . . . 0.0 116.834 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -72.51 -26.64 61.85 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -127.91 129.28 46.6 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -139.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -119.58 143.25 47.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 112.661 162.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -142.2 0.37 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.775 1.63 . . . . 0.0 111.832 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 t -115.43 102.44 9.83 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.122 1.769 . . . . 0.0 111.153 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.258 1.547 0 C-N-CA 126.193 1.797 . . . . 0.0 111.61 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 119.464 -0.303 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.32 -137.31 14.17 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.532 1.539 . . . . 0.0 111.483 -160.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.35 68.86 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.802 1.641 . . . . 0.0 114.8 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -46.34 -13.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 130.778 3.631 . . . . 0.0 119.465 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.96 82.2 0.74 Allowed Glycine 0 CA--C 1.548 2.136 0 CA-C-N 120.286 1.403 . . . . 0.0 114.462 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.79 -83.02 0.58 Allowed Glycine 0 CA--C 1.547 2.055 0 O-C-N 121.65 -0.912 . . . . 0.0 115.286 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.1 130.57 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 125.176 1.39 . . . . 0.0 110.384 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.47 -57.4 1.22 Allowed Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.117 -0.989 . . . . 0.0 114.363 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.51 134.66 56.72 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.16 1.384 . . . . 0.0 113.251 167.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -147.7 -50.42 0.18 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.78 -171.15 1.95 Allowed Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.139 1.615 . . . . 0.0 117.139 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -65.41 39.85 0.13 Allowed 'Trans proline' 0 CA--C 1.56 1.787 1 C-N-CA 125.4 4.067 . . . . 0.0 118.699 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -67.13 35.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 119.962 -1.711 . . . . 0.0 114.876 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.42 142.37 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 119.974 -1.704 . . . . 0.0 115.117 -153.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.32 -156.48 0.11 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.278 1.431 . . . . 0.0 113.145 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 125.938 1.695 . . . . 0.0 113.498 162.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -94.17 -165.15 1.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.618 -1.301 . . . . 0.0 113.991 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.75 -70.03 0.52 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.981 1.753 . . . . 0.0 111.807 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m 86.88 37.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 126.581 1.952 . . . . 0.0 113.017 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -112.96 83.39 1.82 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.949 2.1 . . . . 0.0 112.67 -167.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -72.59 140.89 48.32 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 120.619 -1.301 . . . . 0.0 112.283 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -152.69 175.49 12.77 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.385 1.474 . . . . 0.0 114.018 -156.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.34 114.67 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 125.735 1.614 . . . . 0.0 112.591 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.71 -92.78 0.09 Allowed 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.238 -0.914 . . . . 0.0 108.915 162.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -76.7 154.99 83.47 Favored Pre-proline 0 CA--C 1.562 1.435 0 O-C-N 120.404 -1.435 . . . . 0.0 110.262 148.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -44.18 -42.64 13.14 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.522 2.815 . . . . 0.0 114.314 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.98 20.52 1.51 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.32 96.25 2.74 Favored 'General case' 0 CA--C 1.554 1.135 0 O-C-N 120.304 -1.498 . . . . 0.0 113.514 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.5 t -92.94 119.07 31.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.445 1.898 . . . . 0.0 110.927 165.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -111.93 -120.23 0.29 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -154.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -164.87 93.93 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.342 -1.474 . . . . 0.0 111.456 -159.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 126.855 2.062 . . . . 0.0 112.086 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 120.39 0.138 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.99 -136.88 3.25 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 123.977 0.798 . . . . 0.0 111.231 158.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -56.45 79.8 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 p -52.11 -43.26 63.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.816 2.046 . . . . 0.0 113.098 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.8 152.4 29.03 Favored Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.613 1.101 . . . . 0.0 114.682 -165.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.59 -123.8 4.39 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.965 1.269 . . . . 0.0 111.855 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.4 133.73 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 120.493 -1.592 . . . . 0.0 111.402 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.39 7.55 46.62 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 118.539 2.176 . . . . 0.0 118.539 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.43 117.39 15.27 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 119.41 1.605 . . . . 0.0 110.652 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -164.69 101.14 0.8 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.433 1.093 . . . . 0.0 113.004 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.14 -161.48 34.84 Favored Glycine 0 CA--C 1.547 2.068 0 O-C-N 121.174 -0.954 . . . . 0.0 115.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.44 71.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 125.038 3.825 . . . . 0.0 115.065 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -128.85 16.3 6.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.361 1.864 . . . . 0.0 113.48 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.44 143.79 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -159.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.7 t -87.74 177.0 7.14 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.23 2.212 . . . . 0.0 112.493 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.34 176.23 0.06 Allowed 'General case' 0 CA--C 1.557 1.233 0 O-C-N 120.712 -1.243 . . . . 0.0 113.232 156.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 150.57 48.62 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -173.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.38 -51.4 0.01 OUTLIER Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.996 1.76 . . . . 0.0 112.786 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m 76.26 26.14 0.96 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.496 1.919 . . . . 0.0 112.423 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 p -135.11 73.32 1.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.603 1.961 . . . . 0.0 111.992 -160.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 t -74.1 59.46 0.74 Allowed 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.936 -1.103 . . . . 0.0 112.903 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -112.81 166.54 11.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.68 1.592 . . . . 0.0 112.591 175.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.02 146.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 125.763 1.625 . . . . 0.0 114.66 -153.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -94.47 -67.07 0.87 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.776 1.23 . . . . 0.0 108.447 161.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -122.48 151.76 60.26 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 126.099 1.76 . . . . 0.0 108.144 155.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -35.91 -33.8 0.12 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 124.799 3.666 . . . . 0.0 117.516 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -98.14 94.76 7.0 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 126.869 2.067 . . . . 0.0 110.309 164.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -119.37 -149.97 0.45 Allowed 'General case' 0 CA--C 1.567 1.597 1 C-N-CA 132.906 4.482 . . . . 0.0 112.618 4.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -130.74 130.24 43.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 119.726 -1.859 . . . . 0.0 111.321 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -117.24 -116.79 0.32 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -145.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.0 t -160.65 82.47 0.67 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 120.312 -1.493 . . . . 0.0 112.56 -161.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.259 1.561 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -170.325 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.74 -104.42 1.9 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 160.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.15 99.4 1.12 Allowed 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.47 -1.606 . . . . 0.0 110.436 165.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 p -57.0 -40.05 75.87 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.469 1.908 . . . . 0.0 115.922 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.95 98.94 2.52 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 124.753 1.168 . . . . 0.0 111.643 -164.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.02 -86.24 1.1 Allowed Glycine 0 CA--C 1.544 1.904 0 C-N-CA 123.992 0.806 . . . . 0.0 114.976 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.1 124.22 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.245 1.418 . . . . 0.0 109.62 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.63 -54.32 3.31 Favored Glycine 0 CA--C 1.545 1.928 0 O-C-N 120.415 -1.428 . . . . 0.0 113.221 -168.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.58 131.6 49.62 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 121.253 -1.145 . . . . 0.0 113.107 163.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 t -151.56 164.08 37.63 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.173 1.389 . . . . 0.0 113.335 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.19 -167.63 52.89 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 115.879 1.111 . . . . 0.0 115.879 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.74 60.58 1.2 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.958 3.105 . . . . 0.0 116.999 -168.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -74.53 40.75 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 O-C-N 119.926 -1.734 . . . . 0.0 113.672 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.64 145.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -151.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.03 179.84 5.64 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.307 2.643 . . . . 0.0 111.665 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.55 168.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -69.29 42.97 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -153.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.66 -57.22 9.25 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.632 1.587 . . . . 0.0 115.146 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.337 2.4 t 57.19 19.78 5.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.448 2.299 . . . . 0.0 116.194 -150.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.7 p -98.65 131.74 44.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.969 2.507 . . . . 0.0 112.764 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -119.03 70.84 0.84 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.306 1.842 . . . . 0.0 110.651 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -114.11 134.86 54.6 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -166.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.15 132.0 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.65 -59.81 1.74 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.575 1.15 . . . . 0.0 110.357 158.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -129.11 150.09 74.42 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 125.968 1.707 . . . . 0.0 108.704 161.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -51.18 -33.33 43.8 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.006 2.471 . . . . 0.0 115.12 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -68.41 -15.59 63.61 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.404 0.0 OUTLIER -146.21 120.49 9.57 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 163.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -95.41 124.46 39.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.245 2.618 . . . . 0.0 111.423 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.98 165.23 13.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.558 2.343 . . . . 0.0 115.34 -160.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.82 47.0 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.397 1 C-N-CA 133.464 4.706 . . . . 0.0 116.217 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.926 2.09 . . . . 0.0 111.036 178.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.92 9.06 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.694 0.664 . . . . 0.0 112.639 162.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -60.37 80.77 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.732 1.613 . . . . 0.0 113.935 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -38.44 -39.99 0.51 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.83 100.48 2.56 Favored Glycine 0 CA--C 1.548 2.134 0 C-N-CA 125.415 1.483 . . . . 0.0 113.266 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.49 -169.23 25.66 Favored Glycine 0 CA--C 1.546 2.023 0 C-N-CA 124.939 1.257 . . . . 0.0 115.163 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -43.53 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 C-N-CA 124.995 1.318 . . . . 0.0 114.182 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 15.04 66.55 Favored Glycine 0 CA--C 1.549 2.215 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.62 111.21 10.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 119.413 1.606 . . . . 0.0 114.308 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -125.69 -26.64 3.49 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.524 1.929 . . . . 0.0 114.275 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.03 157.63 46.15 Favored Glycine 0 CA--C 1.551 2.34 0 O-C-N 120.83 -1.169 . . . . 0.0 113.81 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.26 108.89 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.115 2.543 . . . . 0.0 114.211 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.4 t -122.64 61.96 0.99 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.138 1.775 . . . . 0.0 108.354 151.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.71 116.38 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -146.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.27 158.76 28.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.835 1.654 . . . . 0.0 113.644 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 -170.39 0.29 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.2 p -69.06 86.18 0.36 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -165.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.0 -61.21 0.27 Allowed Glycine 0 CA--C 1.549 2.172 0 C-N-CA 126.351 1.929 . . . . 0.0 112.375 160.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m 78.66 45.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.169 2.188 . . . . 0.0 112.88 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 p -113.34 102.41 10.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.453 2.701 . . . . 0.0 111.466 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.38 43.04 0.22 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -95.96 163.3 13.2 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.08 1.752 . . . . 0.0 111.154 165.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.36 143.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -152.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.8 -76.9 0.11 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.584 1.554 . . . . 0.0 110.86 164.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -112.26 134.33 21.53 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 126.604 1.962 . . . . 0.0 110.936 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -34.42 -37.57 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.129 1 C-N-CA 125.356 4.037 . . . . 0.0 118.13 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -80.29 20.61 0.66 Allowed 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.306 1.6 p90 -149.29 -162.08 1.48 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 120.935 -1.103 . . . . 0.0 112.69 137.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 t -149.32 147.67 28.6 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.166 -1.584 . . . . 0.0 112.575 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -121.43 -112.59 0.32 Allowed 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -152.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -176.68 73.5 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.724 1.21 . . . . 0.0 112.269 -150.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 125.901 1.68 . . . . 0.0 113.106 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.96 -117.8 1.54 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.718 1.628 . . . . 0.0 113.199 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -71.77 68.12 0.61 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.969 -1.312 . . . . 0.0 111.655 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -48.26 -32.72 7.63 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 128.761 2.825 . . . . 0.0 116.211 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.83 92.15 0.09 OUTLIER Glycine 0 CA--C 1.542 1.737 0 C-N-CA 126.666 2.079 . . . . 0.0 110.947 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 155.76 47.14 Favored Glycine 0 CA--C 1.546 2.031 0 O-C-N 121.011 -1.288 . . . . 0.0 113.03 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.85 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 120.701 2.25 . . . . 0.0 112.231 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.6 -47.37 1.05 Allowed Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.544 1.545 . . . . 0.0 113.625 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.94 71.96 2.78 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 120.809 -1.407 . . . . 0.0 111.544 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.1 m -92.6 79.57 4.84 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.53 2.332 . . . . 0.0 111.466 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.78 -169.33 39.9 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 117.733 1.853 . . . . 0.0 117.733 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.08 127.73 27.25 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.038 3.825 . . . . 0.0 114.85 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t 169.47 65.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.329 2.652 . . . . 0.0 111.01 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.63 141.54 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.851 1.661 . . . . 0.0 112.602 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -103.85 -141.85 0.36 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 125.008 1.323 . . . . 0.0 112.844 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 -149.33 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 O-C-N 120.565 -1.334 . . . . 0.0 112.456 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.1 p -103.34 101.91 11.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.636 1.574 . . . . 0.0 112.797 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.81 -47.74 0.02 OUTLIER Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.959 1.266 . . . . 0.0 113.439 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m 65.31 29.4 11.6 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.802 1.241 . . . . 0.0 113.39 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -74.7 145.28 43.23 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.404 1.481 . . . . 0.0 111.531 157.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.0 t -153.8 83.94 1.16 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.928 1.691 . . . . 0.0 108.674 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -121.14 139.44 53.35 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.144 1.778 . . . . 0.0 114.324 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.39 123.23 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -171.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -94.18 -52.97 4.14 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.194 0.997 . . . . 0.0 110.609 158.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -135.6 155.72 78.1 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 126.033 1.733 . . . . 0.0 108.244 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.7 -33.06 68.16 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.329 2.019 . . . . 0.0 115.891 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -75.12 -13.63 60.49 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 92.07 3.23 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 127.185 2.194 . . . . 0.0 114.29 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 t -83.96 135.04 34.62 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.746 1.218 . . . . 0.0 112.813 158.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -134.29 164.04 28.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -165.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.8 t -65.56 64.98 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 127.536 2.334 . . . . 0.0 114.722 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.959 2.103 . . . . 0.0 109.458 169.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.77 -66.13 2.11 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.157 -0.964 . . . . 0.0 111.499 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.14 125.4 23.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.17 0.588 . . . . 0.0 110.691 150.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.7 p -80.42 -44.32 19.53 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 67.36 0.75 Allowed Glycine 0 CA--C 1.551 2.323 0 C-N-CA 124.704 1.145 . . . . 0.0 115.514 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.76 -146.33 9.98 Favored Glycine 0 CA--C 1.548 2.116 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -41.97 99.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.61 1.964 . . . . 0.0 112.6 -171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.86 18.7 80.12 Favored Glycine 0 CA--C 1.542 1.75 0 N-CA-C 117.106 1.603 . . . . 0.0 117.106 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 58.25 1.67 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.705 1.753 . . . . 0.0 114.741 -166.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 t -88.2 71.29 9.22 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.306 -1.496 . . . . 0.0 112.274 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.14 167.23 40.31 Favored Glycine 0 CA--C 1.545 1.962 0 C-N-CA 125.857 1.694 . . . . 0.0 112.176 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.81 116.15 4.43 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.244 1.963 . . . . 0.0 113.458 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -147.59 63.78 1.14 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.212 1.805 . . . . 0.0 110.21 159.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -100.84 166.74 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -138.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.0 t -135.54 175.41 9.62 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 127.076 2.15 . . . . 0.0 113.663 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.55 18.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 113.534 164.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -61.58 141.07 58.01 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.0 -71.51 0.21 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.732 1.158 . . . . 0.0 113.162 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.262 4.5 m 93.87 45.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.438 1.895 . . . . 0.0 114.438 163.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -81.5 104.27 11.81 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.366 1.866 . . . . 0.0 112.275 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -83.26 62.85 6.9 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -159.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -106.37 172.33 6.87 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.843 1.257 . . . . 0.0 112.516 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.76 140.01 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 O-C-N 119.596 -1.94 . . . . 0.0 114.17 -157.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.39 -60.05 1.93 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.456 1.102 . . . . 0.0 111.84 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -79.77 -156.21 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 124.947 1.299 . . . . 0.0 111.995 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -75.41 -60.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.681 2.254 . . . . 0.0 110.931 134.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -67.51 78.91 0.17 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.054 1.342 . . . . 0.0 113.775 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -173.18 175.56 3.14 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 127.994 2.518 . . . . 0.0 110.707 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -165.16 120.21 1.33 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.582 -1.324 . . . . 0.0 112.354 134.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -103.9 -122.11 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 112.732 -160.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 t -148.21 61.77 1.1 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.794 2.038 . . . . 0.0 110.479 -154.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 125.417 1.487 . . . . 0.0 111.81 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.101 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.14 -99.67 0.27 Allowed Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -59.83 101.78 0.13 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.623 -0.927 . . . . 0.0 112.921 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 p -41.91 -42.86 2.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.208 1.403 . . . . 0.0 114.618 168.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.67 124.02 2.45 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.411 1.958 . . . . 0.0 110.701 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.7 -138.9 8.86 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 124.063 0.84 . . . . 0.0 113.288 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.92 102.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.21 -1.171 . . . . 0.0 110.72 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.87 49.66 16.47 Favored Glycine 0 CA--C 1.545 1.925 0 C-N-CA 125.127 1.346 . . . . 0.0 114.155 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.28 122.74 0.93 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 m -125.67 -25.6 3.65 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.04 134.82 12.51 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.808 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -46.09 80.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 1 C-N-CA 125.539 4.159 . . . . 0.0 116.309 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 t -79.92 49.81 1.12 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 123.806 1.765 . . . . 0.0 111.112 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.12 144.29 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 115.266 -151.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.5 p -74.76 -132.74 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 125.333 1.453 . . . . 0.0 111.774 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.64 166.33 0.33 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.418 -2.051 . . . . 0.0 112.817 148.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -63.32 158.49 20.23 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.682 -1.262 . . . . 0.0 113.795 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.77 -33.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 t 47.91 22.39 0.37 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 p -140.12 176.62 8.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.308 1.843 . . . . 0.0 112.82 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -121.7 89.12 3.06 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -155.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -123.27 -117.29 0.29 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 171.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -163.0 124.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 121.417 1.917 . . . . 0.0 115.063 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.62 -67.32 0.82 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.587 1.185 . . . . 0.0 110.357 162.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -118.14 154.06 51.57 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 126.346 1.858 . . . . 0.0 109.404 159.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -33.66 -55.41 0.43 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.733 3.622 . . . . 0.0 117.14 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -65.4 -26.05 67.82 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -107.52 95.21 5.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.466 1.906 . . . . 0.0 113.589 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 t -87.97 100.06 12.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.444 1.897 . . . . 0.0 114.904 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.45 ' CG ' ' H ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -163.11 -139.42 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 127.086 2.155 . . . . 0.0 108.957 170.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . 0.45 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 21.73 113.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 129.985 3.314 . . . . 0.0 118.838 176.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.553 1.087 0 C-N-CA 127.334 2.253 . . . . 0.0 111.629 -178.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -6.49 -89.82 0.0 OUTLIER Glycine 0 CA--C 1.549 2.205 0 C-N-CA 127.667 2.556 . . . . 0.0 118.339 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.73 83.4 6.5 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 121.036 -1.273 . . . . 0.0 111.41 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -34.77 -44.76 0.23 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.983 2.113 . . . . 0.0 116.561 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.0 74.86 0.91 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.397 1.475 . . . . 0.0 113.604 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.29 -122.61 5.04 Favored Glycine 0 CA--C 1.544 1.887 0 C-N-CA 124.461 1.029 . . . . 0.0 114.941 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.82 113.45 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 O-C-N 119.922 -1.928 . . . . 0.0 112.26 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.52 37.31 81.84 Favored Glycine 0 CA--C 1.545 1.936 0 C-N-CA 125.037 1.303 . . . . 0.0 115.421 -169.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -147.5 155.85 42.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.887 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -161.69 -37.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.147 -0.971 . . . . 0.0 113.253 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.65 47.99 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -65.32 69.53 0.31 Allowed 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.295 3.33 . . . . 0.0 117.597 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.2 p -72.23 53.09 0.27 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.0 -1.688 . . . . 0.0 113.861 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.97 87.18 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -156.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.3 179.58 6.31 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 126.228 1.811 . . . . 0.0 114.403 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -176.94 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 128.572 2.749 . . . . 0.0 116.938 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 m -88.85 122.47 32.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.306 1.442 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.1 -74.72 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 C-N-CA 126.075 1.798 . . . . 0.0 110.6 167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.304 1.7 m 109.75 29.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 130.706 3.603 . . . . 0.0 114.464 146.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.8 p -89.52 119.63 30.12 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.056 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -75.76 67.03 2.14 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 120.238 -1.539 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -61.91 -177.9 0.13 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 130.69 3.596 . . . . 0.0 115.318 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.5 135.76 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 O-C-N 119.125 -2.235 . . . . 0.0 111.955 162.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mt -111.21 -72.54 0.71 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.057 1.343 . . . . 0.0 110.852 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -59.66 177.84 0.26 Allowed Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 124.717 1.207 . . . . 0.0 109.952 154.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -56.71 -60.23 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 146.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.13 81.96 2.3 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.739 1.616 . . . . 0.0 114.926 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.35 -161.37 0.2 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.356 1.462 . . . . 0.0 114.147 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t 171.92 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.543 2.737 . . . . 0.0 112.868 155.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.96 153.83 34.19 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -160.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.5 t -50.05 66.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 131.401 3.88 . . . . 0.0 116.673 168.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 126.991 2.116 . . . . 0.0 110.654 165.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.62 -102.48 2.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.519 1.533 . . . . 0.0 111.023 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -63.05 72.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.556 1.542 . . . . 0.0 114.896 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 p -39.4 -38.29 0.54 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.25 3.02 . . . . 0.0 116.067 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.12 99.85 2.48 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 125.13 1.348 . . . . 0.0 112.645 -175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.86 -174.56 30.64 Favored Glycine 0 CA--C 1.544 1.881 0 N-CA-C 115.634 1.014 . . . . 0.0 115.634 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -41.16 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 126.979 2.112 . . . . 0.0 114.281 -168.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 38.15 27.24 Favored Glycine 0 CA--C 1.546 1.994 0 C-N-CA 125.646 1.594 . . . . 0.0 116.391 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.98 57.23 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 118.618 1.209 . . . . 0.0 112.264 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -87.26 86.61 7.28 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.323 1.449 . . . . 0.0 114.022 -169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.3 178.56 43.61 Favored Glycine 0 CA--C 1.548 2.15 0 N-CA-C 117.651 1.821 . . . . 0.0 117.651 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -63.06 51.27 0.13 Allowed 'Trans proline' 0 CA--C 1.551 1.363 1 C-N-CA 126.476 4.784 . . . . 0.0 118.318 -171.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 p -82.93 39.28 0.62 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.841 2.056 . . . . 0.0 113.14 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -87.43 82.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -144.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.86 165.53 0.9 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 163.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.04 -160.0 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 129.108 2.963 . . . . 0.0 117.549 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.64 81.97 6.77 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 118.412 -2.68 . . . . 0.0 114.673 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.32 -71.48 1.31 Allowed Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.198 0.904 . . . . 0.0 112.676 166.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m 87.81 22.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.472 2.309 . . . . 0.0 113.12 -164.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -134.0 76.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.16 1.384 . . . . 0.0 111.075 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.04 56.57 0.32 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.686 1.195 . . . . 0.0 113.402 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -110.72 162.15 15.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.436 2.694 . . . . 0.0 111.357 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.54 144.43 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 119.792 -1.817 . . . . 0.0 115.825 -155.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.1 -69.03 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.266 1.427 . . . . 0.0 111.149 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -118.89 130.97 24.53 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 127.152 2.181 . . . . 0.0 111.249 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -34.17 -38.66 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.216 1 C-N-CA 125.704 4.269 . . . . 0.0 119.161 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -70.57 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -166.43 -169.21 1.35 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.926 2.49 . . . . 0.0 112.122 156.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -157.76 119.01 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.291 -1.506 . . . . 0.0 111.047 167.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -103.79 -121.91 0.2 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.327 1.851 . . . . 0.0 115.382 -153.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.0 t -153.72 73.76 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.836 -1.165 . . . . 0.0 111.733 -156.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.03 1.332 . . . . 0.0 111.592 -169.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.913 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -129.88 0.74 Allowed Glycine 0 CA--C 1.544 1.902 0 C-N-CA 124.202 0.906 . . . . 0.0 115.293 168.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.92 80.51 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 0.0 115.53 -166.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 m -27.58 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.51 3.124 . . . . 0.0 117.509 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.95 99.5 1.58 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.101 1.334 . . . . 0.0 110.122 -153.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.11 -134.97 6.25 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 123.898 0.761 . . . . 0.0 113.746 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.7 mt -85.51 115.86 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 O-C-N 121.233 -1.157 . . . . 0.0 109.666 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.45 41.17 98.49 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.359 1.304 . . . . 0.0 116.359 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -162.39 122.29 2.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.894 1.677 . . . . 0.0 110.402 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -160.48 168.51 24.95 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.12 -162.54 29.84 Favored Glycine 0 CA--C 1.548 2.137 0 C-N-CA 125.283 1.42 . . . . 0.0 114.812 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.34 56.38 0.6 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 124.608 3.539 . . . . 0.0 115.448 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -123.87 66.21 1.04 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.407 1.883 . . . . 0.0 110.814 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.26 157.07 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 125.746 1.618 . . . . 0.0 114.069 -157.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 t -121.69 171.66 8.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 127.073 2.149 . . . . 0.0 112.583 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.68 -123.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 129.156 2.982 . . . . 0.0 117.599 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.73 160.14 16.99 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.054 -1.653 . . . . 0.0 112.198 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.66 -57.2 0.12 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.061 0.839 . . . . 0.0 111.854 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 92.4 32.89 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 127.758 2.423 . . . . 0.0 112.513 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 p -137.38 72.93 1.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.631 1.172 . . . . 0.0 113.147 -152.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.64 123.2 20.74 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 120.726 -1.234 . . . . 0.0 111.176 172.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -147.05 -179.8 7.07 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -152.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.91 95.93 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 126.476 1.91 . . . . 0.0 112.957 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.91 -50.34 17.19 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.215 -1.553 . . . . 0.0 110.68 163.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -131.23 164.24 43.74 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.844 2.058 . . . . 0.0 108.387 153.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -51.54 -34.6 52.73 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 CA-C-N 122.479 1.921 . . . . 0.0 115.198 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -78.66 -6.08 54.74 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.86 95.73 4.17 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.304 -1.498 . . . . 0.0 114.636 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 t -85.53 136.77 33.27 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.726 1.61 . . . . 0.0 112.08 153.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -122.4 -120.05 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -170.39 78.61 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.086 0.954 . . . . 0.0 111.051 -153.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.12 1.368 . . . . 0.0 111.51 -171.066 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.67 -103.73 0.12 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 146.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -46.44 107.55 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 117.634 0.717 . . . . 0.0 112.52 152.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.5 p -62.78 -50.39 71.22 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 120.024 -1.672 . . . . 0.0 113.373 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.08 117.22 2.43 Favored Glycine 0 CA--C 1.544 1.875 0 C-N-CA 126.31 1.91 . . . . 0.0 112.477 -168.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.09 -85.48 1.87 Allowed Glycine 0 CA--C 1.54 1.648 0 C-N-CA 124.342 0.972 . . . . 0.0 113.964 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.42 131.23 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 125.474 1.509 . . . . 0.0 109.74 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -55.76 2.57 Favored Glycine 0 CA--C 1.546 1.979 0 O-C-N 120.832 -1.168 . . . . 0.0 114.146 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.4 90.73 3.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.587 1.155 . . . . 0.0 112.191 174.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.0 m -90.82 78.47 6.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.778 1.231 . . . . 0.0 112.728 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.6 -177.47 21.71 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 124.897 1.237 . . . . 0.0 115.534 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.62 166.19 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.224 3.283 . . . . 0.0 114.914 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -179.42 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.654 1.981 . . . . 0.0 111.588 -170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.16 144.95 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 125.828 1.651 . . . . 0.0 112.106 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.4 t 84.97 173.16 0.06 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 127.35 2.26 . . . . 0.0 114.751 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.32 -170.05 2.8 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.418 1.087 . . . . 0.0 111.05 158.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.1 p -66.8 115.62 6.79 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.352 -1.468 . . . . 0.0 114.37 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.87 -49.99 0.15 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 126.045 1.784 . . . . 0.0 114.666 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m 71.52 24.38 3.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.633 1.573 . . . . 0.0 114.277 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -103.58 83.63 2.18 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.54 1.936 . . . . 0.0 111.064 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -70.15 65.47 0.26 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -120.81 157.73 29.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.301 2.641 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -111.06 152.88 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 127.374 2.27 . . . . 0.0 115.935 -165.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.17 -76.76 0.42 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.623 1.969 . . . . 0.0 109.383 160.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -109.13 138.33 20.39 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 126.403 1.881 . . . . 0.0 112.078 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -26.31 -52.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 1 C-N-CA 126.331 4.688 . . . . 0.0 119.288 -175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 24.65 0.09 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -159.76 173.14 16.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.109 1.363 . . . . 0.0 114.185 160.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 t -141.1 127.26 19.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.695 1.198 . . . . 0.0 111.631 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -98.97 -125.62 0.16 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 125.164 1.386 . . . . 0.0 114.588 -165.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.86 101.49 0.56 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.162 3.385 . . . . 0.0 106.034 -157.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.092 1.757 . . . . 0.0 111.982 -163.205 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.149 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.42 -151.75 45.46 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -155.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -64.13 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.111 0.958 . . . . 0.0 112.348 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.8 p -40.4 -56.52 2.0 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 128.376 2.67 . . . . 0.0 115.121 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 120.36 2.67 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.961 1.743 . . . . 0.0 111.346 -166.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.56 -125.92 5.66 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.301 0.953 . . . . 0.0 113.785 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.07 99.48 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.346 -1.091 . . . . 0.0 110.095 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.01 28.71 58.17 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 104.24 3.26 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.91 1.684 . . . . 0.0 110.215 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 m -132.96 151.73 52.02 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.814 1.646 . . . . 0.0 113.791 -164.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.68 -160.54 14.33 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 167.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.02 31.25 0.36 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.405 2.737 . . . . 0.0 114.637 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -75.45 45.38 0.3 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.455 1.902 . . . . 0.0 111.679 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.27 114.12 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -149.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.1 t -50.33 171.35 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 125.766 1.626 . . . . 0.0 114.53 166.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.74 176.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 164.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -70.05 176.22 3.94 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -64.11 0.32 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.167 1.365 . . . . 0.0 112.088 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m 91.08 38.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.254 2.222 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 p -127.36 74.14 1.49 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.188 2.195 . . . . 0.0 112.297 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.0 68.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.754 1.222 . . . . 0.0 113.592 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -113.37 154.46 26.88 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.992 2.117 . . . . 0.0 112.884 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.84 146.89 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.62 -85.65 0.3 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.712 0.805 . . . . 0.0 109.201 151.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -94.85 144.78 28.41 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.718 1.207 . . . . 0.0 111.05 156.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -31.11 -44.65 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.441 4.094 . . . . 0.0 117.219 174.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.97 -25.7 68.25 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.349 0.0 OUTLIER -144.2 107.02 4.45 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 173.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 t -78.08 142.88 37.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.768 2.027 . . . . 0.0 113.287 165.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -128.9 -99.82 0.34 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.94 66.97 0.31 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.924 -1.735 . . . . 0.0 112.273 -160.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.896 1.278 . . . . 0.0 111.526 -170.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -83.5 -50.76 7.96 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -75.48 -76.15 0.16 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.199 1.4 . . . . 0.0 111.247 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -65.01 107.78 1.61 Allowed 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.453 -0.78 . . . . 0.0 110.228 164.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.28 58.49 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.4 -74.06 1.17 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.957 0.789 . . . . 0.0 114.597 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.87 117.14 7.13 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -83.9 -55.0 4.47 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 125.09 1.356 . . . . 0.0 111.801 149.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.5 167.42 21.98 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 125.792 1.663 . . . . 0.0 116.511 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 -119.03 1.85 Allowed Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.061 1.185 . . . . 0.0 116.061 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.72 85.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 125.975 1.71 . . . . 0.0 113.111 -166.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.15 36.05 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 126.047 1.784 . . . . 0.0 115.803 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.69 148.97 23.31 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 t -174.51 -55.59 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.382 1.873 . . . . 0.0 111.6 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.06 152.01 4.22 Favored Glycine 0 CA--C 1.55 2.232 0 C-N-CA 124.051 0.834 . . . . 0.0 114.269 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.97 71.31 5.03 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.359 2.706 . . . . 0.0 113.255 -167.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -75.37 43.0 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.562 1.545 . . . . 0.0 112.744 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.9 93.74 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -148.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.35 158.51 20.29 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.886 -1.133 . . . . 0.0 111.761 148.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.42 -179.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.3 m -51.49 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 129.302 3.041 . . . . 0.0 117.081 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -39.15 34.76 Favored Glycine 0 CA--C 1.545 1.942 0 C-N-CA 123.695 0.664 . . . . 0.0 114.331 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.269 0.5 OUTLIER 64.93 -49.46 0.34 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.3 2.64 . . . . 0.0 114.862 -175.772 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 p -92.75 173.48 7.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.229 1.411 . . . . 0.0 111.901 158.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -129.18 83.44 2.15 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.813 1.245 . . . . 0.0 112.312 -159.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -105.1 -106.43 0.3 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.498 1.119 . . . . 0.0 113.628 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -168.59 147.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 121.596 1.998 . . . . 0.0 114.969 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -98.73 -60.9 1.45 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.536 1.636 . . . . 0.0 110.526 155.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -127.67 138.56 33.11 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.296 2.638 . . . . 0.0 108.751 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -26.35 -57.44 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 126.224 4.616 . . . . 0.0 118.508 -166.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -64.45 -35.67 81.68 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -92.84 85.64 5.25 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.005 1.322 . . . . 0.0 112.336 -172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -69.02 49.25 0.07 Allowed 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -136.25 174.53 10.52 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 118.815 -2.428 . . . . 0.0 114.362 -158.289 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 t 60.44 90.31 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 150.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.491 2.716 . . . . 0.0 111.545 -176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -107.49 102.81 12.05 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -165.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.7 p -57.88 80.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.503 1.921 . . . . 0.0 113.687 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -165.46 -56.02 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.389 2.276 . . . . 0.0 109.055 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.74 125.9 29.75 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.758 1.223 . . . . 0.0 110.399 147.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.93 82.71 0.84 Allowed Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 111.397 -162.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 22.1 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.521 2.728 . . . . 0.0 116.733 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 p -42.99 -72.12 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.898 2.079 . . . . 0.0 115.493 164.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.3 78.08 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 C-N-CA 124.517 1.056 . . . . 0.0 113.812 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 -122.76 4.6 Favored Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.428 1.49 . . . . 0.0 113.836 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.01 121.03 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.872 -1.37 . . . . 0.0 111.971 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.49 27.56 38.9 Favored Glycine 0 CA--C 1.545 1.945 0 C-N-CA 124.898 1.237 . . . . 0.0 114.935 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.38 178.17 10.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.197 1.799 . . . . 0.0 112.065 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 t 179.15 -49.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.604 1.962 . . . . 0.0 111.748 171.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.15 147.01 42.4 Favored Glycine 0 CA--C 1.552 2.374 0 O-C-N 121.21 -0.931 . . . . 0.0 113.836 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.67 142.87 49.5 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 123.509 2.806 . . . . 0.0 113.701 -171.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -140.28 71.06 1.36 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.743 1.735 . . . . 0.0 112.609 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.44 149.25 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -160.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.49 -131.34 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.956 0.902 . . . . 0.0 113.352 166.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.38 -70.92 0.53 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 119.916 -1.74 . . . . 0.0 112.77 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -172.24 -178.41 2.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.824 2.45 . . . . 0.0 111.992 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.6 -34.2 1.82 Allowed Glycine 0 CA--C 1.543 1.835 0 C-N-CA 126.25 1.881 . . . . 0.0 113.998 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.318 13.0 t 51.86 49.54 20.54 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.359 1.864 . . . . 0.0 115.155 -167.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.9 p -114.14 70.11 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.199 2.2 . . . . 0.0 114.194 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.53 70.01 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 O-C-N 120.171 -1.581 . . . . 0.0 111.664 165.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -162.39 0.78 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.664 1.986 . . . . 0.0 112.938 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.8 132.3 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 120.915 -1.116 . . . . 0.0 112.677 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.26 -60.99 1.58 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.129 1.371 . . . . 0.0 110.988 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.23 163.23 27.82 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.105 1.762 . . . . 0.0 109.916 161.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -46.97 -35.76 19.11 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.052 3.168 . . . . 0.0 116.834 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -72.51 -26.64 61.85 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -127.91 129.28 46.6 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -139.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -119.58 143.25 47.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 112.661 162.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -142.2 0.37 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.775 1.63 . . . . 0.0 111.832 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 t -115.43 102.44 9.83 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.122 1.769 . . . . 0.0 111.153 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.258 1.547 0 C-N-CA 126.193 1.797 . . . . 0.0 111.61 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -48.02 -80.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -158.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.9 m -94.29 -73.25 0.58 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.9 0.88 . . . . 0.0 110.554 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 38.41 3.47 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 122.843 1.306 . . . . 0.0 110.233 150.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.54 120.21 10.1 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.859 -1.15 . . . . 0.0 111.568 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.32 -137.31 14.17 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.532 1.539 . . . . 0.0 111.483 -160.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.35 68.86 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.802 1.641 . . . . 0.0 114.8 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -46.34 -13.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 130.778 3.631 . . . . 0.0 119.465 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.96 82.2 0.74 Allowed Glycine 0 CA--C 1.548 2.136 0 CA-C-N 120.286 1.403 . . . . 0.0 114.462 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.79 -83.02 0.58 Allowed Glycine 0 CA--C 1.547 2.055 0 O-C-N 121.65 -0.912 . . . . 0.0 115.286 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.1 130.57 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 125.176 1.39 . . . . 0.0 110.384 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.47 -57.4 1.22 Allowed Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.117 -0.989 . . . . 0.0 114.363 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.51 134.66 56.72 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.16 1.384 . . . . 0.0 113.251 167.566 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -147.7 -50.42 0.18 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.78 -171.15 1.95 Allowed Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.139 1.615 . . . . 0.0 117.139 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -65.41 39.85 0.13 Allowed 'Trans proline' 0 CA--C 1.56 1.787 1 C-N-CA 125.4 4.067 . . . . 0.0 118.699 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -67.13 35.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 119.962 -1.711 . . . . 0.0 114.876 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.42 142.37 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 119.974 -1.704 . . . . 0.0 115.117 -153.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.32 -156.48 0.11 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.278 1.431 . . . . 0.0 113.145 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 125.938 1.695 . . . . 0.0 113.498 162.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -94.17 -165.15 1.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.618 -1.301 . . . . 0.0 113.991 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.75 -70.03 0.52 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.981 1.753 . . . . 0.0 111.807 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m 86.88 37.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 126.581 1.952 . . . . 0.0 113.017 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -112.96 83.39 1.82 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.949 2.1 . . . . 0.0 112.67 -167.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -72.59 140.89 48.32 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 120.619 -1.301 . . . . 0.0 112.283 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -152.69 175.49 12.77 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.385 1.474 . . . . 0.0 114.018 -156.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.34 114.67 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 125.735 1.614 . . . . 0.0 112.591 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.71 -92.78 0.09 Allowed 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.238 -0.914 . . . . 0.0 108.915 162.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -76.7 154.99 83.47 Favored Pre-proline 0 CA--C 1.562 1.435 0 O-C-N 120.404 -1.435 . . . . 0.0 110.262 148.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -44.18 -42.64 13.14 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.522 2.815 . . . . 0.0 114.314 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.98 20.52 1.51 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.32 96.25 2.74 Favored 'General case' 0 CA--C 1.554 1.135 0 O-C-N 120.304 -1.498 . . . . 0.0 113.514 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.5 t -92.94 119.07 31.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.445 1.898 . . . . 0.0 110.927 165.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -111.93 -120.23 0.29 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -154.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -164.87 93.93 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.342 -1.474 . . . . 0.0 111.456 -159.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 126.855 2.062 . . . . 0.0 112.086 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 46.2 p . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -64.83 111.0 2.61 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.315 0.961 . . . . 0.0 111.433 169.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -68.43 115.05 7.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.407 0.683 . . . . 0.0 112.588 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -94.79 -69.29 0.76 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.818 1.647 . . . . 0.0 111.082 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.39 103.1 5.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.927 1.291 . . . . 0.0 111.327 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.99 -136.88 3.25 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 123.977 0.798 . . . . 0.0 111.231 158.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -56.45 79.8 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 p -52.11 -43.26 63.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.816 2.046 . . . . 0.0 113.098 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.8 152.4 29.03 Favored Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.613 1.101 . . . . 0.0 114.682 -165.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.59 -123.8 4.39 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.965 1.269 . . . . 0.0 111.855 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.4 133.73 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 120.493 -1.592 . . . . 0.0 111.402 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.39 7.55 46.62 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 118.539 2.176 . . . . 0.0 118.539 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.43 117.39 15.27 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 119.41 1.605 . . . . 0.0 110.652 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -164.69 101.14 0.8 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.433 1.093 . . . . 0.0 113.004 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.14 -161.48 34.84 Favored Glycine 0 CA--C 1.547 2.068 0 O-C-N 121.174 -0.954 . . . . 0.0 115.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.44 71.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 125.038 3.825 . . . . 0.0 115.065 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -128.85 16.3 6.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.361 1.864 . . . . 0.0 113.48 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.44 143.79 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -159.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.7 t -87.74 177.0 7.14 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.23 2.212 . . . . 0.0 112.493 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.34 176.23 0.06 Allowed 'General case' 0 CA--C 1.557 1.233 0 O-C-N 120.712 -1.243 . . . . 0.0 113.232 156.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 150.57 48.62 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -173.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.38 -51.4 0.01 OUTLIER Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.996 1.76 . . . . 0.0 112.786 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 61.3 m 76.26 26.14 0.96 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.496 1.919 . . . . 0.0 112.423 -171.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 p -135.11 73.32 1.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.603 1.961 . . . . 0.0 111.992 -160.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 t -74.1 59.46 0.74 Allowed 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.936 -1.103 . . . . 0.0 112.903 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -112.81 166.54 11.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.68 1.592 . . . . 0.0 112.591 175.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.02 146.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 125.763 1.625 . . . . 0.0 114.66 -153.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -94.47 -67.07 0.87 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.776 1.23 . . . . 0.0 108.447 161.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -122.48 151.76 60.26 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 126.099 1.76 . . . . 0.0 108.144 155.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -35.91 -33.8 0.12 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 124.799 3.666 . . . . 0.0 117.516 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -98.14 94.76 7.0 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 126.869 2.067 . . . . 0.0 110.309 164.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -119.37 -149.97 0.45 Allowed 'General case' 0 CA--C 1.567 1.597 1 C-N-CA 132.906 4.482 . . . . 0.0 112.618 4.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -130.74 130.24 43.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 119.726 -1.859 . . . . 0.0 111.321 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -117.24 -116.79 0.32 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -145.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.0 t -160.65 82.47 0.67 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 120.312 -1.493 . . . . 0.0 112.56 -161.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.259 1.561 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -170.325 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -111.17 -72.49 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.05 0.94 . . . . 0.0 110.191 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -104.37 -2.42 25.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.682 1.593 . . . . 0.0 114.177 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -63.64 90.03 0.05 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.787 1.635 . . . . 0.0 111.199 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.53 139.69 8.92 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.74 -104.42 1.9 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 160.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.15 99.4 1.12 Allowed 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.47 -1.606 . . . . 0.0 110.436 165.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 p -57.0 -40.05 75.87 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.469 1.908 . . . . 0.0 115.922 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.95 98.94 2.52 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 124.753 1.168 . . . . 0.0 111.643 -164.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.02 -86.24 1.1 Allowed Glycine 0 CA--C 1.544 1.904 0 C-N-CA 123.992 0.806 . . . . 0.0 114.976 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.1 124.22 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.245 1.418 . . . . 0.0 109.62 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.63 -54.32 3.31 Favored Glycine 0 CA--C 1.545 1.928 0 O-C-N 120.415 -1.428 . . . . 0.0 113.221 -168.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.58 131.6 49.62 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 121.253 -1.145 . . . . 0.0 113.107 163.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 t -151.56 164.08 37.63 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.173 1.389 . . . . 0.0 113.335 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.19 -167.63 52.89 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 115.879 1.111 . . . . 0.0 115.879 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.74 60.58 1.2 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.958 3.105 . . . . 0.0 116.999 -168.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -74.53 40.75 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 O-C-N 119.926 -1.734 . . . . 0.0 113.672 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.64 145.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -151.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.03 179.84 5.64 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.307 2.643 . . . . 0.0 111.665 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.55 168.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -69.29 42.97 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -153.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.66 -57.22 9.25 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.632 1.587 . . . . 0.0 115.146 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.337 2.4 t 57.19 19.78 5.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.448 2.299 . . . . 0.0 116.194 -150.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.7 p -98.65 131.74 44.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.969 2.507 . . . . 0.0 112.764 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -119.03 70.84 0.84 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.306 1.842 . . . . 0.0 110.651 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -114.11 134.86 54.6 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -166.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.15 132.0 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.65 -59.81 1.74 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.575 1.15 . . . . 0.0 110.357 158.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -129.11 150.09 74.42 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 125.968 1.707 . . . . 0.0 108.704 161.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -51.18 -33.33 43.8 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.006 2.471 . . . . 0.0 115.12 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -68.41 -15.59 63.61 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.404 0.0 OUTLIER -146.21 120.49 9.57 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 163.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -95.41 124.46 39.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.245 2.618 . . . . 0.0 111.423 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.98 165.23 13.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.558 2.343 . . . . 0.0 115.34 -160.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.82 47.0 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.397 1 C-N-CA 133.464 4.706 . . . . 0.0 116.217 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.926 2.09 . . . . 0.0 111.036 178.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 117.74 -1.124 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -135.0 -57.43 0.81 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 0.0 111.998 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.0 p -64.81 64.41 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.209 1.004 . . . . 0.0 111.411 159.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -66.72 -53.23 35.57 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.118 1.367 . . . . 0.0 112.48 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.8 108.36 1.43 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.371 1.068 . . . . 0.0 113.767 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.92 9.06 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.694 0.664 . . . . 0.0 112.639 162.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -60.37 80.77 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.732 1.613 . . . . 0.0 113.935 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -38.44 -39.99 0.51 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.83 100.48 2.56 Favored Glycine 0 CA--C 1.548 2.134 0 C-N-CA 125.415 1.483 . . . . 0.0 113.266 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.49 -169.23 25.66 Favored Glycine 0 CA--C 1.546 2.023 0 C-N-CA 124.939 1.257 . . . . 0.0 115.163 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -43.53 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 C-N-CA 124.995 1.318 . . . . 0.0 114.182 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 15.04 66.55 Favored Glycine 0 CA--C 1.549 2.215 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -133.62 111.21 10.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 119.413 1.606 . . . . 0.0 114.308 -176.707 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -125.69 -26.64 3.49 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.524 1.929 . . . . 0.0 114.275 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.03 157.63 46.15 Favored Glycine 0 CA--C 1.551 2.34 0 O-C-N 120.83 -1.169 . . . . 0.0 113.81 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.26 108.89 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.115 2.543 . . . . 0.0 114.211 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.4 t -122.64 61.96 0.99 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.138 1.775 . . . . 0.0 108.354 151.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.71 116.38 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -146.586 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.27 158.76 28.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.835 1.654 . . . . 0.0 113.644 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 -170.39 0.29 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.2 p -69.06 86.18 0.36 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -165.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.0 -61.21 0.27 Allowed Glycine 0 CA--C 1.549 2.172 0 C-N-CA 126.351 1.929 . . . . 0.0 112.375 160.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m 78.66 45.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.169 2.188 . . . . 0.0 112.88 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 p -113.34 102.41 10.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.453 2.701 . . . . 0.0 111.466 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.38 43.04 0.22 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -95.96 163.3 13.2 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.08 1.752 . . . . 0.0 111.154 165.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.36 143.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -152.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.8 -76.9 0.11 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.584 1.554 . . . . 0.0 110.86 164.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -112.26 134.33 21.53 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 126.604 1.962 . . . . 0.0 110.936 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -34.42 -37.57 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.129 1 C-N-CA 125.356 4.037 . . . . 0.0 118.13 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -80.29 20.61 0.66 Allowed 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.306 1.6 p90 -149.29 -162.08 1.48 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 120.935 -1.103 . . . . 0.0 112.69 137.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 t -149.32 147.67 28.6 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.166 -1.584 . . . . 0.0 112.575 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -121.43 -112.59 0.32 Allowed 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -152.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -176.68 73.5 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.724 1.21 . . . . 0.0 112.269 -150.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 125.901 1.68 . . . . 0.0 113.106 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -140.11 123.98 17.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.158 2.183 . . . . 0.0 109.552 -164.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p 71.69 175.68 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.326 1.451 . . . . 0.0 113.965 -165.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.63 66.68 0.74 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.645 1.212 . . . . 0.0 110.967 167.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.21 100.76 1.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.667 1.587 . . . . 0.0 112.613 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.96 -117.8 1.54 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.718 1.628 . . . . 0.0 113.199 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -71.77 68.12 0.61 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.969 -1.312 . . . . 0.0 111.655 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -48.26 -32.72 7.63 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 128.761 2.825 . . . . 0.0 116.211 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.83 92.15 0.09 OUTLIER Glycine 0 CA--C 1.542 1.737 0 C-N-CA 126.666 2.079 . . . . 0.0 110.947 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 155.76 47.14 Favored Glycine 0 CA--C 1.546 2.031 0 O-C-N 121.011 -1.288 . . . . 0.0 113.03 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.85 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 120.701 2.25 . . . . 0.0 112.231 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.6 -47.37 1.05 Allowed Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.544 1.545 . . . . 0.0 113.625 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.94 71.96 2.78 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 120.809 -1.407 . . . . 0.0 111.544 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.1 m -92.6 79.57 4.84 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.53 2.332 . . . . 0.0 111.466 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.78 -169.33 39.9 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 117.733 1.853 . . . . 0.0 117.733 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.08 127.73 27.25 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.038 3.825 . . . . 0.0 114.85 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t 169.47 65.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.329 2.652 . . . . 0.0 111.01 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.63 141.54 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.851 1.661 . . . . 0.0 112.602 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -103.85 -141.85 0.36 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 125.008 1.323 . . . . 0.0 112.844 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 -149.33 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 O-C-N 120.565 -1.334 . . . . 0.0 112.456 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.1 p -103.34 101.91 11.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.636 1.574 . . . . 0.0 112.797 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.81 -47.74 0.02 OUTLIER Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.959 1.266 . . . . 0.0 113.439 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m 65.31 29.4 11.6 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.802 1.241 . . . . 0.0 113.39 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -74.7 145.28 43.23 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.404 1.481 . . . . 0.0 111.531 157.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.0 t -153.8 83.94 1.16 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.928 1.691 . . . . 0.0 108.674 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -121.14 139.44 53.35 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.144 1.778 . . . . 0.0 114.324 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.39 123.23 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -171.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -94.18 -52.97 4.14 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.194 0.997 . . . . 0.0 110.609 158.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -135.6 155.72 78.1 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 126.033 1.733 . . . . 0.0 108.244 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.7 -33.06 68.16 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.329 2.019 . . . . 0.0 115.891 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -75.12 -13.63 60.49 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 92.07 3.23 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 127.185 2.194 . . . . 0.0 114.29 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 t -83.96 135.04 34.62 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.746 1.218 . . . . 0.0 112.813 158.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -134.29 164.04 28.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -165.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.8 t -65.56 64.98 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 127.536 2.334 . . . . 0.0 114.722 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.959 2.103 . . . . 0.0 109.458 169.503 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -117.9 175.7 5.55 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.329 2.252 . . . . 0.0 111.678 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -40.34 -35.35 0.42 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -110.97 37.69 2.74 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.757 2.023 . . . . 0.0 113.092 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.43 19.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.59 1.956 . . . . 0.0 111.797 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.77 -66.13 2.11 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.157 -0.964 . . . . 0.0 111.499 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.14 125.4 23.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.17 0.588 . . . . 0.0 110.691 150.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.7 p -80.42 -44.32 19.53 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 67.36 0.75 Allowed Glycine 0 CA--C 1.551 2.323 0 C-N-CA 124.704 1.145 . . . . 0.0 115.514 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.76 -146.33 9.98 Favored Glycine 0 CA--C 1.548 2.116 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -41.97 99.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.61 1.964 . . . . 0.0 112.6 -171.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.86 18.7 80.12 Favored Glycine 0 CA--C 1.542 1.75 0 N-CA-C 117.106 1.603 . . . . 0.0 117.106 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 58.25 1.67 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.705 1.753 . . . . 0.0 114.741 -166.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 t -88.2 71.29 9.22 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.306 -1.496 . . . . 0.0 112.274 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.14 167.23 40.31 Favored Glycine 0 CA--C 1.545 1.962 0 C-N-CA 125.857 1.694 . . . . 0.0 112.176 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.81 116.15 4.43 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.244 1.963 . . . . 0.0 113.458 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -147.59 63.78 1.14 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.212 1.805 . . . . 0.0 110.21 159.443 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -100.84 166.74 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -138.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.0 t -135.54 175.41 9.62 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 127.076 2.15 . . . . 0.0 113.663 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.55 18.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 113.534 164.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -61.58 141.07 58.01 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.0 -71.51 0.21 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.732 1.158 . . . . 0.0 113.162 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.262 4.5 m 93.87 45.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.438 1.895 . . . . 0.0 114.438 163.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -81.5 104.27 11.81 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.366 1.866 . . . . 0.0 112.275 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -83.26 62.85 6.9 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -159.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -106.37 172.33 6.87 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.843 1.257 . . . . 0.0 112.516 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.76 140.01 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 O-C-N 119.596 -1.94 . . . . 0.0 114.17 -157.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.39 -60.05 1.93 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.456 1.102 . . . . 0.0 111.84 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -79.77 -156.21 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 124.947 1.299 . . . . 0.0 111.995 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -75.41 -60.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.681 2.254 . . . . 0.0 110.931 134.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -67.51 78.91 0.17 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.054 1.342 . . . . 0.0 113.775 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -173.18 175.56 3.14 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 127.994 2.518 . . . . 0.0 110.707 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -165.16 120.21 1.33 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.582 -1.324 . . . . 0.0 112.354 134.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -103.9 -122.11 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 112.732 -160.186 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 t -148.21 61.77 1.1 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.794 2.038 . . . . 0.0 110.479 -154.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 125.417 1.487 . . . . 0.0 111.81 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -78.59 60.04 2.6 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.779 1.172 . . . . 0.0 111.449 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 m -72.25 70.57 0.84 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.372 1.069 . . . . 0.0 112.008 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -142.12 -64.32 0.43 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.452 2.301 . . . . 0.0 110.092 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.91 104.3 10.39 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.479 1.112 . . . . 0.0 110.965 169.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.14 -99.67 0.27 Allowed Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 49.4 tt0 -59.83 101.78 0.13 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.623 -0.927 . . . . 0.0 112.921 -175.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 p -41.91 -42.86 2.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.208 1.403 . . . . 0.0 114.618 168.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.67 124.02 2.45 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.411 1.958 . . . . 0.0 110.701 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.7 -138.9 8.86 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 124.063 0.84 . . . . 0.0 113.288 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.92 102.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.21 -1.171 . . . . 0.0 110.72 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.87 49.66 16.47 Favored Glycine 0 CA--C 1.545 1.925 0 C-N-CA 125.127 1.346 . . . . 0.0 114.155 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.28 122.74 0.93 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 m -125.67 -25.6 3.65 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.04 134.82 12.51 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.808 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -46.09 80.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 1 C-N-CA 125.539 4.159 . . . . 0.0 116.309 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 1.2 t -79.92 49.81 1.12 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 123.806 1.765 . . . . 0.0 111.112 175.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.12 144.29 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 115.266 -151.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.5 p -74.76 -132.74 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 125.333 1.453 . . . . 0.0 111.774 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.64 166.33 0.33 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.418 -2.051 . . . . 0.0 112.817 148.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -63.32 158.49 20.23 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.682 -1.262 . . . . 0.0 113.795 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.77 -33.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 t 47.91 22.39 0.37 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 p -140.12 176.62 8.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.308 1.843 . . . . 0.0 112.82 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -121.7 89.12 3.06 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -155.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -123.27 -117.29 0.29 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 171.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -163.0 124.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 121.417 1.917 . . . . 0.0 115.063 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.62 -67.32 0.82 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.587 1.185 . . . . 0.0 110.357 162.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -118.14 154.06 51.57 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 126.346 1.858 . . . . 0.0 109.404 159.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -33.66 -55.41 0.43 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.733 3.622 . . . . 0.0 117.14 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -65.4 -26.05 67.82 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -107.52 95.21 5.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.466 1.906 . . . . 0.0 113.589 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 t -87.97 100.06 12.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.444 1.897 . . . . 0.0 114.904 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.45 ' CG ' ' H ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -163.11 -139.42 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 127.086 2.155 . . . . 0.0 108.957 170.547 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . 0.45 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 21.73 113.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 129.985 3.314 . . . . 0.0 118.838 176.918 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.553 1.087 0 C-N-CA 127.334 2.253 . . . . 0.0 111.629 -178.698 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 63.58 3.38 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 120.159 1.345 . . . . 0.0 111.896 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -166.03 -83.76 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.456 2.702 . . . . 0.0 108.458 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -65.12 80.81 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.323 1.049 . . . . 0.0 110.986 159.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.29 68.65 10.57 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.815 1.646 . . . . 0.0 114.991 -162.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -6.49 -89.82 0.0 OUTLIER Glycine 0 CA--C 1.549 2.205 0 C-N-CA 127.667 2.556 . . . . 0.0 118.339 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.73 83.4 6.5 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 121.036 -1.273 . . . . 0.0 111.41 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -34.77 -44.76 0.23 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.983 2.113 . . . . 0.0 116.561 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.0 74.86 0.91 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.397 1.475 . . . . 0.0 113.604 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.29 -122.61 5.04 Favored Glycine 0 CA--C 1.544 1.887 0 C-N-CA 124.461 1.029 . . . . 0.0 114.941 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.82 113.45 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 O-C-N 119.922 -1.928 . . . . 0.0 112.26 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.52 37.31 81.84 Favored Glycine 0 CA--C 1.545 1.936 0 C-N-CA 125.037 1.303 . . . . 0.0 115.421 -169.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -147.5 155.85 42.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.887 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -161.69 -37.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.147 -0.971 . . . . 0.0 113.253 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.65 47.99 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -65.32 69.53 0.31 Allowed 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.295 3.33 . . . . 0.0 117.597 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.2 p -72.23 53.09 0.27 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.0 -1.688 . . . . 0.0 113.861 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.97 87.18 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -156.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.3 179.58 6.31 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 126.228 1.811 . . . . 0.0 114.403 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -176.94 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 128.572 2.749 . . . . 0.0 116.938 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 m -88.85 122.47 32.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.306 1.442 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.1 -74.72 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 C-N-CA 126.075 1.798 . . . . 0.0 110.6 167.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.304 1.7 m 109.75 29.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 130.706 3.603 . . . . 0.0 114.464 146.611 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.8 p -89.52 119.63 30.12 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.056 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -75.76 67.03 2.14 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 120.238 -1.539 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -61.91 -177.9 0.13 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 130.69 3.596 . . . . 0.0 115.318 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.5 135.76 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 O-C-N 119.125 -2.235 . . . . 0.0 111.955 162.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mt -111.21 -72.54 0.71 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.057 1.343 . . . . 0.0 110.852 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -59.66 177.84 0.26 Allowed Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 124.717 1.207 . . . . 0.0 109.952 154.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -56.71 -60.23 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 146.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.13 81.96 2.3 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.739 1.616 . . . . 0.0 114.926 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.35 -161.37 0.2 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.356 1.462 . . . . 0.0 114.147 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t 171.92 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.543 2.737 . . . . 0.0 112.868 155.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.96 153.83 34.19 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -160.424 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.5 t -50.05 66.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 131.401 3.88 . . . . 0.0 116.673 168.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 126.991 2.116 . . . . 0.0 110.654 165.85 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -75.89 -60.97 2.09 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 p -67.12 -64.32 0.88 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.823 1.249 . . . . 0.0 112.887 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.402 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 3.9 t-80 -124.09 169.42 11.7 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.914 2.086 . . . . 0.0 109.122 159.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 -133.99 0.25 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.168 2.187 . . . . 0.0 111.91 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.62 -102.48 2.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.519 1.533 . . . . 0.0 111.023 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -63.05 72.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.556 1.542 . . . . 0.0 114.896 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 p -39.4 -38.29 0.54 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.25 3.02 . . . . 0.0 116.067 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.12 99.85 2.48 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 125.13 1.348 . . . . 0.0 112.645 -175.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.86 -174.56 30.64 Favored Glycine 0 CA--C 1.544 1.881 0 N-CA-C 115.634 1.014 . . . . 0.0 115.634 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -41.16 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 126.979 2.112 . . . . 0.0 114.281 -168.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 38.15 27.24 Favored Glycine 0 CA--C 1.546 1.994 0 C-N-CA 125.646 1.594 . . . . 0.0 116.391 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.98 57.23 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 118.618 1.209 . . . . 0.0 112.264 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -87.26 86.61 7.28 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.323 1.449 . . . . 0.0 114.022 -169.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.3 178.56 43.61 Favored Glycine 0 CA--C 1.548 2.15 0 N-CA-C 117.651 1.821 . . . . 0.0 117.651 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -63.06 51.27 0.13 Allowed 'Trans proline' 0 CA--C 1.551 1.363 1 C-N-CA 126.476 4.784 . . . . 0.0 118.318 -171.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 p -82.93 39.28 0.62 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.841 2.056 . . . . 0.0 113.14 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -87.43 82.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -144.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.86 165.53 0.9 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 163.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.04 -160.0 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 129.108 2.963 . . . . 0.0 117.549 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.64 81.97 6.77 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 118.412 -2.68 . . . . 0.0 114.673 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.32 -71.48 1.31 Allowed Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.198 0.904 . . . . 0.0 112.676 166.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . 0.402 ' HA ' ' CG ' ' A' ' 4' ' ' HIS . 4.1 m 87.81 22.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.472 2.309 . . . . 0.0 113.12 -164.486 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -134.0 76.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.16 1.384 . . . . 0.0 111.075 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.04 56.57 0.32 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.686 1.195 . . . . 0.0 113.402 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -110.72 162.15 15.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.436 2.694 . . . . 0.0 111.357 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.54 144.43 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 119.792 -1.817 . . . . 0.0 115.825 -155.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.1 -69.03 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.266 1.427 . . . . 0.0 111.149 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -118.89 130.97 24.53 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 127.152 2.181 . . . . 0.0 111.249 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -34.17 -38.66 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.216 1 C-N-CA 125.704 4.269 . . . . 0.0 119.161 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -70.57 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -166.43 -169.21 1.35 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.926 2.49 . . . . 0.0 112.122 156.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -157.76 119.01 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.291 -1.506 . . . . 0.0 111.047 167.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -103.79 -121.91 0.2 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.327 1.851 . . . . 0.0 115.382 -153.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.0 t -153.72 73.76 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.836 -1.165 . . . . 0.0 111.733 -156.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.03 1.332 . . . . 0.0 111.592 -169.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -86.98 74.98 9.61 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 119.98 -1.7 . . . . 0.0 111.605 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 168.69 -81.24 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 130.067 3.347 . . . . 0.0 108.329 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -109.04 152.2 25.33 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 149.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.3 -162.76 1.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 128.947 2.899 . . . . 0.0 113.649 -169.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -129.88 0.74 Allowed Glycine 0 CA--C 1.544 1.902 0 C-N-CA 124.202 0.906 . . . . 0.0 115.293 168.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.92 80.51 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 0.0 115.53 -166.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 m -27.58 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.51 3.124 . . . . 0.0 117.509 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.95 99.5 1.58 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.101 1.334 . . . . 0.0 110.122 -153.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.11 -134.97 6.25 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 123.898 0.761 . . . . 0.0 113.746 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.7 mt -85.51 115.86 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 O-C-N 121.233 -1.157 . . . . 0.0 109.666 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.45 41.17 98.49 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.359 1.304 . . . . 0.0 116.359 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -162.39 122.29 2.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.894 1.677 . . . . 0.0 110.402 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -160.48 168.51 24.95 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.12 -162.54 29.84 Favored Glycine 0 CA--C 1.548 2.137 0 C-N-CA 125.283 1.42 . . . . 0.0 114.812 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.34 56.38 0.6 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 124.608 3.539 . . . . 0.0 115.448 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -123.87 66.21 1.04 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.407 1.883 . . . . 0.0 110.814 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.26 157.07 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 125.746 1.618 . . . . 0.0 114.069 -157.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 t -121.69 171.66 8.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 127.073 2.149 . . . . 0.0 112.583 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.68 -123.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 129.156 2.982 . . . . 0.0 117.599 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.73 160.14 16.99 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.054 -1.653 . . . . 0.0 112.198 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.66 -57.2 0.12 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.061 0.839 . . . . 0.0 111.854 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 92.4 32.89 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 127.758 2.423 . . . . 0.0 112.513 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 p -137.38 72.93 1.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.631 1.172 . . . . 0.0 113.147 -152.087 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.64 123.2 20.74 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 120.726 -1.234 . . . . 0.0 111.176 172.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -147.05 -179.8 7.07 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -152.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.91 95.93 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 126.476 1.91 . . . . 0.0 112.957 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.91 -50.34 17.19 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.215 -1.553 . . . . 0.0 110.68 163.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -131.23 164.24 43.74 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.844 2.058 . . . . 0.0 108.387 153.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -51.54 -34.6 52.73 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 CA-C-N 122.479 1.921 . . . . 0.0 115.198 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -78.66 -6.08 54.74 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.86 95.73 4.17 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.304 -1.498 . . . . 0.0 114.636 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 t -85.53 136.77 33.27 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.726 1.61 . . . . 0.0 112.08 153.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -122.4 -120.05 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -170.39 78.61 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.086 0.954 . . . . 0.0 111.051 -153.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.12 1.368 . . . . 0.0 111.51 -171.066 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -58.74 -31.81 68.67 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.886 -1.134 . . . . 0.0 111.867 158.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -66.44 9.58 0.16 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.503 2.321 . . . . 0.0 116.853 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -127.03 172.79 10.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.28 1.832 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.0 89.36 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 120.996 -1.065 . . . . 0.0 113.162 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.67 -103.73 0.12 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 146.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -46.44 107.55 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 117.634 0.717 . . . . 0.0 112.52 152.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.5 p -62.78 -50.39 71.22 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 120.024 -1.672 . . . . 0.0 113.373 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.08 117.22 2.43 Favored Glycine 0 CA--C 1.544 1.875 0 C-N-CA 126.31 1.91 . . . . 0.0 112.477 -168.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.09 -85.48 1.87 Allowed Glycine 0 CA--C 1.54 1.648 0 C-N-CA 124.342 0.972 . . . . 0.0 113.964 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.42 131.23 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 125.474 1.509 . . . . 0.0 109.74 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -55.76 2.57 Favored Glycine 0 CA--C 1.546 1.979 0 O-C-N 120.832 -1.168 . . . . 0.0 114.146 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.4 90.73 3.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.587 1.155 . . . . 0.0 112.191 174.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.0 m -90.82 78.47 6.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.778 1.231 . . . . 0.0 112.728 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.6 -177.47 21.71 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 124.897 1.237 . . . . 0.0 115.534 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.62 166.19 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.224 3.283 . . . . 0.0 114.914 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.1 t -179.42 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.654 1.981 . . . . 0.0 111.588 -170.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 84.3 t -95.16 144.95 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 125.828 1.651 . . . . 0.0 112.106 174.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.4 t 84.97 173.16 0.06 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 127.35 2.26 . . . . 0.0 114.751 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.32 -170.05 2.8 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.418 1.087 . . . . 0.0 111.05 158.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.1 p -66.8 115.62 6.79 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.352 -1.468 . . . . 0.0 114.37 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.87 -49.99 0.15 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 126.045 1.784 . . . . 0.0 114.666 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m 71.52 24.38 3.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.633 1.573 . . . . 0.0 114.277 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -103.58 83.63 2.18 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.54 1.936 . . . . 0.0 111.064 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -70.15 65.47 0.26 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -120.81 157.73 29.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.301 2.641 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -111.06 152.88 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 127.374 2.27 . . . . 0.0 115.935 -165.236 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.17 -76.76 0.42 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.623 1.969 . . . . 0.0 109.383 160.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -109.13 138.33 20.39 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 126.403 1.881 . . . . 0.0 112.078 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -26.31 -52.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 1 C-N-CA 126.331 4.688 . . . . 0.0 119.288 -175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 24.65 0.09 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -159.76 173.14 16.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.109 1.363 . . . . 0.0 114.185 160.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 t -141.1 127.26 19.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.695 1.198 . . . . 0.0 111.631 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -98.97 -125.62 0.16 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 125.164 1.386 . . . . 0.0 114.588 -165.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.86 101.49 0.56 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.162 3.385 . . . . 0.0 106.034 -157.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.092 1.757 . . . . 0.0 111.982 -163.205 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -163.14 79.03 0.45 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.661 1.984 . . . . 0.0 110.917 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t 49.04 48.91 20.28 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.877 -1.139 . . . . 0.0 112.396 -163.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -156.96 -114.1 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.121 1.368 . . . . 0.0 110.169 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.91 143.78 5.18 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 119.986 -1.697 . . . . 0.0 113.258 160.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.42 -151.75 45.46 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -155.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -64.13 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.111 0.958 . . . . 0.0 112.348 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.8 p -40.4 -56.52 2.0 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 128.376 2.67 . . . . 0.0 115.121 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 120.36 2.67 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.961 1.743 . . . . 0.0 111.346 -166.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.56 -125.92 5.66 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.301 0.953 . . . . 0.0 113.785 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.07 99.48 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.346 -1.091 . . . . 0.0 110.095 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.01 28.71 58.17 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 104.24 3.26 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.91 1.684 . . . . 0.0 110.215 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 m -132.96 151.73 52.02 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.814 1.646 . . . . 0.0 113.791 -164.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.68 -160.54 14.33 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 167.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.02 31.25 0.36 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.405 2.737 . . . . 0.0 114.637 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -75.45 45.38 0.3 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.455 1.902 . . . . 0.0 111.679 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.27 114.12 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -149.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.1 t -50.33 171.35 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 125.766 1.626 . . . . 0.0 114.53 166.417 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.74 176.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 164.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -70.05 176.22 3.94 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -64.11 0.32 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.167 1.365 . . . . 0.0 112.088 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m 91.08 38.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.254 2.222 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 p -127.36 74.14 1.49 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.188 2.195 . . . . 0.0 112.297 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.0 68.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.754 1.222 . . . . 0.0 113.592 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -113.37 154.46 26.88 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.992 2.117 . . . . 0.0 112.884 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.84 146.89 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.62 -85.65 0.3 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.712 0.805 . . . . 0.0 109.201 151.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -94.85 144.78 28.41 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.718 1.207 . . . . 0.0 111.05 156.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -31.11 -44.65 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.441 4.094 . . . . 0.0 117.219 174.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.97 -25.7 68.25 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.349 0.0 OUTLIER -144.2 107.02 4.45 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 173.283 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 t -78.08 142.88 37.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.768 2.027 . . . . 0.0 113.287 165.245 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -128.9 -99.82 0.34 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.94 66.97 0.31 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.924 -1.735 . . . . 0.0 112.273 -160.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.896 1.278 . . . . 0.0 111.526 -170.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.4 -74.06 1.17 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.957 0.789 . . . . 0.0 114.597 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.87 117.14 7.13 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -83.9 -55.0 4.47 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 125.09 1.356 . . . . 0.0 111.801 149.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.5 167.42 21.98 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 125.792 1.663 . . . . 0.0 116.511 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 -119.03 1.85 Allowed Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.061 1.185 . . . . 0.0 116.061 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.72 85.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 125.975 1.71 . . . . 0.0 113.111 -166.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.15 36.05 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 126.047 1.784 . . . . 0.0 115.803 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.69 148.97 23.31 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 t -174.51 -55.59 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.382 1.873 . . . . 0.0 111.6 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.06 152.01 4.22 Favored Glycine 0 CA--C 1.55 2.232 0 C-N-CA 124.051 0.834 . . . . 0.0 114.269 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.97 71.31 5.03 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.359 2.706 . . . . 0.0 113.255 -167.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -75.37 43.0 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.562 1.545 . . . . 0.0 112.744 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.9 93.74 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -148.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.35 158.51 20.29 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.886 -1.133 . . . . 0.0 111.761 148.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.42 -179.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.3 m -51.49 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 129.302 3.041 . . . . 0.0 117.081 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -39.15 34.76 Favored Glycine 0 CA--C 1.545 1.942 0 C-N-CA 123.695 0.664 . . . . 0.0 114.331 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.269 0.5 OUTLIER 64.93 -49.46 0.34 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.3 2.64 . . . . 0.0 114.862 -175.772 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 p -92.75 173.48 7.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.229 1.411 . . . . 0.0 111.901 158.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -129.18 83.44 2.15 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.813 1.245 . . . . 0.0 112.312 -159.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -105.1 -106.43 0.3 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.498 1.119 . . . . 0.0 113.628 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -168.59 147.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 121.596 1.998 . . . . 0.0 114.969 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -98.73 -60.9 1.45 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.536 1.636 . . . . 0.0 110.526 155.467 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -127.67 138.56 33.11 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.296 2.638 . . . . 0.0 108.751 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -26.35 -57.44 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 126.224 4.616 . . . . 0.0 118.508 -166.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -64.45 -35.67 81.68 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 28' ' ' LEU . 3.2 t80 -92.84 85.64 5.25 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.005 1.322 . . . . 0.0 112.336 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -69.02 49.25 0.07 Allowed 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -136.25 174.53 10.52 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 118.815 -2.428 . . . . 0.0 114.362 -158.289 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 t 60.44 90.31 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 150.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.491 2.716 . . . . 0.0 111.545 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.93 82.71 0.84 Allowed Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 111.397 -162.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 22.1 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.521 2.728 . . . . 0.0 116.733 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 p -42.99 -72.12 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.898 2.079 . . . . 0.0 115.493 164.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.3 78.08 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 C-N-CA 124.517 1.056 . . . . 0.0 113.812 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 -122.76 4.6 Favored Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.428 1.49 . . . . 0.0 113.836 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.01 121.03 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.872 -1.37 . . . . 0.0 111.971 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.49 27.56 38.9 Favored Glycine 0 CA--C 1.545 1.945 0 C-N-CA 124.898 1.237 . . . . 0.0 114.935 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.38 178.17 10.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.197 1.799 . . . . 0.0 112.065 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 t 179.15 -49.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.604 1.962 . . . . 0.0 111.748 171.283 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.15 147.01 42.4 Favored Glycine 0 CA--C 1.552 2.374 0 O-C-N 121.21 -0.931 . . . . 0.0 113.836 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.67 142.87 49.5 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 123.509 2.806 . . . . 0.0 113.701 -171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -140.28 71.06 1.36 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.743 1.735 . . . . 0.0 112.609 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.44 149.25 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -160.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.49 -131.34 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.956 0.902 . . . . 0.0 113.352 166.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.38 -70.92 0.53 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 119.916 -1.74 . . . . 0.0 112.77 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -172.24 -178.41 2.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.824 2.45 . . . . 0.0 111.992 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.6 -34.2 1.82 Allowed Glycine 0 CA--C 1.543 1.835 0 C-N-CA 126.25 1.881 . . . . 0.0 113.998 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.318 13.0 t 51.86 49.54 20.54 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.359 1.864 . . . . 0.0 115.155 -167.581 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.9 p -114.14 70.11 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.199 2.2 . . . . 0.0 114.194 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.53 70.01 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 O-C-N 120.171 -1.581 . . . . 0.0 111.664 165.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.98 -162.39 0.78 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.664 1.986 . . . . 0.0 112.938 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.8 132.3 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 120.915 -1.116 . . . . 0.0 112.677 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.26 -60.99 1.58 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.129 1.371 . . . . 0.0 110.988 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.23 163.23 27.82 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.105 1.762 . . . . 0.0 109.916 161.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -46.97 -35.76 19.11 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.052 3.168 . . . . 0.0 116.834 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -72.51 -26.64 61.85 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -127.91 129.28 46.6 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -139.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -119.58 143.25 47.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 112.661 162.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -142.2 0.37 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.775 1.63 . . . . 0.0 111.832 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 t -115.43 102.44 9.83 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.122 1.769 . . . . 0.0 111.153 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.258 1.547 0 C-N-CA 126.193 1.797 . . . . 0.0 111.61 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 119.464 -0.303 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.32 -137.31 14.17 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.532 1.539 . . . . 0.0 111.483 -160.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.35 68.86 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.802 1.641 . . . . 0.0 114.8 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -46.34 -13.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 130.778 3.631 . . . . 0.0 119.465 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.96 82.2 0.74 Allowed Glycine 0 CA--C 1.548 2.136 0 CA-C-N 120.286 1.403 . . . . 0.0 114.462 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.79 -83.02 0.58 Allowed Glycine 0 CA--C 1.547 2.055 0 O-C-N 121.65 -0.912 . . . . 0.0 115.286 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.1 130.57 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 125.176 1.39 . . . . 0.0 110.384 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.47 -57.4 1.22 Allowed Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.117 -0.989 . . . . 0.0 114.363 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.51 134.66 56.72 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.16 1.384 . . . . 0.0 113.251 167.566 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -147.7 -50.42 0.18 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.78 -171.15 1.95 Allowed Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.139 1.615 . . . . 0.0 117.139 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -65.41 39.85 0.13 Allowed 'Trans proline' 0 CA--C 1.56 1.787 1 C-N-CA 125.4 4.067 . . . . 0.0 118.699 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -67.13 35.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 119.962 -1.711 . . . . 0.0 114.876 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.42 142.37 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 119.974 -1.704 . . . . 0.0 115.117 -153.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.32 -156.48 0.11 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.278 1.431 . . . . 0.0 113.145 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 125.938 1.695 . . . . 0.0 113.498 162.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -94.17 -165.15 1.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.618 -1.301 . . . . 0.0 113.991 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.75 -70.03 0.52 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.981 1.753 . . . . 0.0 111.807 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m 86.88 37.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 126.581 1.952 . . . . 0.0 113.017 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -112.96 83.39 1.82 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.949 2.1 . . . . 0.0 112.67 -167.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -72.59 140.89 48.32 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 120.619 -1.301 . . . . 0.0 112.283 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -152.69 175.49 12.77 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.385 1.474 . . . . 0.0 114.018 -156.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.34 114.67 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 125.735 1.614 . . . . 0.0 112.591 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.71 -92.78 0.09 Allowed 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.238 -0.914 . . . . 0.0 108.915 162.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -76.7 154.99 83.47 Favored Pre-proline 0 CA--C 1.562 1.435 0 O-C-N 120.404 -1.435 . . . . 0.0 110.262 148.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -44.18 -42.64 13.14 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.522 2.815 . . . . 0.0 114.314 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.98 20.52 1.51 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.32 96.25 2.74 Favored 'General case' 0 CA--C 1.554 1.135 0 O-C-N 120.304 -1.498 . . . . 0.0 113.514 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.5 t -92.94 119.07 31.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.445 1.898 . . . . 0.0 110.927 165.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -111.93 -120.23 0.29 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -154.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -164.87 93.93 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.342 -1.474 . . . . 0.0 111.456 -159.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 126.855 2.062 . . . . 0.0 112.086 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 120.39 0.138 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.99 -136.88 3.25 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 123.977 0.798 . . . . 0.0 111.231 158.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -56.45 79.8 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 p -52.11 -43.26 63.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.816 2.046 . . . . 0.0 113.098 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.8 152.4 29.03 Favored Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.613 1.101 . . . . 0.0 114.682 -165.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.59 -123.8 4.39 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.965 1.269 . . . . 0.0 111.855 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.4 133.73 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 120.493 -1.592 . . . . 0.0 111.402 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.39 7.55 46.62 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 118.539 2.176 . . . . 0.0 118.539 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.43 117.39 15.27 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 119.41 1.605 . . . . 0.0 110.652 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -164.69 101.14 0.8 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.433 1.093 . . . . 0.0 113.004 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.14 -161.48 34.84 Favored Glycine 0 CA--C 1.547 2.068 0 O-C-N 121.174 -0.954 . . . . 0.0 115.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.44 71.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 125.038 3.825 . . . . 0.0 115.065 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -128.85 16.3 6.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.361 1.864 . . . . 0.0 113.48 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.44 143.79 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -159.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.7 t -87.74 177.0 7.14 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.23 2.212 . . . . 0.0 112.493 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.34 176.23 0.06 Allowed 'General case' 0 CA--C 1.557 1.233 0 O-C-N 120.712 -1.243 . . . . 0.0 113.232 156.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 150.57 48.62 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -173.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.38 -51.4 0.01 OUTLIER Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.996 1.76 . . . . 0.0 112.786 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 23' ' ' THR . 61.3 m 76.26 26.14 0.96 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.496 1.919 . . . . 0.0 112.423 -171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 p -135.11 73.32 1.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.603 1.961 . . . . 0.0 111.992 -160.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 t -74.1 59.46 0.74 Allowed 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.936 -1.103 . . . . 0.0 112.903 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -112.81 166.54 11.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.68 1.592 . . . . 0.0 112.591 175.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.02 146.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 125.763 1.625 . . . . 0.0 114.66 -153.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -94.47 -67.07 0.87 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.776 1.23 . . . . 0.0 108.447 161.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -122.48 151.76 60.26 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 126.099 1.76 . . . . 0.0 108.144 155.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -35.91 -33.8 0.12 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 124.799 3.666 . . . . 0.0 117.516 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -98.14 94.76 7.0 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 126.869 2.067 . . . . 0.0 110.309 164.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -119.37 -149.97 0.45 Allowed 'General case' 0 CA--C 1.567 1.597 1 C-N-CA 132.906 4.482 . . . . 0.0 112.618 4.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -130.74 130.24 43.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 119.726 -1.859 . . . . 0.0 111.321 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -117.24 -116.79 0.32 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -145.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.0 t -160.65 82.47 0.67 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 120.312 -1.493 . . . . 0.0 112.56 -161.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.259 1.561 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -170.325 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.74 -104.42 1.9 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 160.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.15 99.4 1.12 Allowed 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.47 -1.606 . . . . 0.0 110.436 165.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 p -57.0 -40.05 75.87 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.469 1.908 . . . . 0.0 115.922 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.95 98.94 2.52 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 124.753 1.168 . . . . 0.0 111.643 -164.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.02 -86.24 1.1 Allowed Glycine 0 CA--C 1.544 1.904 0 C-N-CA 123.992 0.806 . . . . 0.0 114.976 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.1 124.22 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.245 1.418 . . . . 0.0 109.62 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.63 -54.32 3.31 Favored Glycine 0 CA--C 1.545 1.928 0 O-C-N 120.415 -1.428 . . . . 0.0 113.221 -168.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.58 131.6 49.62 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 121.253 -1.145 . . . . 0.0 113.107 163.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 t -151.56 164.08 37.63 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.173 1.389 . . . . 0.0 113.335 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.19 -167.63 52.89 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 115.879 1.111 . . . . 0.0 115.879 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.74 60.58 1.2 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.958 3.105 . . . . 0.0 116.999 -168.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -74.53 40.75 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 O-C-N 119.926 -1.734 . . . . 0.0 113.672 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.64 145.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -151.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.03 179.84 5.64 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.307 2.643 . . . . 0.0 111.665 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.55 168.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -69.29 42.97 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -153.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.66 -57.22 9.25 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.632 1.587 . . . . 0.0 115.146 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.337 2.4 t 57.19 19.78 5.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.448 2.299 . . . . 0.0 116.194 -150.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.7 p -98.65 131.74 44.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.969 2.507 . . . . 0.0 112.764 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -119.03 70.84 0.84 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.306 1.842 . . . . 0.0 110.651 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -114.11 134.86 54.6 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -166.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.15 132.0 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.65 -59.81 1.74 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.575 1.15 . . . . 0.0 110.357 158.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -129.11 150.09 74.42 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 125.968 1.707 . . . . 0.0 108.704 161.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -51.18 -33.33 43.8 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.006 2.471 . . . . 0.0 115.12 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -68.41 -15.59 63.61 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.404 0.0 OUTLIER -146.21 120.49 9.57 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 163.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -95.41 124.46 39.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.245 2.618 . . . . 0.0 111.423 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.98 165.23 13.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.558 2.343 . . . . 0.0 115.34 -160.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.82 47.0 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.397 1 C-N-CA 133.464 4.706 . . . . 0.0 116.217 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.926 2.09 . . . . 0.0 111.036 178.465 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.92 9.06 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.694 0.664 . . . . 0.0 112.639 162.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -60.37 80.77 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.732 1.613 . . . . 0.0 113.935 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -38.44 -39.99 0.51 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.83 100.48 2.56 Favored Glycine 0 CA--C 1.548 2.134 0 C-N-CA 125.415 1.483 . . . . 0.0 113.266 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.49 -169.23 25.66 Favored Glycine 0 CA--C 1.546 2.023 0 C-N-CA 124.939 1.257 . . . . 0.0 115.163 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -43.53 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 C-N-CA 124.995 1.318 . . . . 0.0 114.182 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 15.04 66.55 Favored Glycine 0 CA--C 1.549 2.215 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -133.62 111.21 10.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 119.413 1.606 . . . . 0.0 114.308 -176.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -125.69 -26.64 3.49 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.524 1.929 . . . . 0.0 114.275 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.03 157.63 46.15 Favored Glycine 0 CA--C 1.551 2.34 0 O-C-N 120.83 -1.169 . . . . 0.0 113.81 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.26 108.89 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.115 2.543 . . . . 0.0 114.211 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 13' ' ' TYR . 4.4 t -122.64 61.96 0.99 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.138 1.775 . . . . 0.0 108.354 151.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.71 116.38 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -146.586 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.27 158.76 28.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.835 1.654 . . . . 0.0 113.644 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 -170.39 0.29 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.2 p -69.06 86.18 0.36 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -165.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.0 -61.21 0.27 Allowed Glycine 0 CA--C 1.549 2.172 0 C-N-CA 126.351 1.929 . . . . 0.0 112.375 160.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m 78.66 45.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.169 2.188 . . . . 0.0 112.88 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 p -113.34 102.41 10.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.453 2.701 . . . . 0.0 111.466 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.38 43.04 0.22 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -95.96 163.3 13.2 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.08 1.752 . . . . 0.0 111.154 165.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.36 143.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -152.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.8 -76.9 0.11 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.584 1.554 . . . . 0.0 110.86 164.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -112.26 134.33 21.53 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 126.604 1.962 . . . . 0.0 110.936 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -34.42 -37.57 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.129 1 C-N-CA 125.356 4.037 . . . . 0.0 118.13 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -80.29 20.61 0.66 Allowed 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.306 1.6 p90 -149.29 -162.08 1.48 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 120.935 -1.103 . . . . 0.0 112.69 137.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 t -149.32 147.67 28.6 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.166 -1.584 . . . . 0.0 112.575 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -121.43 -112.59 0.32 Allowed 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -152.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -176.68 73.5 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.724 1.21 . . . . 0.0 112.269 -150.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 125.901 1.68 . . . . 0.0 113.106 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.96 -117.8 1.54 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.718 1.628 . . . . 0.0 113.199 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -71.77 68.12 0.61 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.969 -1.312 . . . . 0.0 111.655 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -48.26 -32.72 7.63 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 128.761 2.825 . . . . 0.0 116.211 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.83 92.15 0.09 OUTLIER Glycine 0 CA--C 1.542 1.737 0 C-N-CA 126.666 2.079 . . . . 0.0 110.947 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 155.76 47.14 Favored Glycine 0 CA--C 1.546 2.031 0 O-C-N 121.011 -1.288 . . . . 0.0 113.03 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.85 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 120.701 2.25 . . . . 0.0 112.231 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.6 -47.37 1.05 Allowed Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.544 1.545 . . . . 0.0 113.625 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.94 71.96 2.78 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 120.809 -1.407 . . . . 0.0 111.544 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.1 m -92.6 79.57 4.84 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.53 2.332 . . . . 0.0 111.466 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.78 -169.33 39.9 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 117.733 1.853 . . . . 0.0 117.733 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.08 127.73 27.25 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.038 3.825 . . . . 0.0 114.85 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t 169.47 65.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.329 2.652 . . . . 0.0 111.01 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.63 141.54 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.851 1.661 . . . . 0.0 112.602 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -103.85 -141.85 0.36 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 125.008 1.323 . . . . 0.0 112.844 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 -149.33 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 O-C-N 120.565 -1.334 . . . . 0.0 112.456 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.1 p -103.34 101.91 11.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.636 1.574 . . . . 0.0 112.797 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.81 -47.74 0.02 OUTLIER Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.959 1.266 . . . . 0.0 113.439 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m 65.31 29.4 11.6 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.802 1.241 . . . . 0.0 113.39 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -74.7 145.28 43.23 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.404 1.481 . . . . 0.0 111.531 157.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.0 t -153.8 83.94 1.16 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.928 1.691 . . . . 0.0 108.674 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -121.14 139.44 53.35 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.144 1.778 . . . . 0.0 114.324 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.39 123.23 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -171.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -94.18 -52.97 4.14 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.194 0.997 . . . . 0.0 110.609 158.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -135.6 155.72 78.1 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 126.033 1.733 . . . . 0.0 108.244 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.7 -33.06 68.16 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.329 2.019 . . . . 0.0 115.891 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -75.12 -13.63 60.49 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 92.07 3.23 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 127.185 2.194 . . . . 0.0 114.29 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 t -83.96 135.04 34.62 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.746 1.218 . . . . 0.0 112.813 158.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -134.29 164.04 28.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -165.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.8 t -65.56 64.98 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 127.536 2.334 . . . . 0.0 114.722 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.959 2.103 . . . . 0.0 109.458 169.503 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.77 -66.13 2.11 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.157 -0.964 . . . . 0.0 111.499 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.14 125.4 23.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.17 0.588 . . . . 0.0 110.691 150.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.7 p -80.42 -44.32 19.53 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.067 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 67.36 0.75 Allowed Glycine 0 CA--C 1.551 2.323 0 C-N-CA 124.704 1.145 . . . . 0.0 115.514 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.76 -146.33 9.98 Favored Glycine 0 CA--C 1.548 2.116 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -41.97 99.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.61 1.964 . . . . 0.0 112.6 -171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.86 18.7 80.12 Favored Glycine 0 CA--C 1.542 1.75 0 N-CA-C 117.106 1.603 . . . . 0.0 117.106 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 58.25 1.67 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.705 1.753 . . . . 0.0 114.741 -166.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 t -88.2 71.29 9.22 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.306 -1.496 . . . . 0.0 112.274 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.14 167.23 40.31 Favored Glycine 0 CA--C 1.545 1.962 0 C-N-CA 125.857 1.694 . . . . 0.0 112.176 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.81 116.15 4.43 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.244 1.963 . . . . 0.0 113.458 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -147.59 63.78 1.14 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.212 1.805 . . . . 0.0 110.21 159.443 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -100.84 166.74 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -138.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.0 t -135.54 175.41 9.62 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 127.076 2.15 . . . . 0.0 113.663 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.55 18.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 113.534 164.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -61.58 141.07 58.01 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.0 -71.51 0.21 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.732 1.158 . . . . 0.0 113.162 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.262 4.5 m 93.87 45.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.438 1.895 . . . . 0.0 114.438 163.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -81.5 104.27 11.81 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.366 1.866 . . . . 0.0 112.275 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -83.26 62.85 6.9 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -159.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -106.37 172.33 6.87 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.843 1.257 . . . . 0.0 112.516 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.76 140.01 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 O-C-N 119.596 -1.94 . . . . 0.0 114.17 -157.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.39 -60.05 1.93 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.456 1.102 . . . . 0.0 111.84 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -79.77 -156.21 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 124.947 1.299 . . . . 0.0 111.995 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -75.41 -60.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.681 2.254 . . . . 0.0 110.931 134.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -67.51 78.91 0.17 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.054 1.342 . . . . 0.0 113.775 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -173.18 175.56 3.14 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 127.994 2.518 . . . . 0.0 110.707 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -165.16 120.21 1.33 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.582 -1.324 . . . . 0.0 112.354 134.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -103.9 -122.11 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 112.732 -160.186 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 t -148.21 61.77 1.1 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.794 2.038 . . . . 0.0 110.479 -154.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 125.417 1.487 . . . . 0.0 111.81 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.101 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.14 -99.67 0.27 Allowed Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 17' ' ' THR . 49.4 tt0 -59.83 101.78 0.13 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.623 -0.927 . . . . 0.0 112.921 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 p -41.91 -42.86 2.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.208 1.403 . . . . 0.0 114.618 168.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.67 124.02 2.45 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.411 1.958 . . . . 0.0 110.701 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.7 -138.9 8.86 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 124.063 0.84 . . . . 0.0 113.288 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.92 102.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.21 -1.171 . . . . 0.0 110.72 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.87 49.66 16.47 Favored Glycine 0 CA--C 1.545 1.925 0 C-N-CA 125.127 1.346 . . . . 0.0 114.155 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.28 122.74 0.93 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 m -125.67 -25.6 3.65 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.04 134.82 12.51 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.808 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -46.09 80.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 1 C-N-CA 125.539 4.159 . . . . 0.0 116.309 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 1.2 t -79.92 49.81 1.12 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 123.806 1.765 . . . . 0.0 111.112 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.12 144.29 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 115.266 -151.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.5 p -74.76 -132.74 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 125.333 1.453 . . . . 0.0 111.774 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.64 166.33 0.33 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.418 -2.051 . . . . 0.0 112.817 148.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -63.32 158.49 20.23 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.682 -1.262 . . . . 0.0 113.795 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.77 -33.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 t 47.91 22.39 0.37 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 p -140.12 176.62 8.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.308 1.843 . . . . 0.0 112.82 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -121.7 89.12 3.06 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -155.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -123.27 -117.29 0.29 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 171.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -163.0 124.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 121.417 1.917 . . . . 0.0 115.063 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.62 -67.32 0.82 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.587 1.185 . . . . 0.0 110.357 162.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -118.14 154.06 51.57 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 126.346 1.858 . . . . 0.0 109.404 159.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -33.66 -55.41 0.43 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.733 3.622 . . . . 0.0 117.14 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -65.4 -26.05 67.82 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -107.52 95.21 5.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.466 1.906 . . . . 0.0 113.589 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 t -87.97 100.06 12.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.444 1.897 . . . . 0.0 114.904 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.434 ' CG ' ' H ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -163.11 -139.42 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 127.086 2.155 . . . . 0.0 108.957 170.547 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 35' ' ' CYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 21.73 113.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 129.985 3.314 . . . . 0.0 118.838 176.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.553 1.087 0 C-N-CA 127.334 2.253 . . . . 0.0 111.629 -178.698 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -6.49 -89.82 0.0 OUTLIER Glycine 0 CA--C 1.549 2.205 0 C-N-CA 127.667 2.556 . . . . 0.0 118.339 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.73 83.4 6.5 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 121.036 -1.273 . . . . 0.0 111.41 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -34.77 -44.76 0.23 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.983 2.113 . . . . 0.0 116.561 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.0 74.86 0.91 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.397 1.475 . . . . 0.0 113.604 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.29 -122.61 5.04 Favored Glycine 0 CA--C 1.544 1.887 0 C-N-CA 124.461 1.029 . . . . 0.0 114.941 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.82 113.45 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 O-C-N 119.922 -1.928 . . . . 0.0 112.26 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.52 37.31 81.84 Favored Glycine 0 CA--C 1.545 1.936 0 C-N-CA 125.037 1.303 . . . . 0.0 115.421 -169.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -147.5 155.85 42.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.887 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -161.69 -37.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.147 -0.971 . . . . 0.0 113.253 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.65 47.99 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -65.32 69.53 0.31 Allowed 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.295 3.33 . . . . 0.0 117.597 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.2 p -72.23 53.09 0.27 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.0 -1.688 . . . . 0.0 113.861 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.97 87.18 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -156.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.3 179.58 6.31 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 126.228 1.811 . . . . 0.0 114.403 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -176.94 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 128.572 2.749 . . . . 0.0 116.938 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 m -88.85 122.47 32.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.306 1.442 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.1 -74.72 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 C-N-CA 126.075 1.798 . . . . 0.0 110.6 167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.304 1.7 m 109.75 29.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 130.706 3.603 . . . . 0.0 114.464 146.611 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.8 p -89.52 119.63 30.12 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.056 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -75.76 67.03 2.14 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 120.238 -1.539 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -61.91 -177.9 0.13 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 130.69 3.596 . . . . 0.0 115.318 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.5 135.76 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 O-C-N 119.125 -2.235 . . . . 0.0 111.955 162.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mt -111.21 -72.54 0.71 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.057 1.343 . . . . 0.0 110.852 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -59.66 177.84 0.26 Allowed Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 124.717 1.207 . . . . 0.0 109.952 154.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -56.71 -60.23 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 146.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.13 81.96 2.3 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.739 1.616 . . . . 0.0 114.926 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.35 -161.37 0.2 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.356 1.462 . . . . 0.0 114.147 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t 171.92 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.543 2.737 . . . . 0.0 112.868 155.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.96 153.83 34.19 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -160.424 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.5 t -50.05 66.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 131.401 3.88 . . . . 0.0 116.673 168.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 126.991 2.116 . . . . 0.0 110.654 165.85 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.62 -102.48 2.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.519 1.533 . . . . 0.0 111.023 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -63.05 72.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.556 1.542 . . . . 0.0 114.896 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 p -39.4 -38.29 0.54 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.25 3.02 . . . . 0.0 116.067 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.12 99.85 2.48 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 125.13 1.348 . . . . 0.0 112.645 -175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.86 -174.56 30.64 Favored Glycine 0 CA--C 1.544 1.881 0 N-CA-C 115.634 1.014 . . . . 0.0 115.634 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -41.16 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 126.979 2.112 . . . . 0.0 114.281 -168.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 38.15 27.24 Favored Glycine 0 CA--C 1.546 1.994 0 C-N-CA 125.646 1.594 . . . . 0.0 116.391 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.98 57.23 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 118.618 1.209 . . . . 0.0 112.264 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -87.26 86.61 7.28 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.323 1.449 . . . . 0.0 114.022 -169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.3 178.56 43.61 Favored Glycine 0 CA--C 1.548 2.15 0 N-CA-C 117.651 1.821 . . . . 0.0 117.651 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -63.06 51.27 0.13 Allowed 'Trans proline' 0 CA--C 1.551 1.363 1 C-N-CA 126.476 4.784 . . . . 0.0 118.318 -171.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 p -82.93 39.28 0.62 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.841 2.056 . . . . 0.0 113.14 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -87.43 82.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -144.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.86 165.53 0.9 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 163.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.04 -160.0 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 129.108 2.963 . . . . 0.0 117.549 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.64 81.97 6.77 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 118.412 -2.68 . . . . 0.0 114.673 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.32 -71.48 1.31 Allowed Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.198 0.904 . . . . 0.0 112.676 166.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m 87.81 22.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.472 2.309 . . . . 0.0 113.12 -164.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -134.0 76.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.16 1.384 . . . . 0.0 111.075 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.04 56.57 0.32 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.686 1.195 . . . . 0.0 113.402 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -110.72 162.15 15.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.436 2.694 . . . . 0.0 111.357 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.54 144.43 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 119.792 -1.817 . . . . 0.0 115.825 -155.365 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.1 -69.03 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.266 1.427 . . . . 0.0 111.149 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -118.89 130.97 24.53 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 127.152 2.181 . . . . 0.0 111.249 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -34.17 -38.66 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.216 1 C-N-CA 125.704 4.269 . . . . 0.0 119.161 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -70.57 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -166.43 -169.21 1.35 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.926 2.49 . . . . 0.0 112.122 156.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -157.76 119.01 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.291 -1.506 . . . . 0.0 111.047 167.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -103.79 -121.91 0.2 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.327 1.851 . . . . 0.0 115.382 -153.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.0 t -153.72 73.76 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.836 -1.165 . . . . 0.0 111.733 -156.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.03 1.332 . . . . 0.0 111.592 -169.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.913 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -129.88 0.74 Allowed Glycine 0 CA--C 1.544 1.902 0 C-N-CA 124.202 0.906 . . . . 0.0 115.293 168.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.92 80.51 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 0.0 115.53 -166.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 m -27.58 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.51 3.124 . . . . 0.0 117.509 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.95 99.5 1.58 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.101 1.334 . . . . 0.0 110.122 -153.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.11 -134.97 6.25 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 123.898 0.761 . . . . 0.0 113.746 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.7 mt -85.51 115.86 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 O-C-N 121.233 -1.157 . . . . 0.0 109.666 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.45 41.17 98.49 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.359 1.304 . . . . 0.0 116.359 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -162.39 122.29 2.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.894 1.677 . . . . 0.0 110.402 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -160.48 168.51 24.95 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.12 -162.54 29.84 Favored Glycine 0 CA--C 1.548 2.137 0 C-N-CA 125.283 1.42 . . . . 0.0 114.812 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.34 56.38 0.6 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 124.608 3.539 . . . . 0.0 115.448 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -123.87 66.21 1.04 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.407 1.883 . . . . 0.0 110.814 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.26 157.07 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 125.746 1.618 . . . . 0.0 114.069 -157.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 t -121.69 171.66 8.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 127.073 2.149 . . . . 0.0 112.583 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.68 -123.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 129.156 2.982 . . . . 0.0 117.599 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.73 160.14 16.99 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.054 -1.653 . . . . 0.0 112.198 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.66 -57.2 0.12 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.061 0.839 . . . . 0.0 111.854 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 92.4 32.89 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 127.758 2.423 . . . . 0.0 112.513 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 p -137.38 72.93 1.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.631 1.172 . . . . 0.0 113.147 -152.087 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.64 123.2 20.74 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 120.726 -1.234 . . . . 0.0 111.176 172.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -147.05 -179.8 7.07 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -152.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.91 95.93 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 126.476 1.91 . . . . 0.0 112.957 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.91 -50.34 17.19 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.215 -1.553 . . . . 0.0 110.68 163.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -131.23 164.24 43.74 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.844 2.058 . . . . 0.0 108.387 153.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -51.54 -34.6 52.73 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 CA-C-N 122.479 1.921 . . . . 0.0 115.198 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -78.66 -6.08 54.74 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.86 95.73 4.17 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.304 -1.498 . . . . 0.0 114.636 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 t -85.53 136.77 33.27 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.726 1.61 . . . . 0.0 112.08 153.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -122.4 -120.05 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -170.39 78.61 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.086 0.954 . . . . 0.0 111.051 -153.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.12 1.368 . . . . 0.0 111.51 -171.066 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.67 -103.73 0.12 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 146.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -46.44 107.55 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 117.634 0.717 . . . . 0.0 112.52 152.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.5 p -62.78 -50.39 71.22 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 120.024 -1.672 . . . . 0.0 113.373 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.08 117.22 2.43 Favored Glycine 0 CA--C 1.544 1.875 0 C-N-CA 126.31 1.91 . . . . 0.0 112.477 -168.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.09 -85.48 1.87 Allowed Glycine 0 CA--C 1.54 1.648 0 C-N-CA 124.342 0.972 . . . . 0.0 113.964 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.42 131.23 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 125.474 1.509 . . . . 0.0 109.74 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -55.76 2.57 Favored Glycine 0 CA--C 1.546 1.979 0 O-C-N 120.832 -1.168 . . . . 0.0 114.146 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.4 90.73 3.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.587 1.155 . . . . 0.0 112.191 174.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.0 m -90.82 78.47 6.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.778 1.231 . . . . 0.0 112.728 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.6 -177.47 21.71 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 124.897 1.237 . . . . 0.0 115.534 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.62 166.19 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.224 3.283 . . . . 0.0 114.914 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' VAL . 5.1 t -179.42 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.654 1.981 . . . . 0.0 111.588 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 17' ' ' THR . 84.3 t -95.16 144.95 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 125.828 1.651 . . . . 0.0 112.106 174.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.4 t 84.97 173.16 0.06 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 127.35 2.26 . . . . 0.0 114.751 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.32 -170.05 2.8 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.418 1.087 . . . . 0.0 111.05 158.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.1 p -66.8 115.62 6.79 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.352 -1.468 . . . . 0.0 114.37 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.87 -49.99 0.15 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 126.045 1.784 . . . . 0.0 114.666 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m 71.52 24.38 3.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.633 1.573 . . . . 0.0 114.277 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -103.58 83.63 2.18 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.54 1.936 . . . . 0.0 111.064 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -70.15 65.47 0.26 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -120.81 157.73 29.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.301 2.641 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -111.06 152.88 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 127.374 2.27 . . . . 0.0 115.935 -165.236 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.17 -76.76 0.42 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.623 1.969 . . . . 0.0 109.383 160.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -109.13 138.33 20.39 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 126.403 1.881 . . . . 0.0 112.078 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -26.31 -52.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 1 C-N-CA 126.331 4.688 . . . . 0.0 119.288 -175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 24.65 0.09 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -159.76 173.14 16.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.109 1.363 . . . . 0.0 114.185 160.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 t -141.1 127.26 19.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.695 1.198 . . . . 0.0 111.631 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -98.97 -125.62 0.16 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 125.164 1.386 . . . . 0.0 114.588 -165.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.86 101.49 0.56 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.162 3.385 . . . . 0.0 106.034 -157.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.092 1.757 . . . . 0.0 111.982 -163.205 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.149 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.42 -151.75 45.46 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -155.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -64.13 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.111 0.958 . . . . 0.0 112.348 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.8 p -40.4 -56.52 2.0 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 128.376 2.67 . . . . 0.0 115.121 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 120.36 2.67 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.961 1.743 . . . . 0.0 111.346 -166.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.56 -125.92 5.66 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.301 0.953 . . . . 0.0 113.785 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.07 99.48 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.346 -1.091 . . . . 0.0 110.095 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.01 28.71 58.17 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 104.24 3.26 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.91 1.684 . . . . 0.0 110.215 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 m -132.96 151.73 52.02 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.814 1.646 . . . . 0.0 113.791 -164.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.68 -160.54 14.33 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 167.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.02 31.25 0.36 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.405 2.737 . . . . 0.0 114.637 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -75.45 45.38 0.3 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.455 1.902 . . . . 0.0 111.679 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.27 114.12 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -149.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.1 t -50.33 171.35 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 125.766 1.626 . . . . 0.0 114.53 166.417 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.74 176.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 164.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -70.05 176.22 3.94 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -64.11 0.32 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.167 1.365 . . . . 0.0 112.088 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m 91.08 38.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.254 2.222 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 p -127.36 74.14 1.49 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.188 2.195 . . . . 0.0 112.297 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.0 68.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.754 1.222 . . . . 0.0 113.592 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -113.37 154.46 26.88 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.992 2.117 . . . . 0.0 112.884 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.84 146.89 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.62 -85.65 0.3 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.712 0.805 . . . . 0.0 109.201 151.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -94.85 144.78 28.41 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.718 1.207 . . . . 0.0 111.05 156.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -31.11 -44.65 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.441 4.094 . . . . 0.0 117.219 174.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.97 -25.7 68.25 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.349 0.0 OUTLIER -144.2 107.02 4.45 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 173.283 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 t -78.08 142.88 37.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.768 2.027 . . . . 0.0 113.287 165.245 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -128.9 -99.82 0.34 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.94 66.97 0.31 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.924 -1.735 . . . . 0.0 112.273 -160.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.896 1.278 . . . . 0.0 111.526 -170.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -83.5 -50.76 7.96 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -75.48 -76.15 0.16 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.199 1.4 . . . . 0.0 111.247 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -65.01 107.78 1.61 Allowed 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.453 -0.78 . . . . 0.0 110.228 164.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.28 58.49 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.4 -74.06 1.17 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.957 0.789 . . . . 0.0 114.597 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.87 117.14 7.13 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -83.9 -55.0 4.47 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 125.09 1.356 . . . . 0.0 111.801 149.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.5 167.42 21.98 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 125.792 1.663 . . . . 0.0 116.511 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 -119.03 1.85 Allowed Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.061 1.185 . . . . 0.0 116.061 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.72 85.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 125.975 1.71 . . . . 0.0 113.111 -166.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.15 36.05 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 126.047 1.784 . . . . 0.0 115.803 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.69 148.97 23.31 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 t -174.51 -55.59 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.382 1.873 . . . . 0.0 111.6 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.06 152.01 4.22 Favored Glycine 0 CA--C 1.55 2.232 0 C-N-CA 124.051 0.834 . . . . 0.0 114.269 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.97 71.31 5.03 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.359 2.706 . . . . 0.0 113.255 -167.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -75.37 43.0 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.562 1.545 . . . . 0.0 112.744 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.9 93.74 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -148.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.35 158.51 20.29 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.886 -1.133 . . . . 0.0 111.761 148.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.42 -179.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.3 m -51.49 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 129.302 3.041 . . . . 0.0 117.081 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -39.15 34.76 Favored Glycine 0 CA--C 1.545 1.942 0 C-N-CA 123.695 0.664 . . . . 0.0 114.331 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.269 0.5 OUTLIER 64.93 -49.46 0.34 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.3 2.64 . . . . 0.0 114.862 -175.772 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 p -92.75 173.48 7.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.229 1.411 . . . . 0.0 111.901 158.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -129.18 83.44 2.15 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.813 1.245 . . . . 0.0 112.312 -159.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -105.1 -106.43 0.3 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.498 1.119 . . . . 0.0 113.628 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -168.59 147.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 121.596 1.998 . . . . 0.0 114.969 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -98.73 -60.9 1.45 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.536 1.636 . . . . 0.0 110.526 155.467 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -127.67 138.56 33.11 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.296 2.638 . . . . 0.0 108.751 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -26.35 -57.44 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 126.224 4.616 . . . . 0.0 118.508 -166.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -64.45 -35.67 81.68 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 28' ' ' LEU . 3.2 t80 -92.84 85.64 5.25 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.005 1.322 . . . . 0.0 112.336 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -69.02 49.25 0.07 Allowed 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -136.25 174.53 10.52 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 118.815 -2.428 . . . . 0.0 114.362 -158.289 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 t 60.44 90.31 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 150.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.491 2.716 . . . . 0.0 111.545 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -107.49 102.81 12.05 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -165.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.7 p -57.88 80.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.503 1.921 . . . . 0.0 113.687 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -165.46 -56.02 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.389 2.276 . . . . 0.0 109.055 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.74 125.9 29.75 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.758 1.223 . . . . 0.0 110.399 147.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.93 82.71 0.84 Allowed Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 111.397 -162.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 22.1 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.521 2.728 . . . . 0.0 116.733 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 p -42.99 -72.12 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.898 2.079 . . . . 0.0 115.493 164.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.3 78.08 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 C-N-CA 124.517 1.056 . . . . 0.0 113.812 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 -122.76 4.6 Favored Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.428 1.49 . . . . 0.0 113.836 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.01 121.03 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.872 -1.37 . . . . 0.0 111.971 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.49 27.56 38.9 Favored Glycine 0 CA--C 1.545 1.945 0 C-N-CA 124.898 1.237 . . . . 0.0 114.935 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.38 178.17 10.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.197 1.799 . . . . 0.0 112.065 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 t 179.15 -49.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.604 1.962 . . . . 0.0 111.748 171.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.15 147.01 42.4 Favored Glycine 0 CA--C 1.552 2.374 0 O-C-N 121.21 -0.931 . . . . 0.0 113.836 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.67 142.87 49.5 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 123.509 2.806 . . . . 0.0 113.701 -171.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -140.28 71.06 1.36 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.743 1.735 . . . . 0.0 112.609 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.44 149.25 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -160.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.49 -131.34 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.956 0.902 . . . . 0.0 113.352 166.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.38 -70.92 0.53 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 119.916 -1.74 . . . . 0.0 112.77 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -172.24 -178.41 2.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.824 2.45 . . . . 0.0 111.992 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.6 -34.2 1.82 Allowed Glycine 0 CA--C 1.543 1.835 0 C-N-CA 126.25 1.881 . . . . 0.0 113.998 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.318 13.0 t 51.86 49.54 20.54 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.359 1.864 . . . . 0.0 115.155 -167.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.9 p -114.14 70.11 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.199 2.2 . . . . 0.0 114.194 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.53 70.01 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 O-C-N 120.171 -1.581 . . . . 0.0 111.664 165.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tp60 -86.98 -162.39 0.78 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.664 1.986 . . . . 0.0 112.938 -178.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.8 132.3 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 120.915 -1.116 . . . . 0.0 112.677 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.26 -60.99 1.58 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.129 1.371 . . . . 0.0 110.988 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.23 163.23 27.82 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.105 1.762 . . . . 0.0 109.916 161.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -46.97 -35.76 19.11 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.052 3.168 . . . . 0.0 116.834 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -72.51 -26.64 61.85 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -127.91 129.28 46.6 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -139.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -119.58 143.25 47.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 112.661 162.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -142.2 0.37 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.775 1.63 . . . . 0.0 111.832 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 t -115.43 102.44 9.83 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.122 1.769 . . . . 0.0 111.153 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.258 1.547 0 C-N-CA 126.193 1.797 . . . . 0.0 111.61 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -48.02 -80.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -158.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.9 m -94.29 -73.25 0.58 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.9 0.88 . . . . 0.0 110.554 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 38.41 3.47 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 122.843 1.306 . . . . 0.0 110.233 150.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.54 120.21 10.1 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.859 -1.15 . . . . 0.0 111.568 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.32 -137.31 14.17 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.532 1.539 . . . . 0.0 111.483 -160.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.35 68.86 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.802 1.641 . . . . 0.0 114.8 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -46.34 -13.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 130.778 3.631 . . . . 0.0 119.465 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.96 82.2 0.74 Allowed Glycine 0 CA--C 1.548 2.136 0 CA-C-N 120.286 1.403 . . . . 0.0 114.462 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.79 -83.02 0.58 Allowed Glycine 0 CA--C 1.547 2.055 0 O-C-N 121.65 -0.912 . . . . 0.0 115.286 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.1 130.57 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 125.176 1.39 . . . . 0.0 110.384 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.47 -57.4 1.22 Allowed Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.117 -0.989 . . . . 0.0 114.363 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.51 134.66 56.72 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.16 1.384 . . . . 0.0 113.251 167.566 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -147.7 -50.42 0.18 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.78 -171.15 1.95 Allowed Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.139 1.615 . . . . 0.0 117.139 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -65.41 39.85 0.13 Allowed 'Trans proline' 0 CA--C 1.56 1.787 1 C-N-CA 125.4 4.067 . . . . 0.0 118.699 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -67.13 35.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 119.962 -1.711 . . . . 0.0 114.876 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.42 142.37 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 119.974 -1.704 . . . . 0.0 115.117 -153.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.32 -156.48 0.11 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.278 1.431 . . . . 0.0 113.145 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 125.938 1.695 . . . . 0.0 113.498 162.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -94.17 -165.15 1.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.618 -1.301 . . . . 0.0 113.991 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.75 -70.03 0.52 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.981 1.753 . . . . 0.0 111.807 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m 86.88 37.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 126.581 1.952 . . . . 0.0 113.017 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -112.96 83.39 1.82 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.949 2.1 . . . . 0.0 112.67 -167.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -72.59 140.89 48.32 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 120.619 -1.301 . . . . 0.0 112.283 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 25.8 tp60 -152.69 175.49 12.77 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.385 1.474 . . . . 0.0 114.018 -156.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.34 114.67 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 125.735 1.614 . . . . 0.0 112.591 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.71 -92.78 0.09 Allowed 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.238 -0.914 . . . . 0.0 108.915 162.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -76.7 154.99 83.47 Favored Pre-proline 0 CA--C 1.562 1.435 0 O-C-N 120.404 -1.435 . . . . 0.0 110.262 148.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -44.18 -42.64 13.14 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.522 2.815 . . . . 0.0 114.314 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.98 20.52 1.51 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.32 96.25 2.74 Favored 'General case' 0 CA--C 1.554 1.135 0 O-C-N 120.304 -1.498 . . . . 0.0 113.514 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.5 t -92.94 119.07 31.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.445 1.898 . . . . 0.0 110.927 165.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -111.93 -120.23 0.29 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -154.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -164.87 93.93 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.342 -1.474 . . . . 0.0 111.456 -159.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 126.855 2.062 . . . . 0.0 112.086 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 46.2 p . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -64.83 111.0 2.61 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.315 0.961 . . . . 0.0 111.433 169.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -68.43 115.05 7.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.407 0.683 . . . . 0.0 112.588 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -94.79 -69.29 0.76 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.818 1.647 . . . . 0.0 111.082 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.39 103.1 5.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.927 1.291 . . . . 0.0 111.327 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.99 -136.88 3.25 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 123.977 0.798 . . . . 0.0 111.231 158.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -56.45 79.8 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 p -52.11 -43.26 63.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.816 2.046 . . . . 0.0 113.098 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.8 152.4 29.03 Favored Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.613 1.101 . . . . 0.0 114.682 -165.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.59 -123.8 4.39 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.965 1.269 . . . . 0.0 111.855 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.4 133.73 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 120.493 -1.592 . . . . 0.0 111.402 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.39 7.55 46.62 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 118.539 2.176 . . . . 0.0 118.539 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.43 117.39 15.27 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 119.41 1.605 . . . . 0.0 110.652 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -164.69 101.14 0.8 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.433 1.093 . . . . 0.0 113.004 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.14 -161.48 34.84 Favored Glycine 0 CA--C 1.547 2.068 0 O-C-N 121.174 -0.954 . . . . 0.0 115.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.44 71.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 125.038 3.825 . . . . 0.0 115.065 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -128.85 16.3 6.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.361 1.864 . . . . 0.0 113.48 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.44 143.79 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -159.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.7 t -87.74 177.0 7.14 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.23 2.212 . . . . 0.0 112.493 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.34 176.23 0.06 Allowed 'General case' 0 CA--C 1.557 1.233 0 O-C-N 120.712 -1.243 . . . . 0.0 113.232 156.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 150.57 48.62 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -173.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.38 -51.4 0.01 OUTLIER Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.996 1.76 . . . . 0.0 112.786 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 23' ' ' THR . 61.3 m 76.26 26.14 0.96 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.496 1.919 . . . . 0.0 112.423 -171.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 p -135.11 73.32 1.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.603 1.961 . . . . 0.0 111.992 -160.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 t -74.1 59.46 0.74 Allowed 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.936 -1.103 . . . . 0.0 112.903 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -112.81 166.54 11.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.68 1.592 . . . . 0.0 112.591 175.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.02 146.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 125.763 1.625 . . . . 0.0 114.66 -153.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -94.47 -67.07 0.87 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.776 1.23 . . . . 0.0 108.447 161.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -122.48 151.76 60.26 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 126.099 1.76 . . . . 0.0 108.144 155.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -35.91 -33.8 0.12 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 124.799 3.666 . . . . 0.0 117.516 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -98.14 94.76 7.0 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 126.869 2.067 . . . . 0.0 110.309 164.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -119.37 -149.97 0.45 Allowed 'General case' 0 CA--C 1.567 1.597 1 C-N-CA 132.906 4.482 . . . . 0.0 112.618 4.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -130.74 130.24 43.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 119.726 -1.859 . . . . 0.0 111.321 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -117.24 -116.79 0.32 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -145.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.0 t -160.65 82.47 0.67 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 120.312 -1.493 . . . . 0.0 112.56 -161.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.259 1.561 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -170.325 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -111.17 -72.49 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.05 0.94 . . . . 0.0 110.191 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -104.37 -2.42 25.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.682 1.593 . . . . 0.0 114.177 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -63.64 90.03 0.05 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.787 1.635 . . . . 0.0 111.199 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.53 139.69 8.92 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.74 -104.42 1.9 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 160.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.15 99.4 1.12 Allowed 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.47 -1.606 . . . . 0.0 110.436 165.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 p -57.0 -40.05 75.87 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.469 1.908 . . . . 0.0 115.922 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.95 98.94 2.52 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 124.753 1.168 . . . . 0.0 111.643 -164.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.02 -86.24 1.1 Allowed Glycine 0 CA--C 1.544 1.904 0 C-N-CA 123.992 0.806 . . . . 0.0 114.976 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.1 124.22 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.245 1.418 . . . . 0.0 109.62 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.63 -54.32 3.31 Favored Glycine 0 CA--C 1.545 1.928 0 O-C-N 120.415 -1.428 . . . . 0.0 113.221 -168.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.58 131.6 49.62 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 121.253 -1.145 . . . . 0.0 113.107 163.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 t -151.56 164.08 37.63 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.173 1.389 . . . . 0.0 113.335 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.19 -167.63 52.89 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 115.879 1.111 . . . . 0.0 115.879 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.74 60.58 1.2 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.958 3.105 . . . . 0.0 116.999 -168.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -74.53 40.75 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 O-C-N 119.926 -1.734 . . . . 0.0 113.672 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.64 145.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -151.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.03 179.84 5.64 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.307 2.643 . . . . 0.0 111.665 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.55 168.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -69.29 42.97 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -153.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.66 -57.22 9.25 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.632 1.587 . . . . 0.0 115.146 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.337 2.4 t 57.19 19.78 5.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.448 2.299 . . . . 0.0 116.194 -150.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.7 p -98.65 131.74 44.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.969 2.507 . . . . 0.0 112.764 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -119.03 70.84 0.84 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.306 1.842 . . . . 0.0 110.651 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -114.11 134.86 54.6 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -166.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.15 132.0 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.65 -59.81 1.74 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.575 1.15 . . . . 0.0 110.357 158.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -129.11 150.09 74.42 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 125.968 1.707 . . . . 0.0 108.704 161.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -51.18 -33.33 43.8 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.006 2.471 . . . . 0.0 115.12 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -68.41 -15.59 63.61 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.404 0.0 OUTLIER -146.21 120.49 9.57 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 163.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -95.41 124.46 39.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.245 2.618 . . . . 0.0 111.423 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.98 165.23 13.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.558 2.343 . . . . 0.0 115.34 -160.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.82 47.0 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.397 1 C-N-CA 133.464 4.706 . . . . 0.0 116.217 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.926 2.09 . . . . 0.0 111.036 178.465 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 117.74 -1.124 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -135.0 -57.43 0.81 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 0.0 111.998 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.0 p -64.81 64.41 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.209 1.004 . . . . 0.0 111.411 159.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -66.72 -53.23 35.57 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.118 1.367 . . . . 0.0 112.48 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.8 108.36 1.43 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.371 1.068 . . . . 0.0 113.767 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.92 9.06 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.694 0.664 . . . . 0.0 112.639 162.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -60.37 80.77 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.732 1.613 . . . . 0.0 113.935 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -38.44 -39.99 0.51 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.83 100.48 2.56 Favored Glycine 0 CA--C 1.548 2.134 0 C-N-CA 125.415 1.483 . . . . 0.0 113.266 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.49 -169.23 25.66 Favored Glycine 0 CA--C 1.546 2.023 0 C-N-CA 124.939 1.257 . . . . 0.0 115.163 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -43.53 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 C-N-CA 124.995 1.318 . . . . 0.0 114.182 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 15.04 66.55 Favored Glycine 0 CA--C 1.549 2.215 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -133.62 111.21 10.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 119.413 1.606 . . . . 0.0 114.308 -176.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -125.69 -26.64 3.49 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.524 1.929 . . . . 0.0 114.275 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.03 157.63 46.15 Favored Glycine 0 CA--C 1.551 2.34 0 O-C-N 120.83 -1.169 . . . . 0.0 113.81 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.26 108.89 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.115 2.543 . . . . 0.0 114.211 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 13' ' ' TYR . 4.4 t -122.64 61.96 0.99 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.138 1.775 . . . . 0.0 108.354 151.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.71 116.38 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -146.586 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.27 158.76 28.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.835 1.654 . . . . 0.0 113.644 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 -170.39 0.29 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.2 p -69.06 86.18 0.36 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -165.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.0 -61.21 0.27 Allowed Glycine 0 CA--C 1.549 2.172 0 C-N-CA 126.351 1.929 . . . . 0.0 112.375 160.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m 78.66 45.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.169 2.188 . . . . 0.0 112.88 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 p -113.34 102.41 10.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.453 2.701 . . . . 0.0 111.466 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.38 43.04 0.22 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -95.96 163.3 13.2 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.08 1.752 . . . . 0.0 111.154 165.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.36 143.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -152.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.8 -76.9 0.11 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.584 1.554 . . . . 0.0 110.86 164.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -112.26 134.33 21.53 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 126.604 1.962 . . . . 0.0 110.936 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -34.42 -37.57 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.129 1 C-N-CA 125.356 4.037 . . . . 0.0 118.13 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -80.29 20.61 0.66 Allowed 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.306 1.6 p90 -149.29 -162.08 1.48 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 120.935 -1.103 . . . . 0.0 112.69 137.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 t -149.32 147.67 28.6 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.166 -1.584 . . . . 0.0 112.575 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -121.43 -112.59 0.32 Allowed 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -152.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -176.68 73.5 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.724 1.21 . . . . 0.0 112.269 -150.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 125.901 1.68 . . . . 0.0 113.106 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -140.11 123.98 17.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.158 2.183 . . . . 0.0 109.552 -164.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p 71.69 175.68 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.326 1.451 . . . . 0.0 113.965 -165.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.63 66.68 0.74 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.645 1.212 . . . . 0.0 110.967 167.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.21 100.76 1.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.667 1.587 . . . . 0.0 112.613 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.96 -117.8 1.54 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.718 1.628 . . . . 0.0 113.199 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -71.77 68.12 0.61 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.969 -1.312 . . . . 0.0 111.655 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -48.26 -32.72 7.63 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 128.761 2.825 . . . . 0.0 116.211 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.83 92.15 0.09 OUTLIER Glycine 0 CA--C 1.542 1.737 0 C-N-CA 126.666 2.079 . . . . 0.0 110.947 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 155.76 47.14 Favored Glycine 0 CA--C 1.546 2.031 0 O-C-N 121.011 -1.288 . . . . 0.0 113.03 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.85 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 120.701 2.25 . . . . 0.0 112.231 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.6 -47.37 1.05 Allowed Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.544 1.545 . . . . 0.0 113.625 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.94 71.96 2.78 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 120.809 -1.407 . . . . 0.0 111.544 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.1 m -92.6 79.57 4.84 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.53 2.332 . . . . 0.0 111.466 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.78 -169.33 39.9 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 117.733 1.853 . . . . 0.0 117.733 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.08 127.73 27.25 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.038 3.825 . . . . 0.0 114.85 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t 169.47 65.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.329 2.652 . . . . 0.0 111.01 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.63 141.54 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.851 1.661 . . . . 0.0 112.602 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -103.85 -141.85 0.36 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 125.008 1.323 . . . . 0.0 112.844 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 -149.33 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 O-C-N 120.565 -1.334 . . . . 0.0 112.456 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.1 p -103.34 101.91 11.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.636 1.574 . . . . 0.0 112.797 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.81 -47.74 0.02 OUTLIER Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.959 1.266 . . . . 0.0 113.439 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m 65.31 29.4 11.6 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.802 1.241 . . . . 0.0 113.39 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -74.7 145.28 43.23 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.404 1.481 . . . . 0.0 111.531 157.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.0 t -153.8 83.94 1.16 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.928 1.691 . . . . 0.0 108.674 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -121.14 139.44 53.35 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.144 1.778 . . . . 0.0 114.324 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.39 123.23 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -171.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -94.18 -52.97 4.14 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.194 0.997 . . . . 0.0 110.609 158.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -135.6 155.72 78.1 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 126.033 1.733 . . . . 0.0 108.244 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.7 -33.06 68.16 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.329 2.019 . . . . 0.0 115.891 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -75.12 -13.63 60.49 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 92.07 3.23 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 127.185 2.194 . . . . 0.0 114.29 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 t -83.96 135.04 34.62 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.746 1.218 . . . . 0.0 112.813 158.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -134.29 164.04 28.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -165.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.8 t -65.56 64.98 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 127.536 2.334 . . . . 0.0 114.722 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.959 2.103 . . . . 0.0 109.458 169.503 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -117.9 175.7 5.55 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.329 2.252 . . . . 0.0 111.678 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -40.34 -35.35 0.42 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -110.97 37.69 2.74 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.757 2.023 . . . . 0.0 113.092 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.43 19.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.59 1.956 . . . . 0.0 111.797 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.77 -66.13 2.11 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.157 -0.964 . . . . 0.0 111.499 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.14 125.4 23.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.17 0.588 . . . . 0.0 110.691 150.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.7 p -80.42 -44.32 19.53 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 67.36 0.75 Allowed Glycine 0 CA--C 1.551 2.323 0 C-N-CA 124.704 1.145 . . . . 0.0 115.514 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.76 -146.33 9.98 Favored Glycine 0 CA--C 1.548 2.116 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -41.97 99.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.61 1.964 . . . . 0.0 112.6 -171.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.86 18.7 80.12 Favored Glycine 0 CA--C 1.542 1.75 0 N-CA-C 117.106 1.603 . . . . 0.0 117.106 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 58.25 1.67 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.705 1.753 . . . . 0.0 114.741 -166.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 t -88.2 71.29 9.22 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.306 -1.496 . . . . 0.0 112.274 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.14 167.23 40.31 Favored Glycine 0 CA--C 1.545 1.962 0 C-N-CA 125.857 1.694 . . . . 0.0 112.176 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.81 116.15 4.43 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.244 1.963 . . . . 0.0 113.458 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -147.59 63.78 1.14 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.212 1.805 . . . . 0.0 110.21 159.443 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -100.84 166.74 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -138.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.0 t -135.54 175.41 9.62 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 127.076 2.15 . . . . 0.0 113.663 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.55 18.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 113.534 164.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -61.58 141.07 58.01 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.0 -71.51 0.21 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.732 1.158 . . . . 0.0 113.162 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.262 4.5 m 93.87 45.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.438 1.895 . . . . 0.0 114.438 163.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -81.5 104.27 11.81 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.366 1.866 . . . . 0.0 112.275 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -83.26 62.85 6.9 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -159.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -106.37 172.33 6.87 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.843 1.257 . . . . 0.0 112.516 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.76 140.01 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 O-C-N 119.596 -1.94 . . . . 0.0 114.17 -157.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.39 -60.05 1.93 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.456 1.102 . . . . 0.0 111.84 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -79.77 -156.21 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 124.947 1.299 . . . . 0.0 111.995 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -75.41 -60.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.681 2.254 . . . . 0.0 110.931 134.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -67.51 78.91 0.17 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.054 1.342 . . . . 0.0 113.775 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -173.18 175.56 3.14 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 127.994 2.518 . . . . 0.0 110.707 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -165.16 120.21 1.33 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.582 -1.324 . . . . 0.0 112.354 134.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -103.9 -122.11 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 112.732 -160.186 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 t -148.21 61.77 1.1 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.794 2.038 . . . . 0.0 110.479 -154.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 125.417 1.487 . . . . 0.0 111.81 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -78.59 60.04 2.6 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.779 1.172 . . . . 0.0 111.449 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 m -72.25 70.57 0.84 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.372 1.069 . . . . 0.0 112.008 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -142.12 -64.32 0.43 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.452 2.301 . . . . 0.0 110.092 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.91 104.3 10.39 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.479 1.112 . . . . 0.0 110.965 169.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.14 -99.67 0.27 Allowed Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 17' ' ' THR . 49.4 tt0 -59.83 101.78 0.13 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.623 -0.927 . . . . 0.0 112.921 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 p -41.91 -42.86 2.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.208 1.403 . . . . 0.0 114.618 168.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.67 124.02 2.45 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.411 1.958 . . . . 0.0 110.701 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.7 -138.9 8.86 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 124.063 0.84 . . . . 0.0 113.288 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.92 102.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.21 -1.171 . . . . 0.0 110.72 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.87 49.66 16.47 Favored Glycine 0 CA--C 1.545 1.925 0 C-N-CA 125.127 1.346 . . . . 0.0 114.155 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.28 122.74 0.93 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 m -125.67 -25.6 3.65 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.04 134.82 12.51 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.808 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -46.09 80.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 1 C-N-CA 125.539 4.159 . . . . 0.0 116.309 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 1.2 t -79.92 49.81 1.12 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 123.806 1.765 . . . . 0.0 111.112 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.12 144.29 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 115.266 -151.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.5 p -74.76 -132.74 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 125.333 1.453 . . . . 0.0 111.774 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.64 166.33 0.33 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.418 -2.051 . . . . 0.0 112.817 148.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -63.32 158.49 20.23 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.682 -1.262 . . . . 0.0 113.795 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.77 -33.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 t 47.91 22.39 0.37 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 p -140.12 176.62 8.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.308 1.843 . . . . 0.0 112.82 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -121.7 89.12 3.06 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -155.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -123.27 -117.29 0.29 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 171.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -163.0 124.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 121.417 1.917 . . . . 0.0 115.063 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.62 -67.32 0.82 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.587 1.185 . . . . 0.0 110.357 162.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -118.14 154.06 51.57 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 126.346 1.858 . . . . 0.0 109.404 159.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -33.66 -55.41 0.43 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.733 3.622 . . . . 0.0 117.14 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -65.4 -26.05 67.82 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -107.52 95.21 5.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.466 1.906 . . . . 0.0 113.589 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 t -87.97 100.06 12.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.444 1.897 . . . . 0.0 114.904 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.434 ' CG ' ' H ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -163.11 -139.42 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 127.086 2.155 . . . . 0.0 108.957 170.547 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 35' ' ' CYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 21.73 113.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 129.985 3.314 . . . . 0.0 118.838 176.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.553 1.087 0 C-N-CA 127.334 2.253 . . . . 0.0 111.629 -178.698 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 63.58 3.38 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 120.159 1.345 . . . . 0.0 111.896 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -166.03 -83.76 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.456 2.702 . . . . 0.0 108.458 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -65.12 80.81 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.323 1.049 . . . . 0.0 110.986 159.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.29 68.65 10.57 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.815 1.646 . . . . 0.0 114.991 -162.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -6.49 -89.82 0.0 OUTLIER Glycine 0 CA--C 1.549 2.205 0 C-N-CA 127.667 2.556 . . . . 0.0 118.339 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.73 83.4 6.5 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 121.036 -1.273 . . . . 0.0 111.41 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -34.77 -44.76 0.23 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.983 2.113 . . . . 0.0 116.561 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.0 74.86 0.91 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.397 1.475 . . . . 0.0 113.604 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.29 -122.61 5.04 Favored Glycine 0 CA--C 1.544 1.887 0 C-N-CA 124.461 1.029 . . . . 0.0 114.941 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.82 113.45 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 O-C-N 119.922 -1.928 . . . . 0.0 112.26 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.52 37.31 81.84 Favored Glycine 0 CA--C 1.545 1.936 0 C-N-CA 125.037 1.303 . . . . 0.0 115.421 -169.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -147.5 155.85 42.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.887 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -161.69 -37.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.147 -0.971 . . . . 0.0 113.253 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.65 47.99 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -65.32 69.53 0.31 Allowed 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.295 3.33 . . . . 0.0 117.597 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.2 p -72.23 53.09 0.27 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.0 -1.688 . . . . 0.0 113.861 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.97 87.18 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -156.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.3 179.58 6.31 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 126.228 1.811 . . . . 0.0 114.403 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -176.94 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 128.572 2.749 . . . . 0.0 116.938 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 m -88.85 122.47 32.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.306 1.442 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.1 -74.72 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 C-N-CA 126.075 1.798 . . . . 0.0 110.6 167.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.304 1.7 m 109.75 29.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 130.706 3.603 . . . . 0.0 114.464 146.611 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.8 p -89.52 119.63 30.12 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.056 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -75.76 67.03 2.14 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 120.238 -1.539 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -61.91 -177.9 0.13 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 130.69 3.596 . . . . 0.0 115.318 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.5 135.76 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 O-C-N 119.125 -2.235 . . . . 0.0 111.955 162.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mt -111.21 -72.54 0.71 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.057 1.343 . . . . 0.0 110.852 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -59.66 177.84 0.26 Allowed Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 124.717 1.207 . . . . 0.0 109.952 154.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -56.71 -60.23 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 146.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.13 81.96 2.3 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.739 1.616 . . . . 0.0 114.926 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.35 -161.37 0.2 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.356 1.462 . . . . 0.0 114.147 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t 171.92 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.543 2.737 . . . . 0.0 112.868 155.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.96 153.83 34.19 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -160.424 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.5 t -50.05 66.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 131.401 3.88 . . . . 0.0 116.673 168.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 126.991 2.116 . . . . 0.0 110.654 165.85 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -75.89 -60.97 2.09 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 p -67.12 -64.32 0.88 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.823 1.249 . . . . 0.0 112.887 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 3.9 t-80 -124.09 169.42 11.7 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.914 2.086 . . . . 0.0 109.122 159.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 -133.99 0.25 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.168 2.187 . . . . 0.0 111.91 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.62 -102.48 2.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.519 1.533 . . . . 0.0 111.023 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -63.05 72.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.556 1.542 . . . . 0.0 114.896 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 p -39.4 -38.29 0.54 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.25 3.02 . . . . 0.0 116.067 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.12 99.85 2.48 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 125.13 1.348 . . . . 0.0 112.645 -175.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.86 -174.56 30.64 Favored Glycine 0 CA--C 1.544 1.881 0 N-CA-C 115.634 1.014 . . . . 0.0 115.634 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -41.16 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 126.979 2.112 . . . . 0.0 114.281 -168.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 38.15 27.24 Favored Glycine 0 CA--C 1.546 1.994 0 C-N-CA 125.646 1.594 . . . . 0.0 116.391 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.98 57.23 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 118.618 1.209 . . . . 0.0 112.264 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -87.26 86.61 7.28 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.323 1.449 . . . . 0.0 114.022 -169.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.3 178.56 43.61 Favored Glycine 0 CA--C 1.548 2.15 0 N-CA-C 117.651 1.821 . . . . 0.0 117.651 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -63.06 51.27 0.13 Allowed 'Trans proline' 0 CA--C 1.551 1.363 1 C-N-CA 126.476 4.784 . . . . 0.0 118.318 -171.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 p -82.93 39.28 0.62 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.841 2.056 . . . . 0.0 113.14 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -87.43 82.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -144.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.86 165.53 0.9 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 163.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.04 -160.0 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 129.108 2.963 . . . . 0.0 117.549 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.64 81.97 6.77 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 118.412 -2.68 . . . . 0.0 114.673 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.32 -71.48 1.31 Allowed Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.198 0.904 . . . . 0.0 112.676 166.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.408 ' HA ' ' CG ' ' A' ' 4' ' ' HIS . 4.1 m 87.81 22.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.472 2.309 . . . . 0.0 113.12 -164.486 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -134.0 76.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.16 1.384 . . . . 0.0 111.075 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.04 56.57 0.32 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.686 1.195 . . . . 0.0 113.402 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -110.72 162.15 15.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.436 2.694 . . . . 0.0 111.357 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.54 144.43 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 119.792 -1.817 . . . . 0.0 115.825 -155.365 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.1 -69.03 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.266 1.427 . . . . 0.0 111.149 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -118.89 130.97 24.53 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 127.152 2.181 . . . . 0.0 111.249 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -34.17 -38.66 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.216 1 C-N-CA 125.704 4.269 . . . . 0.0 119.161 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -70.57 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -166.43 -169.21 1.35 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.926 2.49 . . . . 0.0 112.122 156.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -157.76 119.01 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.291 -1.506 . . . . 0.0 111.047 167.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -103.79 -121.91 0.2 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.327 1.851 . . . . 0.0 115.382 -153.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.0 t -153.72 73.76 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.836 -1.165 . . . . 0.0 111.733 -156.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.03 1.332 . . . . 0.0 111.592 -169.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -86.98 74.98 9.61 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 119.98 -1.7 . . . . 0.0 111.605 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 168.69 -81.24 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 130.067 3.347 . . . . 0.0 108.329 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -109.04 152.2 25.33 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 149.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.3 -162.76 1.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 128.947 2.899 . . . . 0.0 113.649 -169.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -129.88 0.74 Allowed Glycine 0 CA--C 1.544 1.902 0 C-N-CA 124.202 0.906 . . . . 0.0 115.293 168.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.92 80.51 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 0.0 115.53 -166.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 m -27.58 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.51 3.124 . . . . 0.0 117.509 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.95 99.5 1.58 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.101 1.334 . . . . 0.0 110.122 -153.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.11 -134.97 6.25 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 123.898 0.761 . . . . 0.0 113.746 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.7 mt -85.51 115.86 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 O-C-N 121.233 -1.157 . . . . 0.0 109.666 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.45 41.17 98.49 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.359 1.304 . . . . 0.0 116.359 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -162.39 122.29 2.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.894 1.677 . . . . 0.0 110.402 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -160.48 168.51 24.95 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.12 -162.54 29.84 Favored Glycine 0 CA--C 1.548 2.137 0 C-N-CA 125.283 1.42 . . . . 0.0 114.812 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.34 56.38 0.6 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 124.608 3.539 . . . . 0.0 115.448 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -123.87 66.21 1.04 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.407 1.883 . . . . 0.0 110.814 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.26 157.07 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 125.746 1.618 . . . . 0.0 114.069 -157.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 t -121.69 171.66 8.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 127.073 2.149 . . . . 0.0 112.583 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.68 -123.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 129.156 2.982 . . . . 0.0 117.599 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.73 160.14 16.99 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.054 -1.653 . . . . 0.0 112.198 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.66 -57.2 0.12 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.061 0.839 . . . . 0.0 111.854 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 92.4 32.89 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 127.758 2.423 . . . . 0.0 112.513 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 p -137.38 72.93 1.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.631 1.172 . . . . 0.0 113.147 -152.087 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.64 123.2 20.74 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 120.726 -1.234 . . . . 0.0 111.176 172.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -147.05 -179.8 7.07 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -152.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.91 95.93 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 126.476 1.91 . . . . 0.0 112.957 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.91 -50.34 17.19 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.215 -1.553 . . . . 0.0 110.68 163.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -131.23 164.24 43.74 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.844 2.058 . . . . 0.0 108.387 153.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -51.54 -34.6 52.73 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 CA-C-N 122.479 1.921 . . . . 0.0 115.198 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -78.66 -6.08 54.74 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.86 95.73 4.17 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.304 -1.498 . . . . 0.0 114.636 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 t -85.53 136.77 33.27 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.726 1.61 . . . . 0.0 112.08 153.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -122.4 -120.05 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -170.39 78.61 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.086 0.954 . . . . 0.0 111.051 -153.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.12 1.368 . . . . 0.0 111.51 -171.066 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -58.74 -31.81 68.67 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.886 -1.134 . . . . 0.0 111.867 158.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -66.44 9.58 0.16 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.503 2.321 . . . . 0.0 116.853 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -127.03 172.79 10.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.28 1.832 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.0 89.36 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 120.996 -1.065 . . . . 0.0 113.162 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.67 -103.73 0.12 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 146.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -46.44 107.55 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 117.634 0.717 . . . . 0.0 112.52 152.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.5 p -62.78 -50.39 71.22 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 120.024 -1.672 . . . . 0.0 113.373 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.08 117.22 2.43 Favored Glycine 0 CA--C 1.544 1.875 0 C-N-CA 126.31 1.91 . . . . 0.0 112.477 -168.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.09 -85.48 1.87 Allowed Glycine 0 CA--C 1.54 1.648 0 C-N-CA 124.342 0.972 . . . . 0.0 113.964 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.42 131.23 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 125.474 1.509 . . . . 0.0 109.74 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -55.76 2.57 Favored Glycine 0 CA--C 1.546 1.979 0 O-C-N 120.832 -1.168 . . . . 0.0 114.146 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.4 90.73 3.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.587 1.155 . . . . 0.0 112.191 174.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.0 m -90.82 78.47 6.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.778 1.231 . . . . 0.0 112.728 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.6 -177.47 21.71 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 124.897 1.237 . . . . 0.0 115.534 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.62 166.19 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.224 3.283 . . . . 0.0 114.914 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' VAL . 5.1 t -179.42 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.654 1.981 . . . . 0.0 111.588 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 17' ' ' THR . 84.3 t -95.16 144.95 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 125.828 1.651 . . . . 0.0 112.106 174.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.4 t 84.97 173.16 0.06 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 127.35 2.26 . . . . 0.0 114.751 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.32 -170.05 2.8 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.418 1.087 . . . . 0.0 111.05 158.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.1 p -66.8 115.62 6.79 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.352 -1.468 . . . . 0.0 114.37 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.87 -49.99 0.15 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 126.045 1.784 . . . . 0.0 114.666 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m 71.52 24.38 3.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.633 1.573 . . . . 0.0 114.277 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -103.58 83.63 2.18 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.54 1.936 . . . . 0.0 111.064 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -70.15 65.47 0.26 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -120.81 157.73 29.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.301 2.641 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -111.06 152.88 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 127.374 2.27 . . . . 0.0 115.935 -165.236 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.17 -76.76 0.42 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.623 1.969 . . . . 0.0 109.383 160.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -109.13 138.33 20.39 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 126.403 1.881 . . . . 0.0 112.078 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -26.31 -52.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 1 C-N-CA 126.331 4.688 . . . . 0.0 119.288 -175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 24.65 0.09 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -159.76 173.14 16.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.109 1.363 . . . . 0.0 114.185 160.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 t -141.1 127.26 19.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.695 1.198 . . . . 0.0 111.631 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -98.97 -125.62 0.16 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 125.164 1.386 . . . . 0.0 114.588 -165.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.86 101.49 0.56 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.162 3.385 . . . . 0.0 106.034 -157.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.092 1.757 . . . . 0.0 111.982 -163.205 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -163.14 79.03 0.45 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.661 1.984 . . . . 0.0 110.917 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t 49.04 48.91 20.28 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.877 -1.139 . . . . 0.0 112.396 -163.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -156.96 -114.1 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.121 1.368 . . . . 0.0 110.169 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.91 143.78 5.18 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 119.986 -1.697 . . . . 0.0 113.258 160.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.42 -151.75 45.46 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -155.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -64.13 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.111 0.958 . . . . 0.0 112.348 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.8 p -40.4 -56.52 2.0 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 128.376 2.67 . . . . 0.0 115.121 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 120.36 2.67 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.961 1.743 . . . . 0.0 111.346 -166.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.56 -125.92 5.66 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.301 0.953 . . . . 0.0 113.785 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.07 99.48 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.346 -1.091 . . . . 0.0 110.095 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.01 28.71 58.17 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 104.24 3.26 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.91 1.684 . . . . 0.0 110.215 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 m -132.96 151.73 52.02 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.814 1.646 . . . . 0.0 113.791 -164.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.68 -160.54 14.33 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 167.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.02 31.25 0.36 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.405 2.737 . . . . 0.0 114.637 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -75.45 45.38 0.3 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.455 1.902 . . . . 0.0 111.679 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.27 114.12 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -149.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.1 t -50.33 171.35 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 125.766 1.626 . . . . 0.0 114.53 166.417 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.74 176.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 164.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -70.05 176.22 3.94 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -64.11 0.32 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.167 1.365 . . . . 0.0 112.088 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m 91.08 38.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.254 2.222 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 p -127.36 74.14 1.49 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.188 2.195 . . . . 0.0 112.297 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.0 68.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.754 1.222 . . . . 0.0 113.592 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -113.37 154.46 26.88 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.992 2.117 . . . . 0.0 112.884 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.84 146.89 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.62 -85.65 0.3 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.712 0.805 . . . . 0.0 109.201 151.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -94.85 144.78 28.41 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.718 1.207 . . . . 0.0 111.05 156.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -31.11 -44.65 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.441 4.094 . . . . 0.0 117.219 174.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.97 -25.7 68.25 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.349 0.0 OUTLIER -144.2 107.02 4.45 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 173.283 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 t -78.08 142.88 37.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.768 2.027 . . . . 0.0 113.287 165.245 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -128.9 -99.82 0.34 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.94 66.97 0.31 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.924 -1.735 . . . . 0.0 112.273 -160.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.896 1.278 . . . . 0.0 111.526 -170.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.965 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.4 -74.06 1.17 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.957 0.789 . . . . 0.0 114.597 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.87 117.14 7.13 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -83.9 -55.0 4.47 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 125.09 1.356 . . . . 0.0 111.801 149.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.5 167.42 21.98 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 125.792 1.663 . . . . 0.0 116.511 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 -119.03 1.85 Allowed Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.061 1.185 . . . . 0.0 116.061 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.72 85.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 125.975 1.71 . . . . 0.0 113.111 -166.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.15 36.05 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 126.047 1.784 . . . . 0.0 115.803 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.69 148.97 23.31 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 t -174.51 -55.59 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.382 1.873 . . . . 0.0 111.6 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.06 152.01 4.22 Favored Glycine 0 CA--C 1.55 2.232 0 C-N-CA 124.051 0.834 . . . . 0.0 114.269 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.97 71.31 5.03 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.359 2.706 . . . . 0.0 113.255 -167.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -75.37 43.0 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.562 1.545 . . . . 0.0 112.744 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.9 93.74 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -148.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.35 158.51 20.29 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.886 -1.133 . . . . 0.0 111.761 148.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.42 -179.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.3 m -51.49 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 129.302 3.041 . . . . 0.0 117.081 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -39.15 34.76 Favored Glycine 0 CA--C 1.545 1.942 0 C-N-CA 123.695 0.664 . . . . 0.0 114.331 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.269 0.5 OUTLIER 64.93 -49.46 0.34 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.3 2.64 . . . . 0.0 114.862 -175.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 p -92.75 173.48 7.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.229 1.411 . . . . 0.0 111.901 158.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -129.18 83.44 2.15 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.813 1.245 . . . . 0.0 112.312 -159.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -105.1 -106.43 0.3 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.498 1.119 . . . . 0.0 113.628 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -168.59 147.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 121.596 1.998 . . . . 0.0 114.969 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -98.73 -60.9 1.45 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.536 1.636 . . . . 0.0 110.526 155.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -127.67 138.56 33.11 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.296 2.638 . . . . 0.0 108.751 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -26.35 -57.44 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 126.224 4.616 . . . . 0.0 118.508 -166.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -64.45 -35.67 81.68 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 28' ' ' LEU . 3.2 t80 -92.84 85.64 5.25 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.005 1.322 . . . . 0.0 112.336 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -69.02 49.25 0.07 Allowed 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -136.25 174.53 10.52 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 118.815 -2.428 . . . . 0.0 114.362 -158.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 t 60.44 90.31 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 150.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.491 2.716 . . . . 0.0 111.545 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.131 0 N-CA-C 110.399 -0.223 . . . . 0.0 110.399 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.93 82.71 0.84 Allowed Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 111.397 -162.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 22.1 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.521 2.728 . . . . 0.0 116.733 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 p -42.99 -72.12 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.898 2.079 . . . . 0.0 115.493 164.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.3 78.08 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 C-N-CA 124.517 1.056 . . . . 0.0 113.812 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 -122.76 4.6 Favored Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.428 1.49 . . . . 0.0 113.836 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.01 121.03 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.872 -1.37 . . . . 0.0 111.971 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.49 27.56 38.9 Favored Glycine 0 CA--C 1.545 1.945 0 C-N-CA 124.898 1.237 . . . . 0.0 114.935 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.38 178.17 10.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.197 1.799 . . . . 0.0 112.065 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 t 179.15 -49.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.604 1.962 . . . . 0.0 111.748 171.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.15 147.01 42.4 Favored Glycine 0 CA--C 1.552 2.374 0 O-C-N 121.21 -0.931 . . . . 0.0 113.836 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.67 142.87 49.5 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 123.509 2.806 . . . . 0.0 113.701 -171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -140.28 71.06 1.36 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.743 1.735 . . . . 0.0 112.609 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.44 149.25 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -160.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.49 -131.34 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.956 0.902 . . . . 0.0 113.352 166.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.38 -70.92 0.53 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 119.916 -1.74 . . . . 0.0 112.77 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -172.24 -178.41 2.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.824 2.45 . . . . 0.0 111.992 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.6 -34.2 1.82 Allowed Glycine 0 CA--C 1.543 1.835 0 C-N-CA 126.25 1.881 . . . . 0.0 113.998 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.318 13.0 t 51.86 49.54 20.54 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.359 1.864 . . . . 0.0 115.155 -167.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.9 p -114.14 70.11 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.199 2.2 . . . . 0.0 114.194 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.53 70.01 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 O-C-N 120.171 -1.581 . . . . 0.0 111.664 165.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -162.39 0.78 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.664 1.986 . . . . 0.0 112.938 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.8 132.3 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 120.915 -1.116 . . . . 0.0 112.677 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.26 -60.99 1.58 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.129 1.371 . . . . 0.0 110.988 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.23 163.23 27.82 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.105 1.762 . . . . 0.0 109.916 161.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -46.97 -35.76 19.11 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.052 3.168 . . . . 0.0 116.834 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -72.51 -26.64 61.85 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -127.91 129.28 46.6 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -139.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -119.58 143.25 47.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 112.661 162.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -142.2 0.37 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.775 1.63 . . . . 0.0 111.832 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 t -115.43 102.44 9.83 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.122 1.769 . . . . 0.0 111.153 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.258 1.547 0 C-N-CA 126.193 1.797 . . . . 0.0 111.61 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.544 0.74 0 CA-C-O 119.464 -0.303 . . . . 0.0 111.568 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.32 -137.31 14.17 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.532 1.539 . . . . 0.0 111.483 -160.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.35 68.86 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.802 1.641 . . . . 0.0 114.8 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -46.34 -13.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 130.778 3.631 . . . . 0.0 119.465 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.96 82.2 0.74 Allowed Glycine 0 CA--C 1.548 2.136 0 CA-C-N 120.286 1.403 . . . . 0.0 114.462 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.79 -83.02 0.58 Allowed Glycine 0 CA--C 1.547 2.055 0 O-C-N 121.65 -0.912 . . . . 0.0 115.286 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.1 130.57 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 125.176 1.39 . . . . 0.0 110.384 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.47 -57.4 1.22 Allowed Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.117 -0.989 . . . . 0.0 114.363 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.51 134.66 56.72 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.16 1.384 . . . . 0.0 113.251 167.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -147.7 -50.42 0.18 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.78 -171.15 1.95 Allowed Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.139 1.615 . . . . 0.0 117.139 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -65.41 39.85 0.13 Allowed 'Trans proline' 0 CA--C 1.56 1.787 1 C-N-CA 125.4 4.067 . . . . 0.0 118.699 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -67.13 35.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 119.962 -1.711 . . . . 0.0 114.876 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.42 142.37 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 119.974 -1.704 . . . . 0.0 115.117 -153.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.32 -156.48 0.11 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.278 1.431 . . . . 0.0 113.145 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 125.938 1.695 . . . . 0.0 113.498 162.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -94.17 -165.15 1.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.618 -1.301 . . . . 0.0 113.991 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.75 -70.03 0.52 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.981 1.753 . . . . 0.0 111.807 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m 86.88 37.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 126.581 1.952 . . . . 0.0 113.017 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -112.96 83.39 1.82 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.949 2.1 . . . . 0.0 112.67 -167.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -72.59 140.89 48.32 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 120.619 -1.301 . . . . 0.0 112.283 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -152.69 175.49 12.77 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.385 1.474 . . . . 0.0 114.018 -156.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.34 114.67 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 125.735 1.614 . . . . 0.0 112.591 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.71 -92.78 0.09 Allowed 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.238 -0.914 . . . . 0.0 108.915 162.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -76.7 154.99 83.47 Favored Pre-proline 0 CA--C 1.562 1.435 0 O-C-N 120.404 -1.435 . . . . 0.0 110.262 148.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -44.18 -42.64 13.14 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.522 2.815 . . . . 0.0 114.314 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.98 20.52 1.51 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.32 96.25 2.74 Favored 'General case' 0 CA--C 1.554 1.135 0 O-C-N 120.304 -1.498 . . . . 0.0 113.514 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.5 t -92.94 119.07 31.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.445 1.898 . . . . 0.0 110.927 165.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -111.93 -120.23 0.29 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -154.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -164.87 93.93 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.342 -1.474 . . . . 0.0 111.456 -159.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 126.855 2.062 . . . . 0.0 112.086 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.546 0.821 0 CA-C-O 120.39 0.138 . . . . 0.0 111.327 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.99 -136.88 3.25 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 123.977 0.798 . . . . 0.0 111.231 158.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -56.45 79.8 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 p -52.11 -43.26 63.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.816 2.046 . . . . 0.0 113.098 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.8 152.4 29.03 Favored Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.613 1.101 . . . . 0.0 114.682 -165.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.59 -123.8 4.39 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.965 1.269 . . . . 0.0 111.855 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.4 133.73 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 120.493 -1.592 . . . . 0.0 111.402 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.39 7.55 46.62 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 118.539 2.176 . . . . 0.0 118.539 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.43 117.39 15.27 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 119.41 1.605 . . . . 0.0 110.652 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -164.69 101.14 0.8 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.433 1.093 . . . . 0.0 113.004 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.14 -161.48 34.84 Favored Glycine 0 CA--C 1.547 2.068 0 O-C-N 121.174 -0.954 . . . . 0.0 115.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.44 71.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 125.038 3.825 . . . . 0.0 115.065 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -128.85 16.3 6.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.361 1.864 . . . . 0.0 113.48 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.44 143.79 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -159.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.7 t -87.74 177.0 7.14 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.23 2.212 . . . . 0.0 112.493 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.34 176.23 0.06 Allowed 'General case' 0 CA--C 1.557 1.233 0 O-C-N 120.712 -1.243 . . . . 0.0 113.232 156.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 150.57 48.62 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -173.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.38 -51.4 0.01 OUTLIER Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.996 1.76 . . . . 0.0 112.786 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 23' ' ' THR . 61.3 m 76.26 26.14 0.96 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.496 1.919 . . . . 0.0 112.423 -171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 p -135.11 73.32 1.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.603 1.961 . . . . 0.0 111.992 -160.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 t -74.1 59.46 0.74 Allowed 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.936 -1.103 . . . . 0.0 112.903 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -112.81 166.54 11.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.68 1.592 . . . . 0.0 112.591 175.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.02 146.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 125.763 1.625 . . . . 0.0 114.66 -153.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -94.47 -67.07 0.87 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.776 1.23 . . . . 0.0 108.447 161.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -122.48 151.76 60.26 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 126.099 1.76 . . . . 0.0 108.144 155.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -35.91 -33.8 0.12 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 124.799 3.666 . . . . 0.0 117.516 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -98.14 94.76 7.0 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 126.869 2.067 . . . . 0.0 110.309 164.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -119.37 -149.97 0.45 Allowed 'General case' 0 CA--C 1.567 1.597 1 C-N-CA 132.906 4.482 . . . . 0.0 112.618 4.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -130.74 130.24 43.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 119.726 -1.859 . . . . 0.0 111.321 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -117.24 -116.79 0.32 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -145.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.0 t -160.65 82.47 0.67 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 120.312 -1.493 . . . . 0.0 112.56 -161.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.259 1.561 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -170.325 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.044 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.74 -104.42 1.9 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 160.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.15 99.4 1.12 Allowed 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.47 -1.606 . . . . 0.0 110.436 165.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 p -57.0 -40.05 75.87 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.469 1.908 . . . . 0.0 115.922 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.95 98.94 2.52 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 124.753 1.168 . . . . 0.0 111.643 -164.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.02 -86.24 1.1 Allowed Glycine 0 CA--C 1.544 1.904 0 C-N-CA 123.992 0.806 . . . . 0.0 114.976 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.1 124.22 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.245 1.418 . . . . 0.0 109.62 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.63 -54.32 3.31 Favored Glycine 0 CA--C 1.545 1.928 0 O-C-N 120.415 -1.428 . . . . 0.0 113.221 -168.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.58 131.6 49.62 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 121.253 -1.145 . . . . 0.0 113.107 163.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 t -151.56 164.08 37.63 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.173 1.389 . . . . 0.0 113.335 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.19 -167.63 52.89 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 115.879 1.111 . . . . 0.0 115.879 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.74 60.58 1.2 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.958 3.105 . . . . 0.0 116.999 -168.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -74.53 40.75 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 O-C-N 119.926 -1.734 . . . . 0.0 113.672 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.64 145.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -151.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.03 179.84 5.64 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.307 2.643 . . . . 0.0 111.665 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.55 168.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -69.29 42.97 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -153.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.66 -57.22 9.25 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.632 1.587 . . . . 0.0 115.146 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.337 2.4 t 57.19 19.78 5.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.448 2.299 . . . . 0.0 116.194 -150.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.7 p -98.65 131.74 44.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.969 2.507 . . . . 0.0 112.764 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -119.03 70.84 0.84 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.306 1.842 . . . . 0.0 110.651 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -114.11 134.86 54.6 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -166.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.15 132.0 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.65 -59.81 1.74 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.575 1.15 . . . . 0.0 110.357 158.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -129.11 150.09 74.42 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 125.968 1.707 . . . . 0.0 108.704 161.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -51.18 -33.33 43.8 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.006 2.471 . . . . 0.0 115.12 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -68.41 -15.59 63.61 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.404 0.0 OUTLIER -146.21 120.49 9.57 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 163.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -95.41 124.46 39.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.245 2.618 . . . . 0.0 111.423 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.98 165.23 13.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.558 2.343 . . . . 0.0 115.34 -160.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.82 47.0 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.397 1 C-N-CA 133.464 4.706 . . . . 0.0 116.217 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.926 2.09 . . . . 0.0 111.036 178.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.899 0 N-CA-C 113.767 1.025 . . . . 0.0 113.767 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.92 9.06 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.694 0.664 . . . . 0.0 112.639 162.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -60.37 80.77 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.732 1.613 . . . . 0.0 113.935 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -38.44 -39.99 0.51 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.83 100.48 2.56 Favored Glycine 0 CA--C 1.548 2.134 0 C-N-CA 125.415 1.483 . . . . 0.0 113.266 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.49 -169.23 25.66 Favored Glycine 0 CA--C 1.546 2.023 0 C-N-CA 124.939 1.257 . . . . 0.0 115.163 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -43.53 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 C-N-CA 124.995 1.318 . . . . 0.0 114.182 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 15.04 66.55 Favored Glycine 0 CA--C 1.549 2.215 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -133.62 111.21 10.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 119.413 1.606 . . . . 0.0 114.308 -176.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -125.69 -26.64 3.49 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.524 1.929 . . . . 0.0 114.275 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.03 157.63 46.15 Favored Glycine 0 CA--C 1.551 2.34 0 O-C-N 120.83 -1.169 . . . . 0.0 113.81 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.26 108.89 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.115 2.543 . . . . 0.0 114.211 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 13' ' ' TYR . 4.4 t -122.64 61.96 0.99 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.138 1.775 . . . . 0.0 108.354 151.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.71 116.38 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -146.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.27 158.76 28.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.835 1.654 . . . . 0.0 113.644 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 -170.39 0.29 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.2 p -69.06 86.18 0.36 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -165.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.0 -61.21 0.27 Allowed Glycine 0 CA--C 1.549 2.172 0 C-N-CA 126.351 1.929 . . . . 0.0 112.375 160.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m 78.66 45.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.169 2.188 . . . . 0.0 112.88 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 p -113.34 102.41 10.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.453 2.701 . . . . 0.0 111.466 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.38 43.04 0.22 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -95.96 163.3 13.2 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.08 1.752 . . . . 0.0 111.154 165.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.36 143.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -152.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.8 -76.9 0.11 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.584 1.554 . . . . 0.0 110.86 164.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -112.26 134.33 21.53 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 126.604 1.962 . . . . 0.0 110.936 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -34.42 -37.57 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.129 1 C-N-CA 125.356 4.037 . . . . 0.0 118.13 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -80.29 20.61 0.66 Allowed 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.306 1.6 p90 -149.29 -162.08 1.48 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 120.935 -1.103 . . . . 0.0 112.69 137.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 t -149.32 147.67 28.6 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.166 -1.584 . . . . 0.0 112.575 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -121.43 -112.59 0.32 Allowed 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -152.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -176.68 73.5 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.724 1.21 . . . . 0.0 112.269 -150.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 125.901 1.68 . . . . 0.0 113.106 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.547 0.849 0 N-CA-C 112.613 0.598 . . . . 0.0 112.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.96 -117.8 1.54 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.718 1.628 . . . . 0.0 113.199 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -71.77 68.12 0.61 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.969 -1.312 . . . . 0.0 111.655 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -48.26 -32.72 7.63 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 128.761 2.825 . . . . 0.0 116.211 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.83 92.15 0.09 OUTLIER Glycine 0 CA--C 1.542 1.737 0 C-N-CA 126.666 2.079 . . . . 0.0 110.947 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 155.76 47.14 Favored Glycine 0 CA--C 1.546 2.031 0 O-C-N 121.011 -1.288 . . . . 0.0 113.03 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.85 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 120.701 2.25 . . . . 0.0 112.231 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.6 -47.37 1.05 Allowed Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.544 1.545 . . . . 0.0 113.625 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.94 71.96 2.78 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 120.809 -1.407 . . . . 0.0 111.544 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.1 m -92.6 79.57 4.84 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.53 2.332 . . . . 0.0 111.466 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.78 -169.33 39.9 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 117.733 1.853 . . . . 0.0 117.733 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.08 127.73 27.25 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.038 3.825 . . . . 0.0 114.85 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t 169.47 65.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.329 2.652 . . . . 0.0 111.01 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.63 141.54 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.851 1.661 . . . . 0.0 112.602 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -103.85 -141.85 0.36 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 125.008 1.323 . . . . 0.0 112.844 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 -149.33 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 O-C-N 120.565 -1.334 . . . . 0.0 112.456 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.1 p -103.34 101.91 11.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.636 1.574 . . . . 0.0 112.797 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.81 -47.74 0.02 OUTLIER Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.959 1.266 . . . . 0.0 113.439 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m 65.31 29.4 11.6 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.802 1.241 . . . . 0.0 113.39 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -74.7 145.28 43.23 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.404 1.481 . . . . 0.0 111.531 157.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.0 t -153.8 83.94 1.16 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.928 1.691 . . . . 0.0 108.674 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -121.14 139.44 53.35 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.144 1.778 . . . . 0.0 114.324 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.39 123.23 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -171.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -94.18 -52.97 4.14 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.194 0.997 . . . . 0.0 110.609 158.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -135.6 155.72 78.1 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 126.033 1.733 . . . . 0.0 108.244 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.7 -33.06 68.16 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.329 2.019 . . . . 0.0 115.891 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -75.12 -13.63 60.49 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 92.07 3.23 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 127.185 2.194 . . . . 0.0 114.29 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 t -83.96 135.04 34.62 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.746 1.218 . . . . 0.0 112.813 158.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -134.29 164.04 28.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -165.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.8 t -65.56 64.98 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 127.536 2.334 . . . . 0.0 114.722 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.959 2.103 . . . . 0.0 109.458 169.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.548 0.875 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.77 -66.13 2.11 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.157 -0.964 . . . . 0.0 111.499 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.14 125.4 23.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.17 0.588 . . . . 0.0 110.691 150.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.7 p -80.42 -44.32 19.53 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 67.36 0.75 Allowed Glycine 0 CA--C 1.551 2.323 0 C-N-CA 124.704 1.145 . . . . 0.0 115.514 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.76 -146.33 9.98 Favored Glycine 0 CA--C 1.548 2.116 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -41.97 99.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.61 1.964 . . . . 0.0 112.6 -171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.86 18.7 80.12 Favored Glycine 0 CA--C 1.542 1.75 0 N-CA-C 117.106 1.603 . . . . 0.0 117.106 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 58.25 1.67 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.705 1.753 . . . . 0.0 114.741 -166.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 t -88.2 71.29 9.22 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.306 -1.496 . . . . 0.0 112.274 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.14 167.23 40.31 Favored Glycine 0 CA--C 1.545 1.962 0 C-N-CA 125.857 1.694 . . . . 0.0 112.176 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.81 116.15 4.43 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.244 1.963 . . . . 0.0 113.458 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -147.59 63.78 1.14 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.212 1.805 . . . . 0.0 110.21 159.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -100.84 166.74 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -138.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.0 t -135.54 175.41 9.62 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 127.076 2.15 . . . . 0.0 113.663 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.55 18.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 113.534 164.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -61.58 141.07 58.01 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.0 -71.51 0.21 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.732 1.158 . . . . 0.0 113.162 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.262 4.5 m 93.87 45.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.438 1.895 . . . . 0.0 114.438 163.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -81.5 104.27 11.81 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.366 1.866 . . . . 0.0 112.275 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -83.26 62.85 6.9 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -159.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -106.37 172.33 6.87 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.843 1.257 . . . . 0.0 112.516 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.76 140.01 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 O-C-N 119.596 -1.94 . . . . 0.0 114.17 -157.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.39 -60.05 1.93 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.456 1.102 . . . . 0.0 111.84 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -79.77 -156.21 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 124.947 1.299 . . . . 0.0 111.995 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -75.41 -60.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.681 2.254 . . . . 0.0 110.931 134.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -67.51 78.91 0.17 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.054 1.342 . . . . 0.0 113.775 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -173.18 175.56 3.14 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 127.994 2.518 . . . . 0.0 110.707 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -165.16 120.21 1.33 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.582 -1.324 . . . . 0.0 112.354 134.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -103.9 -122.11 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 112.732 -160.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 t -148.21 61.77 1.1 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.794 2.038 . . . . 0.0 110.479 -154.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 125.417 1.487 . . . . 0.0 111.81 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.554 1.101 0 CA-C-O 120.849 0.357 . . . . 0.0 110.965 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.14 -99.67 0.27 Allowed Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 17' ' ' THR . 49.4 tt0 -59.83 101.78 0.13 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.623 -0.927 . . . . 0.0 112.921 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 p -41.91 -42.86 2.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.208 1.403 . . . . 0.0 114.618 168.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.67 124.02 2.45 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.411 1.958 . . . . 0.0 110.701 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.7 -138.9 8.86 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 124.063 0.84 . . . . 0.0 113.288 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.92 102.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.21 -1.171 . . . . 0.0 110.72 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.87 49.66 16.47 Favored Glycine 0 CA--C 1.545 1.925 0 C-N-CA 125.127 1.346 . . . . 0.0 114.155 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.28 122.74 0.93 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 m -125.67 -25.6 3.65 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.04 134.82 12.51 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.808 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -46.09 80.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 1 C-N-CA 125.539 4.159 . . . . 0.0 116.309 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 1.2 t -79.92 49.81 1.12 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 123.806 1.765 . . . . 0.0 111.112 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.12 144.29 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 115.266 -151.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.5 p -74.76 -132.74 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 125.333 1.453 . . . . 0.0 111.774 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.64 166.33 0.33 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.418 -2.051 . . . . 0.0 112.817 148.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -63.32 158.49 20.23 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.682 -1.262 . . . . 0.0 113.795 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.77 -33.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 t 47.91 22.39 0.37 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 p -140.12 176.62 8.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.308 1.843 . . . . 0.0 112.82 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -121.7 89.12 3.06 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -155.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -123.27 -117.29 0.29 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 171.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -163.0 124.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 121.417 1.917 . . . . 0.0 115.063 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.62 -67.32 0.82 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.587 1.185 . . . . 0.0 110.357 162.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -118.14 154.06 51.57 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 126.346 1.858 . . . . 0.0 109.404 159.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -33.66 -55.41 0.43 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.733 3.622 . . . . 0.0 117.14 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -65.4 -26.05 67.82 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -107.52 95.21 5.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.466 1.906 . . . . 0.0 113.589 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 t -87.97 100.06 12.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.444 1.897 . . . . 0.0 114.904 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.434 ' CG ' ' H ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -163.11 -139.42 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 127.086 2.155 . . . . 0.0 108.957 170.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 21.73 113.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 129.985 3.314 . . . . 0.0 118.838 176.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.553 1.087 0 C-N-CA 127.334 2.253 . . . . 0.0 111.629 -178.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.55 0.956 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -6.49 -89.82 0.0 OUTLIER Glycine 0 CA--C 1.549 2.205 0 C-N-CA 127.667 2.556 . . . . 0.0 118.339 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.73 83.4 6.5 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 121.036 -1.273 . . . . 0.0 111.41 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -34.77 -44.76 0.23 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.983 2.113 . . . . 0.0 116.561 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.0 74.86 0.91 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.397 1.475 . . . . 0.0 113.604 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.29 -122.61 5.04 Favored Glycine 0 CA--C 1.544 1.887 0 C-N-CA 124.461 1.029 . . . . 0.0 114.941 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.82 113.45 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 O-C-N 119.922 -1.928 . . . . 0.0 112.26 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.52 37.31 81.84 Favored Glycine 0 CA--C 1.545 1.936 0 C-N-CA 125.037 1.303 . . . . 0.0 115.421 -169.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -147.5 155.85 42.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.887 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -161.69 -37.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.147 -0.971 . . . . 0.0 113.253 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.65 47.99 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -65.32 69.53 0.31 Allowed 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.295 3.33 . . . . 0.0 117.597 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.2 p -72.23 53.09 0.27 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.0 -1.688 . . . . 0.0 113.861 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.97 87.18 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -156.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.3 179.58 6.31 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 126.228 1.811 . . . . 0.0 114.403 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -176.94 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 128.572 2.749 . . . . 0.0 116.938 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 m -88.85 122.47 32.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.306 1.442 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.1 -74.72 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 C-N-CA 126.075 1.798 . . . . 0.0 110.6 167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.304 1.7 m 109.75 29.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 130.706 3.603 . . . . 0.0 114.464 146.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.8 p -89.52 119.63 30.12 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.056 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -75.76 67.03 2.14 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 120.238 -1.539 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -61.91 -177.9 0.13 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 130.69 3.596 . . . . 0.0 115.318 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.5 135.76 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 O-C-N 119.125 -2.235 . . . . 0.0 111.955 162.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mt -111.21 -72.54 0.71 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.057 1.343 . . . . 0.0 110.852 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -59.66 177.84 0.26 Allowed Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 124.717 1.207 . . . . 0.0 109.952 154.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -56.71 -60.23 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 146.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.13 81.96 2.3 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.739 1.616 . . . . 0.0 114.926 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.35 -161.37 0.2 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.356 1.462 . . . . 0.0 114.147 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t 171.92 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.543 2.737 . . . . 0.0 112.868 155.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.96 153.83 34.19 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -160.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.5 t -50.05 66.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 131.401 3.88 . . . . 0.0 116.673 168.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 126.991 2.116 . . . . 0.0 110.654 165.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.552 1.029 0 N-CA-C 111.91 0.337 . . . . 0.0 111.91 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.62 -102.48 2.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.519 1.533 . . . . 0.0 111.023 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -63.05 72.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.556 1.542 . . . . 0.0 114.896 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 p -39.4 -38.29 0.54 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.25 3.02 . . . . 0.0 116.067 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.12 99.85 2.48 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 125.13 1.348 . . . . 0.0 112.645 -175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.86 -174.56 30.64 Favored Glycine 0 CA--C 1.544 1.881 0 N-CA-C 115.634 1.014 . . . . 0.0 115.634 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -41.16 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 126.979 2.112 . . . . 0.0 114.281 -168.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 38.15 27.24 Favored Glycine 0 CA--C 1.546 1.994 0 C-N-CA 125.646 1.594 . . . . 0.0 116.391 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.98 57.23 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 118.618 1.209 . . . . 0.0 112.264 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -87.26 86.61 7.28 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.323 1.449 . . . . 0.0 114.022 -169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.3 178.56 43.61 Favored Glycine 0 CA--C 1.548 2.15 0 N-CA-C 117.651 1.821 . . . . 0.0 117.651 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -63.06 51.27 0.13 Allowed 'Trans proline' 0 CA--C 1.551 1.363 1 C-N-CA 126.476 4.784 . . . . 0.0 118.318 -171.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 p -82.93 39.28 0.62 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.841 2.056 . . . . 0.0 113.14 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -87.43 82.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -144.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.86 165.53 0.9 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 163.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.04 -160.0 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 129.108 2.963 . . . . 0.0 117.549 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.64 81.97 6.77 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 118.412 -2.68 . . . . 0.0 114.673 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.32 -71.48 1.31 Allowed Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.198 0.904 . . . . 0.0 112.676 166.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 4.1 m 87.81 22.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.472 2.309 . . . . 0.0 113.12 -164.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -134.0 76.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.16 1.384 . . . . 0.0 111.075 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.04 56.57 0.32 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.686 1.195 . . . . 0.0 113.402 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -110.72 162.15 15.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.436 2.694 . . . . 0.0 111.357 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.54 144.43 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 119.792 -1.817 . . . . 0.0 115.825 -155.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.1 -69.03 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.266 1.427 . . . . 0.0 111.149 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -118.89 130.97 24.53 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 127.152 2.181 . . . . 0.0 111.249 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -34.17 -38.66 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.216 1 C-N-CA 125.704 4.269 . . . . 0.0 119.161 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -70.57 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -166.43 -169.21 1.35 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.926 2.49 . . . . 0.0 112.122 156.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -157.76 119.01 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.291 -1.506 . . . . 0.0 111.047 167.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -103.79 -121.91 0.2 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.327 1.851 . . . . 0.0 115.382 -153.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.0 t -153.72 73.76 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.836 -1.165 . . . . 0.0 111.733 -156.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.03 1.332 . . . . 0.0 111.592 -169.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.549 0.913 0 N-CA-C 113.649 0.981 . . . . 0.0 113.649 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -129.88 0.74 Allowed Glycine 0 CA--C 1.544 1.902 0 C-N-CA 124.202 0.906 . . . . 0.0 115.293 168.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.92 80.51 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 0.0 115.53 -166.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 m -27.58 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.51 3.124 . . . . 0.0 117.509 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.95 99.5 1.58 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.101 1.334 . . . . 0.0 110.122 -153.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.11 -134.97 6.25 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 123.898 0.761 . . . . 0.0 113.746 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.7 mt -85.51 115.86 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 O-C-N 121.233 -1.157 . . . . 0.0 109.666 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.45 41.17 98.49 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.359 1.304 . . . . 0.0 116.359 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -162.39 122.29 2.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.894 1.677 . . . . 0.0 110.402 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -160.48 168.51 24.95 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.12 -162.54 29.84 Favored Glycine 0 CA--C 1.548 2.137 0 C-N-CA 125.283 1.42 . . . . 0.0 114.812 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.34 56.38 0.6 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 124.608 3.539 . . . . 0.0 115.448 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -123.87 66.21 1.04 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.407 1.883 . . . . 0.0 110.814 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.26 157.07 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 125.746 1.618 . . . . 0.0 114.069 -157.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 t -121.69 171.66 8.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 127.073 2.149 . . . . 0.0 112.583 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.68 -123.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 129.156 2.982 . . . . 0.0 117.599 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.73 160.14 16.99 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.054 -1.653 . . . . 0.0 112.198 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.66 -57.2 0.12 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.061 0.839 . . . . 0.0 111.854 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 92.4 32.89 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 127.758 2.423 . . . . 0.0 112.513 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 p -137.38 72.93 1.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.631 1.172 . . . . 0.0 113.147 -152.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.64 123.2 20.74 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 120.726 -1.234 . . . . 0.0 111.176 172.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -147.05 -179.8 7.07 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -152.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.91 95.93 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 126.476 1.91 . . . . 0.0 112.957 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.91 -50.34 17.19 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.215 -1.553 . . . . 0.0 110.68 163.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -131.23 164.24 43.74 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.844 2.058 . . . . 0.0 108.387 153.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -51.54 -34.6 52.73 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 CA-C-N 122.479 1.921 . . . . 0.0 115.198 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -78.66 -6.08 54.74 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.86 95.73 4.17 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.304 -1.498 . . . . 0.0 114.636 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 t -85.53 136.77 33.27 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.726 1.61 . . . . 0.0 112.08 153.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -122.4 -120.05 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -170.39 78.61 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.086 0.954 . . . . 0.0 111.051 -153.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.12 1.368 . . . . 0.0 111.51 -171.066 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.551 1.003 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.67 -103.73 0.12 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 146.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -46.44 107.55 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 117.634 0.717 . . . . 0.0 112.52 152.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.5 p -62.78 -50.39 71.22 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 120.024 -1.672 . . . . 0.0 113.373 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.08 117.22 2.43 Favored Glycine 0 CA--C 1.544 1.875 0 C-N-CA 126.31 1.91 . . . . 0.0 112.477 -168.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.09 -85.48 1.87 Allowed Glycine 0 CA--C 1.54 1.648 0 C-N-CA 124.342 0.972 . . . . 0.0 113.964 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.42 131.23 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 125.474 1.509 . . . . 0.0 109.74 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -55.76 2.57 Favored Glycine 0 CA--C 1.546 1.979 0 O-C-N 120.832 -1.168 . . . . 0.0 114.146 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.4 90.73 3.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.587 1.155 . . . . 0.0 112.191 174.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.0 m -90.82 78.47 6.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.778 1.231 . . . . 0.0 112.728 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.6 -177.47 21.71 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 124.897 1.237 . . . . 0.0 115.534 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.62 166.19 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.224 3.283 . . . . 0.0 114.914 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' VAL . 5.1 t -179.42 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.654 1.981 . . . . 0.0 111.588 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 17' ' ' THR . 84.3 t -95.16 144.95 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 125.828 1.651 . . . . 0.0 112.106 174.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.4 t 84.97 173.16 0.06 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 127.35 2.26 . . . . 0.0 114.751 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.32 -170.05 2.8 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.418 1.087 . . . . 0.0 111.05 158.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.1 p -66.8 115.62 6.79 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.352 -1.468 . . . . 0.0 114.37 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.87 -49.99 0.15 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 126.045 1.784 . . . . 0.0 114.666 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m 71.52 24.38 3.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.633 1.573 . . . . 0.0 114.277 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -103.58 83.63 2.18 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.54 1.936 . . . . 0.0 111.064 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -70.15 65.47 0.26 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -120.81 157.73 29.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.301 2.641 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -111.06 152.88 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 127.374 2.27 . . . . 0.0 115.935 -165.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.17 -76.76 0.42 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.623 1.969 . . . . 0.0 109.383 160.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -109.13 138.33 20.39 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 126.403 1.881 . . . . 0.0 112.078 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -26.31 -52.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 1 C-N-CA 126.331 4.688 . . . . 0.0 119.288 -175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 24.65 0.09 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -159.76 173.14 16.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.109 1.363 . . . . 0.0 114.185 160.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 t -141.1 127.26 19.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.695 1.198 . . . . 0.0 111.631 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -98.97 -125.62 0.16 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 125.164 1.386 . . . . 0.0 114.588 -165.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.86 101.49 0.56 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.162 3.385 . . . . 0.0 106.034 -157.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.092 1.757 . . . . 0.0 111.982 -163.205 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.555 1.149 0 N-CA-C 113.258 0.836 . . . . 0.0 113.258 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.42 -151.75 45.46 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -155.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -64.13 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.111 0.958 . . . . 0.0 112.348 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.8 p -40.4 -56.52 2.0 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 128.376 2.67 . . . . 0.0 115.121 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 120.36 2.67 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.961 1.743 . . . . 0.0 111.346 -166.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.56 -125.92 5.66 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.301 0.953 . . . . 0.0 113.785 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.07 99.48 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.346 -1.091 . . . . 0.0 110.095 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.01 28.71 58.17 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 104.24 3.26 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.91 1.684 . . . . 0.0 110.215 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 m -132.96 151.73 52.02 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.814 1.646 . . . . 0.0 113.791 -164.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.68 -160.54 14.33 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 167.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.02 31.25 0.36 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.405 2.737 . . . . 0.0 114.637 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -75.45 45.38 0.3 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.455 1.902 . . . . 0.0 111.679 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.27 114.12 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -149.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.1 t -50.33 171.35 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 125.766 1.626 . . . . 0.0 114.53 166.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.74 176.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 164.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -70.05 176.22 3.94 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -64.11 0.32 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.167 1.365 . . . . 0.0 112.088 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m 91.08 38.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.254 2.222 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 p -127.36 74.14 1.49 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.188 2.195 . . . . 0.0 112.297 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.0 68.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.754 1.222 . . . . 0.0 113.592 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -113.37 154.46 26.88 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.992 2.117 . . . . 0.0 112.884 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.84 146.89 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.62 -85.65 0.3 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.712 0.805 . . . . 0.0 109.201 151.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -94.85 144.78 28.41 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.718 1.207 . . . . 0.0 111.05 156.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -31.11 -44.65 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.441 4.094 . . . . 0.0 117.219 174.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.97 -25.7 68.25 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.349 0.0 OUTLIER -144.2 107.02 4.45 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 173.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 t -78.08 142.88 37.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.768 2.027 . . . . 0.0 113.287 165.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -128.9 -99.82 0.34 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.94 66.97 0.31 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.924 -1.735 . . . . 0.0 112.273 -160.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.896 1.278 . . . . 0.0 111.526 -170.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 7.2 m . . . . . 0 N--CA 1.495 1.789 0 N-CA-C 115.682 1.734 . . . . 0.0 115.682 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 19.4 tp60 -83.5 -50.76 7.96 Favored 'General case' 0 N--CA 1.478 0.974 0 N-CA-C 114.15 1.167 . . . . 0.0 114.15 -178.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.7 p -75.48 -76.15 0.16 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 125.199 1.4 . . . . 0.0 111.247 172.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 42.6 t-80 -65.01 107.78 1.61 Allowed 'General case' 0 CA--C 1.55 0.957 0 O-C-N 121.453 -0.78 . . . . 0.0 110.228 164.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.27 140.28 58.49 Favored 'General case' 0 CA--C 1.55 0.965 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 -179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -81.4 -74.06 1.17 Allowed Glycine 0 CA--C 1.545 1.92 0 C-N-CA 123.957 0.789 . . . . 0.0 114.597 178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 48.5 tt0 -64.87 117.14 7.13 Favored 'General case' 0 CA--C 1.557 1.23 0 N-CA-C 116.439 2.014 . . . . 0.0 116.439 -168.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -83.9 -55.0 4.47 Favored 'General case' 0 CA--C 1.561 1.403 0 C-N-CA 125.09 1.356 . . . . 0.0 111.801 149.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 75.5 167.42 21.98 Favored Glycine 0 CA--C 1.55 2.252 0 C-N-CA 125.792 1.663 . . . . 0.0 116.511 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -135.91 -119.03 1.85 Allowed Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.061 1.185 . . . . 0.0 116.061 -178.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 62.0 mt -58.72 85.1 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.161 0 C-N-CA 125.975 1.71 . . . . 0.0 113.111 -166.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 84.68 27.15 36.05 Favored Glycine 0 CA--C 1.545 1.941 0 C-N-CA 126.047 1.784 . . . . 0.0 115.803 -178.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -98.69 148.97 23.31 Favored 'General case' 0 CA--C 1.55 0.961 0 N-CA-C 114.29 1.219 . . . . 0.0 114.29 -178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.8 t -174.51 -55.59 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 126.382 1.873 . . . . 0.0 111.6 177.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -50.06 152.01 4.22 Favored Glycine 0 CA--C 1.55 2.232 0 C-N-CA 124.051 0.834 . . . . 0.0 114.269 170.262 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -74.97 71.31 5.03 Favored 'Trans proline' 0 CA--C 1.549 1.239 0 C-N-CA 123.359 2.706 . . . . 0.0 113.255 -167.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 79.9 p -75.37 43.0 0.22 Allowed 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 125.562 1.545 . . . . 0.0 112.744 172.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 14.1 p -81.9 93.74 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 116.958 2.207 . . . . 0.0 116.958 -148.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 49.5 t -63.35 158.51 20.29 Favored 'General case' 0 CA--C 1.563 1.463 0 O-C-N 120.886 -1.133 . . . . 0.0 111.761 148.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.42 -179.69 0.02 OUTLIER 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 118.273 2.694 . . . . 0.0 118.273 -177.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.3 m -51.49 86.59 0.0 OUTLIER 'General case' 0 CA--C 1.552 1.027 0 C-N-CA 129.302 3.041 . . . . 0.0 117.081 -178.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -75.77 -39.15 34.76 Favored Glycine 0 CA--C 1.545 1.942 0 C-N-CA 123.695 0.664 . . . . 0.0 114.331 175.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.269 0.5 OUTLIER 64.93 -49.46 0.34 Allowed 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 128.3 2.64 . . . . 0.0 114.862 -175.772 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 18.6 p -92.75 173.48 7.75 Favored 'General case' 0 CA--C 1.549 0.929 0 C-N-CA 125.229 1.411 . . . . 0.0 111.901 158.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.8 t -129.18 83.44 2.15 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 124.813 1.245 . . . . 0.0 112.312 -159.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -105.1 -106.43 0.3 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 124.498 1.119 . . . . 0.0 113.628 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 6.0 p -168.59 147.05 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 CA-C-N 121.596 1.998 . . . . 0.0 114.969 178.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . 0.656 HD13 ' CD2' ' A' ' 32' ' ' TYR . 0.2 OUTLIER -98.73 -60.9 1.45 Allowed 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 123.536 1.636 . . . . 0.0 110.526 155.467 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 11.7 m120 -127.67 138.56 33.11 Favored Pre-proline 0 CA--C 1.553 1.084 0 C-N-CA 128.296 2.638 . . . . 0.0 108.751 177.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo -26.35 -57.44 0.09 OUTLIER 'Trans proline' 0 CA--C 1.545 1.043 1 C-N-CA 126.224 4.616 . . . . 0.0 118.508 -166.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.2 m-30 -64.45 -35.67 81.68 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -178.194 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.656 ' CD2' HD13 ' A' ' 28' ' ' LEU . 3.2 t80 -92.84 85.64 5.25 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 125.005 1.322 . . . . 0.0 112.336 -172.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 9.6 t -69.02 49.25 0.07 Allowed 'General case' 0 CA--C 1.561 1.397 0 N-CA-C 117.086 2.254 . . . . 0.0 117.086 -170.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 69.8 tp60 -136.25 174.53 10.52 Favored 'General case' 0 CA--C 1.549 0.932 0 O-C-N 118.815 -2.428 . . . . 0.0 114.362 -158.289 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 4.8 t 60.44 90.31 0.06 Allowed 'General case' 0 CA--C 1.551 1.016 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 150.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.492 ' H ' HD12 ' A' ' 36' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.252 1.189 0 C-N-CA 128.491 2.716 . . . . 0.0 111.545 -176.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 64.4 p . . . . . 0 N--CA 1.497 1.889 0 CA-C-O 118.387 -0.816 . . . . 0.0 112.715 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 59.7 tp60 -107.49 102.81 12.05 Favored 'General case' 0 CA--C 1.555 1.148 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 -165.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 88.7 p -57.88 80.88 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 126.503 1.921 . . . . 0.0 113.687 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 12.4 t-80 -165.46 -56.02 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.153 0 C-N-CA 127.389 2.276 . . . . 0.0 109.055 -175.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.74 125.9 29.75 Favored 'General case' 0 CA--C 1.554 1.131 0 C-N-CA 124.758 1.223 . . . . 0.0 110.399 147.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.93 82.71 0.84 Allowed Glycine 0 CA--C 1.541 1.701 0 O-C-N 120.953 -1.092 . . . . 0.0 111.397 -162.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 22.1 93.57 0.01 OUTLIER 'General case' 0 CA--C 1.557 1.214 0 C-N-CA 128.521 2.728 . . . . 0.0 116.733 -175.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.4 p -42.99 -72.12 0.07 Allowed 'General case' 0 CA--C 1.56 1.337 0 C-N-CA 126.898 2.079 . . . . 0.0 115.493 164.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.3 78.08 0.04 OUTLIER Glycine 0 CA--C 1.546 2.01 0 C-N-CA 124.517 1.056 . . . . 0.0 113.812 -176.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -98.11 -122.76 4.6 Favored Glycine 0 CA--C 1.545 1.956 0 C-N-CA 125.428 1.49 . . . . 0.0 113.836 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 61.9 mt -105.01 121.03 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 O-C-N 120.872 -1.37 . . . . 0.0 111.971 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.49 27.56 38.9 Favored Glycine 0 CA--C 1.545 1.945 0 C-N-CA 124.898 1.237 . . . . 0.0 114.935 -173.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -155.38 178.17 10.53 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 126.197 1.799 . . . . 0.0 112.065 -177.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 24.0 t 179.15 -49.1 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 126.604 1.962 . . . . 0.0 111.748 171.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -59.15 147.01 42.4 Favored Glycine 0 CA--C 1.552 2.374 0 O-C-N 121.21 -0.931 . . . . 0.0 113.836 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -69.67 142.87 49.5 Favored 'Trans proline' 0 CA--C 1.549 1.261 0 C-N-CA 123.509 2.806 . . . . 0.0 113.701 -171.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.1 t -140.28 71.06 1.36 Allowed 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 123.743 1.735 . . . . 0.0 112.609 175.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.44 149.25 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.98 0 N-CA-C 116.731 2.123 . . . . 0.0 116.731 -160.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 30.8 p -95.49 -131.34 0.17 Allowed 'General case' 0 CA--C 1.559 1.293 0 C-N-CA 123.956 0.902 . . . . 0.0 113.352 166.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -83.38 -70.92 0.53 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 119.916 -1.74 . . . . 0.0 112.77 176.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 9.1 t -172.24 -178.41 2.05 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 127.824 2.45 . . . . 0.0 111.992 177.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 142.6 -34.2 1.82 Allowed Glycine 0 CA--C 1.543 1.835 0 C-N-CA 126.25 1.881 . . . . 0.0 113.998 -177.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.318 13.0 t 51.86 49.54 20.54 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 126.359 1.864 . . . . 0.0 115.155 -167.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 40.9 p -114.14 70.11 0.72 Allowed 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 127.199 2.2 . . . . 0.0 114.194 -171.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 35.4 t -66.53 70.01 0.07 Allowed 'General case' 0 CA--C 1.554 1.119 0 O-C-N 120.171 -1.581 . . . . 0.0 111.664 165.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -86.98 -162.39 0.78 Allowed 'General case' 0 CA--C 1.554 1.133 0 C-N-CA 126.664 1.986 . . . . 0.0 112.938 -178.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.5 p -144.8 132.3 16.42 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.933 0 O-C-N 120.915 -1.116 . . . . 0.0 112.677 173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.7 mp -106.26 -60.99 1.58 Allowed 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 125.129 1.371 . . . . 0.0 110.988 173.191 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -119.23 163.23 27.82 Favored Pre-proline 0 CA--C 1.558 1.258 0 C-N-CA 126.105 1.762 . . . . 0.0 109.916 161.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_exo -46.97 -35.76 19.11 Favored 'Trans proline' 0 CA--C 1.542 0.911 0 C-N-CA 124.052 3.168 . . . . 0.0 116.834 -170.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-30 -72.51 -26.64 61.85 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 178.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -127.91 129.28 46.6 Favored 'General case' 0 CA--C 1.551 0.994 0 N-CA-C 116.504 2.039 . . . . 0.0 116.504 -139.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.0 t -119.58 143.25 47.74 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 125.185 1.394 . . . . 0.0 112.661 162.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.6 -142.2 0.37 Allowed 'General case' 0 CA--C 1.557 1.245 0 C-N-CA 125.775 1.63 . . . . 0.0 111.832 -174.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 19.8 t -115.43 102.44 9.83 Favored 'General case' 0 CA--C 1.552 1.03 0 C-N-CA 126.122 1.769 . . . . 0.0 111.153 170.407 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.258 1.547 0 C-N-CA 126.193 1.797 . . . . 0.0 111.61 177.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 64.9 p . . . . . 0 N--CA 1.503 2.197 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -48.02 -80.88 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.75 2.13 . . . . 0.0 116.75 -158.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 38.9 m -94.29 -73.25 0.58 Allowed 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.9 0.88 . . . . 0.0 110.554 175.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -132.3 38.41 3.47 Favored 'General case' 0 CA--C 1.552 1.025 0 CA-C-O 122.843 1.306 . . . . 0.0 110.233 150.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -61.54 120.21 10.1 Favored 'General case' 0 CA--C 1.544 0.74 0 O-C-N 120.859 -1.15 . . . . 0.0 111.568 -176.138 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 112.32 -137.31 14.17 Favored Glycine 0 CA--C 1.543 1.783 0 C-N-CA 125.532 1.539 . . . . 0.0 111.483 -160.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 45.0 tt0 -65.35 68.86 0.04 OUTLIER 'General case' 0 CA--C 1.559 1.31 0 C-N-CA 125.802 1.641 . . . . 0.0 114.8 -178.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.5 p -46.34 -13.02 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 130.778 3.631 . . . . 0.0 119.465 -171.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 79.96 82.2 0.74 Allowed Glycine 0 CA--C 1.548 2.136 0 CA-C-N 120.286 1.403 . . . . 0.0 114.462 -170.8 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -77.79 -83.02 0.58 Allowed Glycine 0 CA--C 1.547 2.055 0 O-C-N 121.65 -0.912 . . . . 0.0 115.286 -179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 27.6 mt -129.1 130.57 68.16 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.941 0 C-N-CA 125.176 1.39 . . . . 0.0 110.384 177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.47 -57.4 1.22 Allowed Glycine 0 CA--C 1.547 2.069 0 O-C-N 121.117 -0.989 . . . . 0.0 114.363 -172.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.51 134.66 56.72 Favored 'General case' 0 CA--C 1.555 1.171 0 C-N-CA 125.16 1.384 . . . . 0.0 113.251 167.566 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.4 m -147.7 -50.42 0.18 Allowed 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.03 1.493 . . . . 0.0 115.03 -179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -63.78 -171.15 1.95 Allowed Glycine 0 CA--C 1.553 2.441 0 N-CA-C 117.139 1.615 . . . . 0.0 117.139 -176.232 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -65.41 39.85 0.13 Allowed 'Trans proline' 0 CA--C 1.56 1.787 1 C-N-CA 125.4 4.067 . . . . 0.0 118.699 -172.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.3 t -67.13 35.88 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 119.962 -1.711 . . . . 0.0 114.876 175.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 3.7 p -96.42 142.37 14.02 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.773 0 O-C-N 119.974 -1.704 . . . . 0.0 115.117 -153.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 15.6 p -79.32 -156.48 0.11 Allowed 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 125.278 1.431 . . . . 0.0 113.145 171.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.35 -147.65 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.393 0 C-N-CA 125.938 1.695 . . . . 0.0 113.498 162.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.7 t -94.17 -165.15 1.27 Allowed 'General case' 0 N--CA 1.479 0.975 0 O-C-N 120.618 -1.301 . . . . 0.0 113.991 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 132.75 -70.03 0.52 Allowed Glycine 0 CA--C 1.534 1.254 0 C-N-CA 125.981 1.753 . . . . 0.0 111.807 -178.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.6 m 86.88 37.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 126.581 1.952 . . . . 0.0 113.017 -178.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.1 p -112.96 83.39 1.82 Allowed 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 126.949 2.1 . . . . 0.0 112.67 -167.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -72.59 140.89 48.32 Favored 'General case' 0 CA--C 1.564 1.513 0 O-C-N 120.619 -1.301 . . . . 0.0 112.283 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -152.69 175.49 12.77 Favored 'General case' 0 CA--C 1.556 1.179 0 C-N-CA 125.385 1.474 . . . . 0.0 114.018 -156.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.6 p -132.34 114.67 23.94 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.159 0 C-N-CA 125.735 1.614 . . . . 0.0 112.591 163.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -86.71 -92.78 0.09 Allowed 'General case' 0 N--CA 1.48 1.045 0 O-C-N 121.238 -0.914 . . . . 0.0 108.915 162.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 15.5 p-10 -76.7 154.99 83.47 Favored Pre-proline 0 CA--C 1.562 1.435 0 O-C-N 120.404 -1.435 . . . . 0.0 110.262 148.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -44.18 -42.64 13.14 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 123.522 2.815 . . . . 0.0 114.314 176.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 71.8 m-85 -83.98 20.52 1.51 Allowed 'General case' 0 CA--C 1.556 1.21 0 N-CA-C 115.809 1.781 . . . . 0.0 115.809 177.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -146.32 96.25 2.74 Favored 'General case' 0 CA--C 1.554 1.135 0 O-C-N 120.304 -1.498 . . . . 0.0 113.514 170.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.5 t -92.94 119.07 31.84 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 126.445 1.898 . . . . 0.0 110.927 165.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -111.93 -120.23 0.29 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 -154.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.1 t -164.87 93.93 0.65 Allowed 'General case' 0 CA--C 1.547 0.849 0 O-C-N 120.342 -1.474 . . . . 0.0 111.456 -159.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.553 1.077 0 C-N-CA 126.855 2.062 . . . . 0.0 112.086 -170.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 46.2 p . . . . . 0 N--CA 1.499 1.986 0 N-CA-C 113.19 0.811 . . . . 0.0 113.19 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tp60 -64.83 111.0 2.61 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 119.315 0.961 . . . . 0.0 111.433 169.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.5 t -68.43 115.05 7.41 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 123.407 0.683 . . . . 0.0 112.588 -178.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 44.3 t-80 -94.79 -69.29 0.76 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 125.818 1.647 . . . . 0.0 111.082 174.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -135.39 103.1 5.36 Favored 'General case' 0 CA--C 1.546 0.821 0 C-N-CA 124.927 1.291 . . . . 0.0 111.327 163.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.99 -136.88 3.25 Favored Glycine 0 CA--C 1.545 1.955 0 C-N-CA 123.977 0.798 . . . . 0.0 111.231 158.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -56.45 79.8 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 177.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 23.6 p -52.11 -43.26 63.86 Favored 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.816 2.046 . . . . 0.0 113.098 166.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 92.8 152.4 29.03 Favored Glycine 0 CA--C 1.547 2.091 0 C-N-CA 124.613 1.101 . . . . 0.0 114.682 -165.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -111.59 -123.8 4.39 Favored Glycine 0 CA--C 1.541 1.661 0 C-N-CA 124.965 1.269 . . . . 0.0 111.855 175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 44.5 mt -69.4 133.73 31.36 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 O-C-N 120.493 -1.592 . . . . 0.0 111.402 173.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.39 7.55 46.62 Favored Glycine 0 CA--C 1.548 2.104 0 N-CA-C 118.539 2.176 . . . . 0.0 118.539 172.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -135.43 117.39 15.27 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-N 119.41 1.605 . . . . 0.0 110.652 -174.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 17.3 t -164.69 101.14 0.8 Allowed 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 124.433 1.093 . . . . 0.0 113.004 -173.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 165.14 -161.48 34.84 Favored Glycine 0 CA--C 1.547 2.068 0 O-C-N 121.174 -0.954 . . . . 0.0 115.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -61.44 71.18 0.09 OUTLIER 'Trans proline' 0 CA--C 1.554 1.481 0 C-N-CA 125.038 3.825 . . . . 0.0 115.065 176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.8 t -128.85 16.3 6.33 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 126.361 1.864 . . . . 0.0 113.48 175.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 p -75.44 143.79 12.82 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.278 1.584 . . . . 0.0 115.278 -159.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 42.7 t -87.74 177.0 7.14 Favored 'General case' 0 CA--C 1.558 1.282 0 C-N-CA 127.23 2.212 . . . . 0.0 112.493 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.34 176.23 0.06 Allowed 'General case' 0 CA--C 1.557 1.233 0 O-C-N 120.712 -1.243 . . . . 0.0 113.232 156.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.59 150.57 48.62 Favored 'General case' 0 N--CA 1.48 1.043 0 N-CA-C 115.511 1.671 . . . . 0.0 115.511 -173.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -153.38 -51.4 0.01 OUTLIER Glycine 0 CA--C 1.543 1.793 0 C-N-CA 125.996 1.76 . . . . 0.0 112.786 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.409 ' O ' HG22 ' A' ' 23' ' ' THR . 61.3 m 76.26 26.14 0.96 Allowed 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 126.496 1.919 . . . . 0.0 112.423 -171.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 31.5 p -135.11 73.32 1.47 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 126.603 1.961 . . . . 0.0 111.992 -160.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 26.5 t -74.1 59.46 0.74 Allowed 'General case' 0 CA--C 1.551 0.988 0 O-C-N 120.936 -1.103 . . . . 0.0 112.903 176.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . 0.269 0.0 OUTLIER -112.81 166.54 11.28 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 125.68 1.592 . . . . 0.0 112.591 175.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -102.02 146.1 10.73 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 C-N-CA 125.763 1.625 . . . . 0.0 114.66 -153.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -94.47 -67.07 0.87 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.776 1.23 . . . . 0.0 108.447 161.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -122.48 151.76 60.26 Favored Pre-proline 0 CA--C 1.555 1.161 0 C-N-CA 126.099 1.76 . . . . 0.0 108.144 155.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -35.91 -33.8 0.12 Allowed 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 124.799 3.666 . . . . 0.0 117.516 177.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.3 m-85 -98.14 94.76 7.0 Favored 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 126.869 2.067 . . . . 0.0 110.309 164.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -119.37 -149.97 0.45 Allowed 'General case' 0 CA--C 1.567 1.597 1 C-N-CA 132.906 4.482 . . . . 0.0 112.618 4.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.1 t -130.74 130.24 43.52 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 119.726 -1.859 . . . . 0.0 111.321 173.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -117.24 -116.79 0.32 Allowed 'General case' 0 CA--C 1.562 1.424 0 N-CA-C 116.317 1.969 . . . . 0.0 116.317 -145.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 23.0 t -160.65 82.47 0.67 Allowed 'General case' 0 CA--C 1.554 1.108 0 O-C-N 120.312 -1.493 . . . . 0.0 112.56 -161.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mm? . . . . . 0 C--O 1.259 1.561 0 C-N-CA 125.406 1.483 . . . . 0.0 114.291 -170.325 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.5 2.027 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.3 tm0? -111.17 -72.49 0.72 Allowed 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 124.05 0.94 . . . . 0.0 110.191 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 83.1 p -104.37 -2.42 25.5 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.682 1.593 . . . . 0.0 114.177 166.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 9.7 m80 -63.64 90.03 0.05 Allowed 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.787 1.635 . . . . 0.0 111.199 179.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.53 139.69 8.92 Favored 'General case' 0 CA--C 1.552 1.044 0 N-CA-C 115.422 1.638 . . . . 0.0 115.422 -172.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -94.74 -104.42 1.9 Allowed Glycine 0 CA--C 1.539 1.577 0 N-CA-C 110.05 -1.22 . . . . 0.0 110.05 160.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -69.15 99.4 1.12 Allowed 'General case' 0 CA--C 1.552 1.043 0 O-C-N 120.47 -1.606 . . . . 0.0 110.436 165.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 18.0 p -57.0 -40.05 75.87 Favored 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 126.469 1.908 . . . . 0.0 115.922 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.95 98.94 2.52 Favored Glycine 0 CA--C 1.544 1.893 0 C-N-CA 124.753 1.168 . . . . 0.0 111.643 -164.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.02 -86.24 1.1 Allowed Glycine 0 CA--C 1.544 1.904 0 C-N-CA 123.992 0.806 . . . . 0.0 114.976 -173.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.1 mt -133.1 124.22 49.34 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.863 0 C-N-CA 125.245 1.418 . . . . 0.0 109.62 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 76.63 -54.32 3.31 Favored Glycine 0 CA--C 1.545 1.928 0 O-C-N 120.415 -1.428 . . . . 0.0 113.221 -168.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -62.58 131.6 49.62 Favored 'General case' 0 CA--C 1.551 0.994 0 O-C-N 121.253 -1.145 . . . . 0.0 113.107 163.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 40.6 t -151.56 164.08 37.63 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 125.173 1.389 . . . . 0.0 113.335 179.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.19 -167.63 52.89 Favored Glycine 0 CA--C 1.549 2.204 0 N-CA-C 115.879 1.111 . . . . 0.0 115.879 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -68.74 60.58 1.2 Allowed 'Trans proline' 0 CA--C 1.546 1.097 0 C-N-CA 123.958 3.105 . . . . 0.0 116.999 -168.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -74.53 40.75 0.14 Allowed 'General case' 0 CA--C 1.553 1.085 0 O-C-N 119.926 -1.734 . . . . 0.0 113.672 175.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.2 p -76.64 145.24 10.63 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.252 0 N-CA-C 117.797 2.518 . . . . 0.0 117.797 -151.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -130.03 179.84 5.64 Favored 'General case' 0 CA--C 1.556 1.208 0 C-N-CA 128.307 2.643 . . . . 0.0 111.665 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -45.55 168.53 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.2 m -69.29 42.97 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.024 0 N-CA-C 118.037 2.606 . . . . 0.0 118.037 -153.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -67.66 -57.22 9.25 Favored Glycine 0 CA--C 1.542 1.776 0 C-N-CA 125.632 1.587 . . . . 0.0 115.146 -174.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.337 2.4 t 57.19 19.78 5.15 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.448 2.299 . . . . 0.0 116.194 -150.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 4.7 p -98.65 131.74 44.6 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 127.969 2.507 . . . . 0.0 112.764 -178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 33.6 t -119.03 70.84 0.84 Allowed 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 126.306 1.842 . . . . 0.0 110.651 -178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -114.11 134.86 54.6 Favored 'General case' 0 CA--C 1.559 1.32 0 N-CA-C 115.083 1.512 . . . . 0.0 115.083 -166.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.3 p -73.15 132.0 34.06 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.198 0 N-CA-C 115.999 1.851 . . . . 0.0 115.999 -169.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.9 mp -96.65 -59.81 1.74 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.575 1.15 . . . . 0.0 110.357 158.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -129.11 150.09 74.42 Favored Pre-proline 0 CA--C 1.558 1.25 0 C-N-CA 125.968 1.707 . . . . 0.0 108.704 161.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -51.18 -33.33 43.8 Favored 'Trans proline' 0 CA--C 1.547 1.153 0 C-N-CA 123.006 2.471 . . . . 0.0 115.12 -170.292 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -68.41 -15.59 63.61 Favored 'General case' 0 CA--C 1.547 0.865 0 N-CA-C 116.186 1.921 . . . . 0.0 116.186 177.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.404 0.0 OUTLIER -146.21 120.49 9.57 Favored 'General case' 0 CA--C 1.553 1.079 0 N-CA-C 116.061 1.874 . . . . 0.0 116.061 163.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.1 t -95.41 124.46 39.45 Favored 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 128.245 2.618 . . . . 0.0 111.423 175.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -116.98 165.23 13.59 Favored 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 127.558 2.343 . . . . 0.0 115.34 -160.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 8.8 t -54.82 47.0 0.0 OUTLIER 'General case' 0 CA--C 1.561 1.397 1 C-N-CA 133.464 4.706 . . . . 0.0 116.217 172.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 9.7 mp . . . . . 0 C--O 1.253 1.262 0 C-N-CA 126.926 2.09 . . . . 0.0 111.036 178.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.503 2.19 0 CA-C-O 117.74 -1.124 . . . . 0.0 113.921 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -135.0 -57.43 0.81 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 125.595 1.558 . . . . 0.0 111.998 179.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 78.0 p -64.81 64.41 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 124.209 1.004 . . . . 0.0 111.411 159.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -66.72 -53.23 35.57 Favored 'General case' 0 CA--C 1.55 0.951 0 C-N-CA 125.118 1.367 . . . . 0.0 112.48 -173.42 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -63.8 108.36 1.43 Allowed 'General case' 0 CA--C 1.548 0.899 0 C-N-CA 124.371 1.068 . . . . 0.0 113.767 -179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -64.46 -58.92 9.06 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.694 0.664 . . . . 0.0 112.639 162.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -60.37 80.77 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 125.732 1.613 . . . . 0.0 113.935 -177.826 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.6 p -38.44 -39.99 0.51 Allowed 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 116.41 2.004 . . . . 0.0 116.41 173.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 102.83 100.48 2.56 Favored Glycine 0 CA--C 1.548 2.134 0 C-N-CA 125.415 1.483 . . . . 0.0 113.266 -173.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -103.49 -169.23 25.66 Favored Glycine 0 CA--C 1.546 2.023 0 C-N-CA 124.939 1.257 . . . . 0.0 115.163 -178.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 56.2 mt -43.53 95.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 C-N-CA 124.995 1.318 . . . . 0.0 114.182 -171.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.69 15.04 66.55 Favored Glycine 0 CA--C 1.549 2.215 0 N-CA-C 117.668 1.827 . . . . 0.0 117.668 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.402 ' CE1' HG22 ' A' ' 17' ' ' THR . 0.2 OUTLIER -133.62 111.21 10.44 Favored 'General case' 0 CA--C 1.553 1.058 0 CA-C-N 119.413 1.606 . . . . 0.0 114.308 -176.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -125.69 -26.64 3.49 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 126.524 1.929 . . . . 0.0 114.275 177.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -65.03 157.63 46.15 Favored Glycine 0 CA--C 1.551 2.34 0 O-C-N 120.83 -1.169 . . . . 0.0 113.81 169.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -71.26 108.89 2.45 Favored 'Trans proline' 0 CA--C 1.547 1.13 0 C-N-CA 123.115 2.543 . . . . 0.0 114.211 -174.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.402 HG22 ' CE1' ' A' ' 13' ' ' TYR . 4.4 t -122.64 61.96 0.99 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 126.138 1.775 . . . . 0.0 108.354 151.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 8.5 p -107.71 116.38 51.05 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 -146.586 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 48.6 t -66.27 158.76 28.18 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 125.835 1.654 . . . . 0.0 113.644 166.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -69.55 -170.39 0.29 Allowed 'General case' 0 CA--C 1.556 1.2 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 175.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.2 p -69.06 86.18 0.36 Allowed 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 116.434 2.012 . . . . 0.0 116.434 -165.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -119.0 -61.21 0.27 Allowed Glycine 0 CA--C 1.549 2.172 0 C-N-CA 126.351 1.929 . . . . 0.0 112.375 160.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.1 m 78.66 45.26 0.06 Allowed 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 127.169 2.188 . . . . 0.0 112.88 171.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.1 p -113.34 102.41 10.31 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 128.453 2.701 . . . . 0.0 111.466 -174.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.7 t -75.38 43.04 0.22 Allowed 'General case' 0 CA--C 1.556 1.185 0 N-CA-C 116.292 1.96 . . . . 0.0 116.292 -168.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.3 tp-100 -95.96 163.3 13.2 Favored 'General case' 0 CA--C 1.555 1.173 0 C-N-CA 126.08 1.752 . . . . 0.0 111.154 165.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 7.2 p -132.36 143.17 40.69 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 N-CA-C 115.838 1.792 . . . . 0.0 115.838 -152.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.1 mp -72.8 -76.9 0.11 Allowed 'General case' 0 CA--C 1.551 0.984 0 C-N-CA 125.584 1.554 . . . . 0.0 110.86 164.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.8 p-10 -112.26 134.33 21.53 Favored Pre-proline 0 CA--C 1.56 1.34 0 C-N-CA 126.604 1.962 . . . . 0.0 110.936 170.132 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_exo -34.42 -37.57 0.13 Allowed 'Trans proline' 0 CA--C 1.547 1.129 1 C-N-CA 125.356 4.037 . . . . 0.0 118.13 -177.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 85.7 m-85 -80.29 20.61 0.66 Allowed 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 116.93 2.196 . . . . 0.0 116.93 -178.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.306 1.6 p90 -149.29 -162.08 1.48 Allowed 'General case' 0 CA--C 1.553 1.074 0 O-C-N 120.935 -1.103 . . . . 0.0 112.69 137.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 46.7 t -149.32 147.67 28.6 Favored 'General case' 0 N--CA 1.482 1.151 0 O-C-N 120.166 -1.584 . . . . 0.0 112.575 163.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -121.43 -112.59 0.32 Allowed 'General case' 0 CA--C 1.564 1.492 0 N-CA-C 117.088 2.255 . . . . 0.0 117.088 -152.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 35.3 t -176.68 73.5 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 124.724 1.21 . . . . 0.0 112.269 -150.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 125.901 1.68 . . . . 0.0 113.106 -172.64 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 N--CA 1.497 1.903 0 N-CA-C 114.305 1.224 . . . . 0.0 114.305 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -140.11 123.98 17.45 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 127.158 2.183 . . . . 0.0 109.552 -164.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.0 p 71.69 175.68 0.28 Allowed 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 125.326 1.451 . . . . 0.0 113.965 -165.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -72.63 66.68 0.74 Allowed 'General case' 0 CA--C 1.55 0.955 0 CA-C-O 122.645 1.212 . . . . 0.0 110.967 167.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -68.21 100.76 1.07 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 125.667 1.587 . . . . 0.0 112.613 -176.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 137.96 -117.8 1.54 Allowed Glycine 0 CA--C 1.538 1.504 0 C-N-CA 125.718 1.628 . . . . 0.0 113.199 175.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -71.77 68.12 0.61 Allowed 'General case' 0 CA--C 1.554 1.126 0 O-C-N 120.969 -1.312 . . . . 0.0 111.655 172.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 24.8 p -48.26 -32.72 7.63 Favored 'General case' 0 CA--C 1.557 1.218 0 C-N-CA 128.761 2.825 . . . . 0.0 116.211 -173.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 160.83 92.15 0.09 OUTLIER Glycine 0 CA--C 1.542 1.737 0 C-N-CA 126.666 2.079 . . . . 0.0 110.947 -175.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -75.66 155.76 47.14 Favored Glycine 0 CA--C 1.546 2.031 0 O-C-N 121.011 -1.288 . . . . 0.0 113.03 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 64.3 mt -49.85 81.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 120.701 2.25 . . . . 0.0 112.231 171.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 112.6 -47.37 1.05 Allowed Glycine 0 CA--C 1.542 1.723 0 C-N-CA 125.544 1.545 . . . . 0.0 113.625 -172.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -75.94 71.96 2.78 Favored 'General case' 0 CA--C 1.555 1.148 0 O-C-N 120.809 -1.407 . . . . 0.0 111.544 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 48.1 m -92.6 79.57 4.84 Favored 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 127.53 2.332 . . . . 0.0 111.466 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -179.78 -169.33 39.9 Favored Glycine 0 CA--C 1.547 2.072 0 N-CA-C 117.733 1.853 . . . . 0.0 117.733 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -56.08 127.73 27.25 Favored 'Trans proline' 0 CA--C 1.546 1.078 0 C-N-CA 125.038 3.825 . . . . 0.0 114.85 177.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 3.6 t 169.47 65.21 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.329 2.652 . . . . 0.0 111.01 179.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -105.63 141.54 20.73 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.035 0 C-N-CA 125.851 1.661 . . . . 0.0 112.602 -170.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 21.1 p -103.85 -141.85 0.36 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 125.008 1.323 . . . . 0.0 112.844 -178.415 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -77.79 -149.33 0.04 OUTLIER 'General case' 0 CA--C 1.555 1.145 0 O-C-N 120.565 -1.334 . . . . 0.0 112.456 173.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 81.1 p -103.34 101.91 11.84 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 125.636 1.574 . . . . 0.0 112.797 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.81 -47.74 0.02 OUTLIER Glycine 0 CA--C 1.539 1.569 0 C-N-CA 124.959 1.266 . . . . 0.0 113.439 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.7 m 65.31 29.4 11.6 Favored 'General case' 0 N--CA 1.48 1.074 0 C-N-CA 124.802 1.241 . . . . 0.0 113.39 179.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.7 p -74.7 145.28 43.23 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 125.404 1.481 . . . . 0.0 111.531 157.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 10.0 t -153.8 83.94 1.16 Allowed 'General case' 0 CA--C 1.554 1.102 0 C-N-CA 125.928 1.691 . . . . 0.0 108.674 -170.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -121.14 139.44 53.35 Favored 'General case' 0 CA--C 1.556 1.205 0 C-N-CA 126.144 1.778 . . . . 0.0 114.324 -163.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 14.7 p -65.39 123.23 17.84 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 N-CA-C 115.703 1.742 . . . . 0.0 115.703 -171.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 9.9 mp -94.18 -52.97 4.14 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-O 122.194 0.997 . . . . 0.0 110.609 158.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.9 p30 -135.6 155.72 78.1 Favored Pre-proline 0 CA--C 1.557 1.216 0 C-N-CA 126.033 1.733 . . . . 0.0 108.244 161.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -53.7 -33.06 68.16 Favored 'Trans proline' 0 CA--C 1.551 1.362 0 C-N-CA 122.329 2.019 . . . . 0.0 115.891 -168.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -75.12 -13.63 60.49 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 173.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -130.11 92.07 3.23 Favored 'General case' 0 CA--C 1.56 1.339 0 C-N-CA 127.185 2.194 . . . . 0.0 114.29 175.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 44.2 t -83.96 135.04 34.62 Favored 'General case' 0 CA--C 1.559 1.304 0 C-N-CA 124.746 1.218 . . . . 0.0 112.813 158.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -134.29 164.04 28.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.442 1.645 . . . . 0.0 115.442 -165.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 44.8 t -65.56 64.98 0.03 OUTLIER 'General case' 0 CA--C 1.555 1.172 0 C-N-CA 127.536 2.334 . . . . 0.0 114.722 176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.8 mp . . . . . 0 C--O 1.251 1.176 0 C-N-CA 126.959 2.103 . . . . 0.0 109.458 169.503 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.2 p . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 15.3 mp0 -117.9 175.7 5.55 Favored 'General case' 0 CA--C 1.552 1.046 0 C-N-CA 127.329 2.252 . . . . 0.0 111.678 -175.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -40.34 -35.35 0.42 Allowed 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 30.9 m80 -110.97 37.69 2.74 Favored 'General case' 0 CA--C 1.558 1.278 0 C-N-CA 126.757 2.023 . . . . 0.0 113.092 -178.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -134.74 120.43 19.44 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 126.59 1.956 . . . . 0.0 111.797 174.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.77 -66.13 2.11 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.157 -0.964 . . . . 0.0 111.499 -171.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 47.9 tt0 -62.14 125.4 23.74 Favored 'General case' 0 CA--C 1.548 0.903 0 C-N-CA 123.17 0.588 . . . . 0.0 110.691 150.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 27.7 p -80.42 -44.32 19.53 Favored 'General case' 0 CA--C 1.555 1.16 0 N-CA-C 114.227 1.195 . . . . 0.0 114.227 169.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 103.31 67.36 0.75 Allowed Glycine 0 CA--C 1.551 2.323 0 C-N-CA 124.704 1.145 . . . . 0.0 115.514 178.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -86.76 -146.33 9.98 Favored Glycine 0 CA--C 1.548 2.116 0 N-CA-C 118.105 2.002 . . . . 0.0 118.105 -172.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 67.8 mt -41.97 99.92 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.483 1.223 0 C-N-CA 126.61 1.964 . . . . 0.0 112.6 -171.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.86 18.7 80.12 Favored Glycine 0 CA--C 1.542 1.75 0 N-CA-C 117.106 1.603 . . . . 0.0 117.106 176.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -138.44 58.25 1.67 Allowed 'General case' 0 CA--C 1.554 1.126 0 CA-C-N 119.705 1.753 . . . . 0.0 114.741 -166.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.2 t -88.2 71.29 9.22 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.306 -1.496 . . . . 0.0 112.274 169.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -169.14 167.23 40.31 Favored Glycine 0 CA--C 1.545 1.962 0 C-N-CA 125.857 1.694 . . . . 0.0 112.176 -175.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo -69.81 116.15 4.43 Favored 'Trans proline' 0 CA--C 1.548 1.19 0 C-N-CA 122.244 1.963 . . . . 0.0 113.458 -170.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 12.5 t -147.59 63.78 1.14 Allowed 'General case' 0 N--CA 1.482 1.126 0 C-N-CA 126.212 1.805 . . . . 0.0 110.21 159.443 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.7 p -100.84 166.74 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.202 0 N-CA-C 116.761 2.134 . . . . 0.0 116.761 -138.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 37.0 t -135.54 175.41 9.62 Favored 'General case' 0 CA--C 1.563 1.461 0 C-N-CA 127.076 2.15 . . . . 0.0 113.663 -171.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.68 155.55 18.8 Favored 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.48 1.512 . . . . 0.0 113.534 164.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.8 t -61.58 141.07 58.01 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.276 1.584 . . . . 0.0 115.276 -174.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 162.0 -71.51 0.21 Allowed Glycine 0 CA--C 1.541 1.664 0 C-N-CA 124.732 1.158 . . . . 0.0 113.162 176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.262 4.5 m 93.87 45.84 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 126.438 1.895 . . . . 0.0 114.438 163.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -81.5 104.27 11.81 Favored 'General case' 0 CA--C 1.548 0.897 0 C-N-CA 126.366 1.866 . . . . 0.0 112.275 175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 6.7 t -83.26 62.85 6.9 Favored 'General case' 0 CA--C 1.549 0.926 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 -159.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.6 tp-100 -106.37 172.33 6.87 Favored 'General case' 0 CA--C 1.553 1.084 0 C-N-CA 124.843 1.257 . . . . 0.0 112.516 173.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 8.9 p -127.76 140.01 50.33 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.952 0 O-C-N 119.596 -1.94 . . . . 0.0 114.17 -157.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.8 mp -92.39 -60.05 1.93 Allowed 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.456 1.102 . . . . 0.0 111.84 173.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 66.8 m-20 -79.77 -156.21 0.0 OUTLIER Pre-proline 0 CA--C 1.56 1.362 0 C-N-CA 124.947 1.299 . . . . 0.0 111.995 171.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_exo -75.41 -60.73 0.04 OUTLIER 'Trans proline' 0 CA--C 1.548 1.183 0 C-N-CA 122.681 2.254 . . . . 0.0 110.931 134.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -67.51 78.91 0.17 Allowed 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 125.054 1.342 . . . . 0.0 113.775 179.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -173.18 175.56 3.14 Favored 'General case' 0 CA--C 1.564 1.506 0 C-N-CA 127.994 2.518 . . . . 0.0 110.707 170.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.2 t -165.16 120.21 1.33 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.582 -1.324 . . . . 0.0 112.354 134.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -103.9 -122.11 0.2 Allowed 'General case' 0 CA--C 1.554 1.124 0 C-N-CA 126.383 1.873 . . . . 0.0 112.732 -160.186 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 15.2 t -148.21 61.77 1.1 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.794 2.038 . . . . 0.0 110.479 -154.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 125.417 1.487 . . . . 0.0 111.81 -176.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.5 2.032 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 36.2 tp60 -78.59 60.04 2.6 Favored 'General case' 0 CA--C 1.553 1.067 0 CA-C-N 119.779 1.172 . . . . 0.0 111.449 170.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 60.3 m -72.25 70.57 0.84 Allowed 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 124.372 1.069 . . . . 0.0 112.008 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 70.1 m80 -142.12 -64.32 0.43 Allowed 'General case' 0 CA--C 1.546 0.793 0 C-N-CA 127.452 2.301 . . . . 0.0 110.092 -175.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -79.91 104.3 10.39 Favored 'General case' 0 CA--C 1.554 1.101 0 C-N-CA 124.479 1.112 . . . . 0.0 110.965 169.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -145.14 -99.67 0.27 Allowed Glycine 0 CA--C 1.538 1.53 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -172.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.467 ' OE1' HG22 ' A' ' 17' ' ' THR . 49.4 tt0 -59.83 101.78 0.13 Allowed 'General case' 0 CA--C 1.548 0.9 0 O-C-N 121.623 -0.927 . . . . 0.0 112.921 -175.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 14.9 p -41.91 -42.86 2.88 Favored 'General case' 0 CA--C 1.549 0.94 0 C-N-CA 125.208 1.403 . . . . 0.0 114.618 168.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 133.67 124.02 2.45 Favored Glycine 0 CA--C 1.539 1.556 0 C-N-CA 126.411 1.958 . . . . 0.0 110.701 -172.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -107.7 -138.9 8.86 Favored Glycine 0 CA--C 1.54 1.615 0 C-N-CA 124.063 0.84 . . . . 0.0 113.288 -178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 57.3 mt -96.92 102.65 13.73 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 O-C-N 121.21 -1.171 . . . . 0.0 110.72 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 72.87 49.66 16.47 Favored Glycine 0 CA--C 1.545 1.925 0 C-N-CA 125.127 1.346 . . . . 0.0 114.155 -172.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.28 122.74 0.93 Allowed 'General case' 0 CA--C 1.551 1.012 0 N-CA-C 113.284 0.846 . . . . 0.0 113.284 -167.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 13.6 m -125.67 -25.6 3.65 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.241 1.571 . . . . 0.0 115.241 -174.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -91.04 134.82 12.51 Favored Glycine 0 CA--C 1.544 1.887 0 CA-C-O 118.214 -1.326 . . . . 0.0 113.808 -178.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -46.09 80.21 0.01 OUTLIER 'Trans proline' 0 CA--C 1.546 1.093 1 C-N-CA 125.539 4.159 . . . . 0.0 116.309 174.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.475 ' O ' HG23 ' A' ' 17' ' ' THR . 1.2 t -79.92 49.81 1.12 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-O 123.806 1.765 . . . . 0.0 111.112 175.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -79.12 144.29 11.23 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 C-N-CA 126.151 1.78 . . . . 0.0 115.266 -151.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 20.5 p -74.76 -132.74 0.01 OUTLIER 'General case' 0 CA--C 1.561 1.383 0 C-N-CA 125.333 1.453 . . . . 0.0 111.774 170.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.64 166.33 0.33 Allowed 'General case' 0 CA--C 1.558 1.279 0 O-C-N 119.418 -2.051 . . . . 0.0 112.817 148.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.9 t -63.32 158.49 20.23 Favored 'General case' 0 CA--C 1.548 0.878 0 O-C-N 120.682 -1.262 . . . . 0.0 113.795 174.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -179.77 -33.89 0.06 OUTLIER Glycine 0 CA--C 1.539 1.534 0 N-CA-C 115.431 0.932 . . . . 0.0 115.431 -176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 12.6 t 47.91 22.39 0.37 Allowed 'General case' 0 N--CA 1.484 1.231 0 N-CA-C 117.324 2.342 . . . . 0.0 117.324 174.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 p -140.12 176.62 8.61 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 126.308 1.843 . . . . 0.0 112.82 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -121.7 89.12 3.06 Favored 'General case' 0 CA--C 1.554 1.106 0 N-CA-C 114.055 1.131 . . . . 0.0 114.055 -155.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -123.27 -117.29 0.29 Allowed 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 171.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 13.0 p -163.0 124.45 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.166 0 CA-C-N 121.417 1.917 . . . . 0.0 115.063 -174.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.4 mp -86.62 -67.32 0.82 Allowed 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 122.587 1.185 . . . . 0.0 110.357 162.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -118.14 154.06 51.57 Favored Pre-proline 0 CA--C 1.553 1.062 0 C-N-CA 126.346 1.858 . . . . 0.0 109.404 159.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -33.66 -55.41 0.43 Allowed 'Trans proline' 0 CA--C 1.543 0.942 0 C-N-CA 124.733 3.622 . . . . 0.0 117.14 -174.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.1 m-30 -65.4 -26.05 67.82 Favored 'General case' 0 CA--C 1.553 1.069 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 -179.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -107.52 95.21 5.54 Favored 'General case' 0 CA--C 1.558 1.258 0 C-N-CA 126.466 1.906 . . . . 0.0 113.589 -174.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 28.2 t -87.97 100.06 12.62 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.444 1.897 . . . . 0.0 114.904 174.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.434 ' CG ' ' H ' ' A' ' 35' ' ' CYS . 0.0 OUTLIER -163.11 -139.42 0.04 OUTLIER 'General case' 0 CA--C 1.556 1.177 0 C-N-CA 127.086 2.155 . . . . 0.0 108.957 170.547 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . 0.434 ' H ' ' CG ' ' A' ' 34' ' ' GLN . 0.0 OUTLIER 21.73 113.04 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.251 0 C-N-CA 129.985 3.314 . . . . 0.0 118.838 176.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.2 mp . . . . . 0 CA--C 1.553 1.087 0 C-N-CA 127.334 2.253 . . . . 0.0 111.629 -178.698 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 N--CA 1.497 1.881 0 N-CA-C 113.968 1.099 . . . . 0.0 113.968 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.53 63.58 3.38 Favored 'General case' 0 CA--C 1.555 1.143 0 CA-C-N 120.159 1.345 . . . . 0.0 111.896 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.8 m -166.03 -83.76 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 128.456 2.702 . . . . 0.0 108.458 178.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -65.12 80.81 0.05 OUTLIER 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 124.323 1.049 . . . . 0.0 110.986 159.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -85.29 68.65 10.57 Favored 'General case' 0 CA--C 1.55 0.956 0 C-N-CA 125.815 1.646 . . . . 0.0 114.991 -162.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -6.49 -89.82 0.0 OUTLIER Glycine 0 CA--C 1.549 2.205 0 C-N-CA 127.667 2.556 . . . . 0.0 118.339 179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 55.4 tt0 -80.73 83.4 6.5 Favored 'General case' 0 CA--C 1.551 1.0 0 O-C-N 121.036 -1.273 . . . . 0.0 111.41 174.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 25.2 p -34.77 -44.76 0.23 Allowed 'General case' 0 CA--C 1.556 1.174 0 C-N-CA 126.983 2.113 . . . . 0.0 116.561 -178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 107.0 74.86 0.91 Allowed Glycine 0 CA--C 1.543 1.822 0 C-N-CA 125.397 1.475 . . . . 0.0 113.604 -175.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -101.29 -122.61 5.04 Favored Glycine 0 CA--C 1.544 1.887 0 C-N-CA 124.461 1.029 . . . . 0.0 114.941 -178.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 58.5 mt -67.82 113.45 3.72 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 O-C-N 119.922 -1.928 . . . . 0.0 112.26 -166.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 57.52 37.31 81.84 Favored Glycine 0 CA--C 1.545 1.936 0 C-N-CA 125.037 1.303 . . . . 0.0 115.421 -169.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 m-85 -147.5 155.85 42.28 Favored 'General case' 0 CA--C 1.548 0.87 0 C-N-CA 125.957 1.703 . . . . 0.0 111.887 169.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 4.3 m -161.69 -37.64 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.148 0 O-C-N 121.147 -0.971 . . . . 0.0 113.253 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -69.33 166.65 47.99 Favored Glycine 0 CA--C 1.552 2.399 0 N-CA-C 115.581 0.992 . . . . 0.0 115.581 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -65.32 69.53 0.31 Allowed 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 124.295 3.33 . . . . 0.0 117.597 -170.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.2 p -72.23 53.09 0.27 Allowed 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.0 -1.688 . . . . 0.0 113.861 170.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -85.97 87.18 2.54 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.452 0 N-CA-C 117.574 2.435 . . . . 0.0 117.574 -156.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.8 t -77.3 179.58 6.31 Favored 'General case' 0 CA--C 1.565 1.528 0 C-N-CA 126.228 1.811 . . . . 0.0 114.403 171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.82 -176.94 0.0 OUTLIER 'General case' 0 CA--C 1.558 1.257 0 C-N-CA 128.572 2.749 . . . . 0.0 116.938 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.3 m -88.85 122.47 32.27 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 125.306 1.442 . . . . 0.0 114.574 -169.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -159.1 -74.72 0.02 OUTLIER Glycine 0 CA--C 1.548 2.108 0 C-N-CA 126.075 1.798 . . . . 0.0 110.6 167.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . 0.304 1.7 m 109.75 29.83 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 130.706 3.603 . . . . 0.0 114.464 146.611 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.8 p -89.52 119.63 30.12 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 126.06 1.744 . . . . 0.0 112.056 174.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.3 t -75.76 67.03 2.14 Favored 'General case' 0 CA--C 1.563 1.448 0 O-C-N 120.238 -1.539 . . . . 0.0 112.529 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 2.4 tp-100 -61.91 -177.9 0.13 Allowed 'General case' 0 CA--C 1.557 1.238 0 C-N-CA 130.69 3.596 . . . . 0.0 115.318 -178.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -149.5 135.76 12.16 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.216 0 O-C-N 119.125 -2.235 . . . . 0.0 111.955 162.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 5.7 mt -111.21 -72.54 0.71 Allowed 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 125.057 1.343 . . . . 0.0 110.852 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -59.66 177.84 0.26 Allowed Pre-proline 0 CA--C 1.556 1.201 0 C-N-CA 124.717 1.207 . . . . 0.0 109.952 154.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_exo -56.71 -60.23 0.5 Allowed 'Trans proline' 0 CA--C 1.549 1.232 0 N-CA-C 109.372 -1.049 . . . . 0.0 109.372 146.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -75.13 81.96 2.3 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 125.739 1.616 . . . . 0.0 114.926 179.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -171.35 -161.37 0.2 Allowed 'General case' 0 CA--C 1.562 1.426 0 C-N-CA 125.356 1.462 . . . . 0.0 114.147 169.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 19.9 t 171.92 85.38 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 128.543 2.737 . . . . 0.0 112.868 155.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 31.3 tt0 -76.96 153.83 34.19 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 118.353 2.723 . . . . 0.0 118.353 -160.424 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.5 t -50.05 66.45 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.109 0 C-N-CA 131.401 3.88 . . . . 0.0 116.673 168.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.4 mp . . . . . 0 CA--C 1.553 1.095 0 C-N-CA 126.991 2.116 . . . . 0.0 110.654 165.85 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 52.4 p . . . . . 0 N--CA 1.496 1.872 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -75.89 -60.97 2.09 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -171.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 45.5 p -67.12 -64.32 0.88 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.823 1.249 . . . . 0.0 112.887 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.408 ' CG ' ' HA ' ' A' ' 23' ' ' THR . 3.9 t-80 -124.09 169.42 11.7 Favored 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 126.914 2.086 . . . . 0.0 109.122 159.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.24 -133.99 0.25 Allowed 'General case' 0 CA--C 1.552 1.029 0 C-N-CA 127.168 2.187 . . . . 0.0 111.91 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -102.62 -102.48 2.67 Favored Glycine 0 CA--C 1.536 1.361 0 C-N-CA 125.519 1.533 . . . . 0.0 111.023 167.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -63.05 72.87 0.02 OUTLIER 'General case' 0 CA--C 1.557 1.225 0 C-N-CA 125.556 1.542 . . . . 0.0 114.896 -170.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 5.8 p -39.4 -38.29 0.54 Allowed 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 129.25 3.02 . . . . 0.0 116.067 175.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 112.12 99.85 2.48 Favored Glycine 0 CA--C 1.543 1.825 0 C-N-CA 125.13 1.348 . . . . 0.0 112.645 -175.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -99.86 -174.56 30.64 Favored Glycine 0 CA--C 1.544 1.881 0 N-CA-C 115.634 1.014 . . . . 0.0 115.634 179.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 65.8 mt -41.16 89.52 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.557 1.233 0 C-N-CA 126.979 2.112 . . . . 0.0 114.281 -168.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 78.03 38.15 27.24 Favored Glycine 0 CA--C 1.546 1.994 0 C-N-CA 125.646 1.594 . . . . 0.0 116.391 178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.98 57.23 1.34 Allowed 'General case' 0 CA--C 1.556 1.21 0 CA-C-N 118.618 1.209 . . . . 0.0 112.264 176.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 16.5 m -87.26 86.61 7.28 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 125.323 1.449 . . . . 0.0 114.022 -169.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -171.3 178.56 43.61 Favored Glycine 0 CA--C 1.548 2.15 0 N-CA-C 117.651 1.821 . . . . 0.0 117.651 175.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -63.06 51.27 0.13 Allowed 'Trans proline' 0 CA--C 1.551 1.363 1 C-N-CA 126.476 4.784 . . . . 0.0 118.318 -171.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.1 p -82.93 39.28 0.62 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 126.841 2.056 . . . . 0.0 113.14 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.7 p -87.43 82.97 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.146 0 N-CA-C 116.944 2.202 . . . . 0.0 116.944 -144.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 53.4 t -55.86 165.53 0.9 Allowed 'General case' 0 CA--C 1.568 1.662 0 N-CA-C 115.129 1.529 . . . . 0.0 115.129 163.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.04 -160.0 0.01 OUTLIER 'General case' 0 CA--C 1.563 1.48 0 C-N-CA 129.108 2.963 . . . . 0.0 117.549 -168.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 43.2 p -80.64 81.97 6.77 Favored 'General case' 0 N--CA 1.482 1.136 0 O-C-N 118.412 -2.68 . . . . 0.0 114.673 -176.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -85.32 -71.48 1.31 Allowed Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.198 0.904 . . . . 0.0 112.676 166.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.408 ' HA ' ' CG ' ' A' ' 4' ' ' HIS . 4.1 m 87.81 22.06 0.05 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.472 2.309 . . . . 0.0 113.12 -164.486 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 7.5 p -134.0 76.18 1.64 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.16 1.384 . . . . 0.0 111.075 -153.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 4.9 t -72.04 56.57 0.32 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 124.686 1.195 . . . . 0.0 113.402 179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 4.6 tp-100 -110.72 162.15 15.05 Favored 'General case' 0 CA--C 1.552 1.049 0 C-N-CA 128.436 2.694 . . . . 0.0 111.357 175.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 11.0 p -133.54 144.43 36.01 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.948 0 O-C-N 119.792 -1.817 . . . . 0.0 115.825 -155.365 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 6.7 mp -73.1 -69.03 0.44 Allowed 'General case' 0 CA--C 1.555 1.157 0 C-N-CA 125.266 1.427 . . . . 0.0 111.149 167.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -118.89 130.97 24.53 Favored Pre-proline 0 CA--C 1.563 1.45 0 C-N-CA 127.152 2.181 . . . . 0.0 111.249 171.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -34.17 -38.66 0.14 Allowed 'Trans proline' 0 CA--C 1.548 1.216 1 C-N-CA 125.704 4.269 . . . . 0.0 119.161 -173.352 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -70.57 32.13 0.04 OUTLIER 'General case' 0 CA--C 1.56 1.33 0 N-CA-C 116.222 1.934 . . . . 0.0 116.222 176.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -166.43 -169.21 1.35 Allowed 'General case' 0 CA--C 1.554 1.117 0 C-N-CA 127.926 2.49 . . . . 0.0 112.122 156.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 45.5 t -157.76 119.01 3.56 Favored 'General case' 0 N--CA 1.478 0.973 0 O-C-N 120.291 -1.506 . . . . 0.0 111.047 167.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -103.79 -121.91 0.2 Allowed 'General case' 0 CA--C 1.56 1.336 0 C-N-CA 126.327 1.851 . . . . 0.0 115.382 -153.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 37.0 t -153.72 73.76 0.97 Allowed 'General case' 0 CA--C 1.549 0.92 0 O-C-N 120.836 -1.165 . . . . 0.0 111.733 -156.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.141 0 C-N-CA 125.03 1.332 . . . . 0.0 111.592 -169.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 115.924 1.824 . . . . 0.0 115.924 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.1 mm-40 -86.98 74.98 9.61 Favored 'General case' 0 N--CA 1.478 0.971 0 O-C-N 119.98 -1.7 . . . . 0.0 111.605 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 7.6 t 168.69 -81.24 0.0 OUTLIER 'General case' 0 CA--C 1.55 0.975 0 C-N-CA 130.067 3.347 . . . . 0.0 108.329 -178.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -109.04 152.2 25.33 Favored 'General case' 0 CA--C 1.558 1.28 0 C-N-CA 124.534 1.134 . . . . 0.0 112.013 149.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -131.3 -162.76 1.25 Allowed 'General case' 0 CA--C 1.549 0.913 0 C-N-CA 128.947 2.899 . . . . 0.0 113.649 -169.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -79.62 -129.88 0.74 Allowed Glycine 0 CA--C 1.544 1.902 0 C-N-CA 124.202 0.906 . . . . 0.0 115.293 168.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -53.92 80.51 0.0 OUTLIER 'General case' 0 CA--C 1.553 1.093 0 C-N-CA 126.587 1.955 . . . . 0.0 115.53 -166.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 38.2 m -27.58 -41.18 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 129.51 3.124 . . . . 0.0 117.509 179.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 93.95 99.5 1.58 Allowed Glycine 0 CA--C 1.542 1.745 0 C-N-CA 125.101 1.334 . . . . 0.0 110.122 -153.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -91.11 -134.97 6.25 Favored Glycine 0 CA--C 1.54 1.647 0 C-N-CA 123.898 0.761 . . . . 0.0 113.746 -175.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 39.7 mt -85.51 115.86 27.79 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.935 0 O-C-N 121.233 -1.157 . . . . 0.0 109.666 175.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 60.45 41.17 98.49 Favored Glycine 0 CA--C 1.548 2.154 0 N-CA-C 116.359 1.304 . . . . 0.0 116.359 -177.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 48.4 t80 -162.39 122.29 2.4 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 125.894 1.677 . . . . 0.0 110.402 179.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 18.2 m -160.48 168.51 24.95 Favored 'General case' 0 N--CA 1.481 1.087 0 N-CA-C 114.776 1.399 . . . . 0.0 114.776 -164.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.12 -162.54 29.84 Favored Glycine 0 CA--C 1.548 2.137 0 C-N-CA 125.283 1.42 . . . . 0.0 114.812 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -67.34 56.38 0.6 Allowed 'Trans proline' 0 CA--C 1.551 1.37 0 C-N-CA 124.608 3.539 . . . . 0.0 115.448 179.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 9.8 t -123.87 66.21 1.04 Allowed 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 126.407 1.883 . . . . 0.0 110.814 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -132.26 157.07 43.01 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.027 0 C-N-CA 125.746 1.618 . . . . 0.0 114.069 -157.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 4.5 t -121.69 171.66 8.69 Favored 'General case' 0 CA--C 1.558 1.283 0 C-N-CA 127.073 2.149 . . . . 0.0 112.583 -175.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -51.68 -123.65 0.0 OUTLIER 'General case' 0 CA--C 1.56 1.365 0 C-N-CA 129.156 2.982 . . . . 0.0 117.599 -171.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.73 160.14 16.99 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 120.054 -1.653 . . . . 0.0 112.198 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 174.66 -57.2 0.12 Allowed Glycine 0 CA--C 1.539 1.545 0 C-N-CA 124.061 0.839 . . . . 0.0 111.854 179.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.6 m 92.4 32.89 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 127.758 2.423 . . . . 0.0 112.513 176.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 12.7 p -137.38 72.93 1.43 Allowed 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 124.631 1.172 . . . . 0.0 113.147 -152.087 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -69.64 123.2 20.74 Favored 'General case' 0 CA--C 1.561 1.368 0 O-C-N 120.726 -1.234 . . . . 0.0 111.176 172.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 9.9 tp-100 -147.05 -179.8 7.07 Favored 'General case' 0 CA--C 1.558 1.284 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 -152.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 3.3 p -132.91 95.93 2.11 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.301 0 C-N-CA 126.476 1.91 . . . . 0.0 112.957 175.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 10.5 mp -74.91 -50.34 17.19 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.215 -1.553 . . . . 0.0 110.68 163.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.7 p30 -131.23 164.24 43.74 Favored Pre-proline 0 CA--C 1.561 1.397 0 C-N-CA 126.844 2.058 . . . . 0.0 108.387 153.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -51.54 -34.6 52.73 Favored 'Trans proline' 0 CA--C 1.547 1.138 0 CA-C-N 122.479 1.921 . . . . 0.0 115.198 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.8 m-85 -78.66 -6.08 54.74 Favored 'General case' 0 CA--C 1.558 1.275 0 N-CA-C 114.375 1.25 . . . . 0.0 114.375 175.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.86 95.73 4.17 Favored 'General case' 0 CA--C 1.56 1.333 0 O-C-N 120.304 -1.498 . . . . 0.0 114.636 -176.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 42.4 t -85.53 136.77 33.27 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 125.726 1.61 . . . . 0.0 112.08 153.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -122.4 -120.05 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 N-CA-C 114.204 1.187 . . . . 0.0 114.204 -169.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 42.3 t -170.39 78.61 0.09 Allowed 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.086 0.954 . . . . 0.0 111.051 -153.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mm? . . . . . 0 C--O 1.251 1.154 0 C-N-CA 125.12 1.368 . . . . 0.0 111.51 -171.066 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.492 1.658 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 20.1 mp0 -58.74 -31.81 68.67 Favored 'General case' 0 CA--C 1.558 1.261 0 O-C-N 120.886 -1.134 . . . . 0.0 111.867 158.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 58.3 p -66.44 9.58 0.16 Allowed 'General case' 0 CA--C 1.556 1.194 0 C-N-CA 127.503 2.321 . . . . 0.0 116.853 161.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -127.03 172.79 10.18 Favored 'General case' 0 CA--C 1.55 0.946 0 C-N-CA 126.28 1.832 . . . . 0.0 110.434 169.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -62.0 89.36 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.003 0 O-C-N 120.996 -1.065 . . . . 0.0 113.162 171.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -75.67 -103.73 0.12 Allowed Glycine 0 CA--C 1.534 1.238 0 N-CA-C 109.325 -1.51 . . . . 0.0 109.325 146.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 7.8 tt0 -46.44 107.55 0.11 Allowed 'General case' 0 CA--C 1.554 1.133 0 CA-C-N 117.634 0.717 . . . . 0.0 112.52 152.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 26.5 p -62.78 -50.39 71.22 Favored 'General case' 0 CA--C 1.554 1.105 0 O-C-N 120.024 -1.672 . . . . 0.0 113.373 178.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 122.08 117.22 2.43 Favored Glycine 0 CA--C 1.544 1.875 0 C-N-CA 126.31 1.91 . . . . 0.0 112.477 -168.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -102.09 -85.48 1.87 Allowed Glycine 0 CA--C 1.54 1.648 0 C-N-CA 124.342 0.972 . . . . 0.0 113.964 -174.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 76.8 mt -125.42 131.23 72.48 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.878 0 C-N-CA 125.474 1.509 . . . . 0.0 109.74 174.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.74 -55.76 2.57 Favored Glycine 0 CA--C 1.546 1.979 0 O-C-N 120.832 -1.168 . . . . 0.0 114.146 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -77.4 90.73 3.82 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 124.587 1.155 . . . . 0.0 112.191 174.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 69.0 m -90.82 78.47 6.09 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.778 1.231 . . . . 0.0 112.728 178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 142.6 -177.47 21.71 Favored Glycine 0 CA--C 1.547 2.077 0 C-N-CA 124.897 1.237 . . . . 0.0 115.534 176.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -74.62 166.19 29.93 Favored 'Trans proline' 0 CA--C 1.538 0.693 0 C-N-CA 124.224 3.283 . . . . 0.0 114.914 -179.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.442 HG23 ' H ' ' A' ' 18' ' ' VAL . 5.1 t -179.42 -60.11 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 126.654 1.981 . . . . 0.0 111.588 -170.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 17' ' ' THR . 84.3 t -95.16 144.95 8.89 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.108 0 C-N-CA 125.828 1.651 . . . . 0.0 112.106 174.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 2.4 t 84.97 173.16 0.06 Allowed 'General case' 0 CA--C 1.558 1.27 0 C-N-CA 127.35 2.26 . . . . 0.0 114.751 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -88.32 -170.05 2.8 Favored 'General case' 0 CA--C 1.555 1.166 0 C-N-CA 124.418 1.087 . . . . 0.0 111.05 158.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.1 p -66.8 115.62 6.79 Favored 'General case' 0 N--CA 1.479 1.005 0 O-C-N 120.352 -1.468 . . . . 0.0 114.37 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.87 -49.99 0.15 Allowed Glycine 0 CA--C 1.546 2.011 0 C-N-CA 126.045 1.784 . . . . 0.0 114.666 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.9 m 71.52 24.38 3.61 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 125.633 1.573 . . . . 0.0 114.277 175.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 22.6 p -103.58 83.63 2.18 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 126.54 1.936 . . . . 0.0 111.064 177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.7 t -70.15 65.47 0.26 Allowed 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 114.806 1.41 . . . . 0.0 114.806 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 39.4 tp60 -120.81 157.73 29.11 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 128.301 2.641 . . . . 0.0 111.6 177.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 4.1 p -111.06 152.88 12.94 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 C-N-CA 127.374 2.27 . . . . 0.0 115.935 -165.236 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 8.9 mp -90.17 -76.76 0.42 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.623 1.969 . . . . 0.0 109.383 160.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 19.7 p-10 -109.13 138.33 20.39 Favored Pre-proline 0 CA--C 1.564 1.488 0 C-N-CA 126.403 1.881 . . . . 0.0 112.078 168.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_exo -26.31 -52.31 0.09 OUTLIER 'Trans proline' 0 CA--C 1.546 1.076 1 C-N-CA 126.331 4.688 . . . . 0.0 119.288 -175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.9 m-30 -74.76 24.65 0.09 Allowed 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 116.282 1.956 . . . . 0.0 116.282 -174.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.8 p90 -159.76 173.14 16.47 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 125.109 1.363 . . . . 0.0 114.185 160.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 40.9 t -141.1 127.26 19.59 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.695 1.198 . . . . 0.0 111.631 170.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -98.97 -125.62 0.16 Allowed 'General case' 0 CA--C 1.561 1.37 0 C-N-CA 125.164 1.386 . . . . 0.0 114.588 -165.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 49.9 t -166.86 101.49 0.56 Allowed 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 130.162 3.385 . . . . 0.0 106.034 -157.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.3 mp . . . . . 0 C--O 1.254 1.333 0 C-N-CA 126.092 1.757 . . . . 0.0 111.982 -163.205 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 1.9 m . . . . . 0 N--CA 1.497 1.894 0 N-CA-C 114.332 1.234 . . . . 0.0 114.332 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -163.14 79.03 0.45 Allowed 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 126.661 1.984 . . . . 0.0 110.917 -167.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 t 49.04 48.91 20.28 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 120.877 -1.139 . . . . 0.0 112.396 -163.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 45.3 t-80 -156.96 -114.1 0.02 OUTLIER 'General case' 0 CA--C 1.551 1.018 0 C-N-CA 125.121 1.368 . . . . 0.0 110.169 -178.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -48.91 143.78 5.18 Favored 'General case' 0 CA--C 1.555 1.149 0 O-C-N 119.986 -1.697 . . . . 0.0 113.258 160.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 73.42 -151.75 45.46 Favored Glycine 0 CA--C 1.544 1.865 0 N-CA-C 111.663 -0.575 . . . . 0.0 111.663 -155.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 54.3 tt0 -64.13 83.24 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 122.111 0.958 . . . . 0.0 112.348 174.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . . . . . . . . . 4.8 p -40.4 -56.52 2.0 Allowed 'General case' 0 CA--C 1.547 0.841 0 C-N-CA 128.376 2.67 . . . . 0.0 115.121 172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 121.9 120.36 2.67 Favored Glycine 0 CA--C 1.542 1.751 0 C-N-CA 125.961 1.743 . . . . 0.0 111.346 -166.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -100.56 -125.92 5.66 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 124.301 0.953 . . . . 0.0 113.785 -175.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 69.5 mt -98.07 99.48 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.936 0 O-C-N 121.346 -1.091 . . . . 0.0 110.095 -179.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.01 28.71 58.17 Favored Glycine 0 CA--C 1.548 2.149 0 N-CA-C 116.479 1.352 . . . . 0.0 116.479 -179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -150.08 104.24 3.26 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 125.91 1.684 . . . . 0.0 110.215 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 38.7 m -132.96 151.73 52.02 Favored 'General case' 0 CA--C 1.551 1.002 0 C-N-CA 125.814 1.646 . . . . 0.0 113.791 -164.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.68 -160.54 14.33 Favored Glycine 0 CA--C 1.547 2.06 0 N-CA-C 115.93 1.132 . . . . 0.0 115.93 167.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -75.02 31.25 0.36 Allowed 'Trans proline' 0 CA--C 1.553 1.436 0 C-N-CA 123.405 2.737 . . . . 0.0 114.637 -169.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 5.4 t -75.45 45.38 0.3 Allowed 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 126.455 1.902 . . . . 0.0 111.679 170.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -109.27 114.12 46.04 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.014 0 N-CA-C 115.025 1.491 . . . . 0.0 115.025 -149.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.1 t -50.33 171.35 0.03 OUTLIER 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 125.766 1.626 . . . . 0.0 114.53 166.417 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -50.74 176.14 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.124 0 N-CA-C 114.645 1.35 . . . . 0.0 114.645 164.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.0 t -70.05 176.22 3.94 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 114.977 1.473 . . . . 0.0 114.977 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 156.73 -64.11 0.32 Allowed Glycine 0 CA--C 1.535 1.333 0 C-N-CA 125.167 1.365 . . . . 0.0 112.088 -175.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m 91.08 38.08 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 127.254 2.222 . . . . 0.0 113.306 179.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 11.4 p -127.36 74.14 1.49 Allowed 'General case' 0 CA--C 1.543 0.707 0 C-N-CA 127.188 2.195 . . . . 0.0 112.297 -165.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 8.2 t -69.0 68.88 0.17 Allowed 'General case' 0 CA--C 1.559 1.298 0 C-N-CA 124.754 1.222 . . . . 0.0 113.592 179.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 8.3 tp-100 -113.37 154.46 26.88 Favored 'General case' 0 CA--C 1.557 1.23 0 C-N-CA 126.992 2.117 . . . . 0.0 112.884 -178.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 9.0 p -89.84 146.89 5.63 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.117 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 -161.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 7.4 mp -94.62 -85.65 0.3 Allowed 'General case' 0 N--CA 1.48 1.028 0 C-N-CA 123.712 0.805 . . . . 0.0 109.201 151.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 23.2 p-10 -94.85 144.78 28.41 Favored Pre-proline 0 CA--C 1.561 1.38 0 C-N-CA 124.718 1.207 . . . . 0.0 111.05 156.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -31.11 -44.65 0.14 Allowed 'Trans proline' 0 CA--C 1.545 1.044 1 C-N-CA 125.441 4.094 . . . . 0.0 117.219 174.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -63.97 -25.7 68.25 Favored 'General case' 0 CA--C 1.555 1.151 0 N-CA-C 116.16 1.911 . . . . 0.0 116.16 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . 0.349 0.0 OUTLIER -144.2 107.02 4.45 Favored 'General case' 0 CA--C 1.558 1.282 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 173.283 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.5 t -78.08 142.88 37.83 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 126.768 2.027 . . . . 0.0 113.287 165.245 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tm0? -128.9 -99.82 0.34 Allowed 'General case' 0 CA--C 1.556 1.175 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -157.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' CYS . . . . . . . . . . . . . 5.6 t -160.94 66.97 0.31 Allowed 'General case' 0 CA--C 1.547 0.858 0 O-C-N 119.924 -1.735 . . . . 0.0 112.273 -160.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.126 0 C-N-CA 124.896 1.278 . . . . 0.0 111.526 -170.229 . . . . . . . . 1 1 . 1 stop_ save_